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2. Abstract 
 
 
 
The generation of the first blood cells in the vertebrate embryo is spatially, temporally 
and molecularly closely linked to vasculogenesis pointing to a close developmental 
relationship between endothelial and hematopoietic cells. However, despite decades of 
long research, it still remains disputed whether blood cells arise directly from mesoderm, 
from a common endothelial-hematopoietic precursor or from hemogenic endothelium.  
Employing a new imaging and tracking technology we address the question of the 
existence of hemogenic endothelium. This novel imaging technology allows one to 
constantly follow the fate of all cells in a culture at the single cell level over long periods 
of time. To examine whether endothelium can generate blood, we used a well 
established mesodermal differentiation system of mouse embryonic stem cells (ESCs) in 
addition to purified primary cells from mouse embryos, imaged the appearance of 
endothelial and hematopoietic cells from their mesodermal precursors by time lapse 
microscopy followed by single cell tracking.  
We could observe that blood cells can be generated from endothelial cells. Clonal 
endothelial colonies arising from single mesodermal Flk1+-cells contain hemogenic and 
non-hemogenic subsets of endothelial cells. Both share the same phase contrast 
morphology and the capacity to take up acetylated low density lipoprotein – exclusive 
characteristics of endothelial cells in ESC-derived cultures at this developmental stage. In 
addition the endothelial nature of the blood precursors was verified by the expression on 
vascular endothelial (VE)-Cadherin and the formation of tight junctions that contain the 
endothelial-specific protein Claudin-5. 
Despite their typical hematopoietic morphology endothelium-derived blood cells 
expressed the pan-hematopoietic markers CD45 and partly Mac1, a surface molecule 
being detectable on cells of the myeloid lineage. In addition, we characterized the 
hemogenic endothelial cells by their expression of CD41, c-kit and Tie2. Not only the 
expression of markers but also the characteristic sequence of cellular behaviour with 
highly similar kinetics was highly reproducible between ESC-derived and embryo-derived 
cultures suggesting that this process is precisely regulated at the cellular and molecular 
level. 
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In summary we show direct evidence that endothelial cells can act as direct precursors 
of hematopoietic cells. By continuously observing the whole process of endothelial to 
blood cell transition at the single cell level, we can rule out the longstanding doubts 
about the existence of hemogenic endothelial cells and provide insights into the cellular 
and molecular processes involved in their regulation. 
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3. Introduction 
 
 
3.1. The hematopoietic system: overview and function 
The hematopoietic system is highly regenerative. In contrast to other organs in the body 
like the brain or the skeleton, blood and skin can recover very fast and efficiently if 
larger portions are removed. Most blood cells have a short life time and are continuously 
lost and regenerated. Each day an adult human loses about 1011 blood cells that have to 
be replaced (Gilbert, 2003). As the hematopoietic system recovers in a highly efficient 
manner, hematopoietic cells can be removed from the organism without harming it. This 
makes blood easily accessible for research and consequently has led to the broad 
knowledge about the hematopoietic system and its stem cell biology which made blood 
one of the best understood tissues. 
The hematopoietic system of vertebrates consists of more than 9 lineages which can be 
subdivided in myeloid and lymphoid blood cells. Myeloid cells contain erythrocytes, 
megakaryoyctes, monocytes and granulocytes of different subtypes whereas the B and T 
cells as well as dendritic and natural killer cells are lymphoid. Erythrocytes perform 
oxygen and carbon dioxide transport to and from peripheral tissues and organs, whereas 
megakaryocytes are responsible for blood clotting. Monocytes and granulocytes fulfill the 
innate immune response by engulfing pathogens, dead cells and debris from the body or 
killing pathogens by secretion of cytotoxic substances. In contrast, lymphoid cells protect 
the body from invaders by the adaptive immune response (Janeway et al., 1999). 
In accordance with these functions the hematopoietic system is a flexible system that is 
in constant flux and movement. This allows fighting invaders at different peripheric or 
central locations within the body, removal apoptotic cells and guarantees proper gas 
exchange in all areas. 
 
3.2. Adult and embryonic hematopoiesis 
3.2.1. Adult hematopoiesis 
According to the current model of the stem cell hierarchy, all blood cells found in the 
adult organism originate from hematopoietic stem cells (HSCs). Based on their ability to 
either self-renew leading to the production of more stem cells, or to differentiate into 
cells of all different blood lineages, the HSCs can give rise to a complete new 
hematopoietic system, e.g. if transplanted into lethally irradiated recipients. This 
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distinguishes the long-term repopulating HSCs (LTR-HSCs) from more committed 
progenitors that have lost the potential to provide multi-lineage reconstitution for the 
entire life (Orkin, 2000). 
The continuous production of sufficient but not excessive numbers of blood cells of all 
lineages and the equilibrium between undifferentiated and differentiated cells has to be 
tightly controlled as its loss leads to the acquisition of anaemia and leukaemia (Orkin, 
2000).  
The control of the blood stem cell pool is mainly maintained by the bone marrow, the 
niche for the HSCs as well as for many progenitors and differentiated blood cells (Zhang, 
J. et al., 2003). Containing a variety of cell types like fibroblasts, adipocytes, endothelial 
cells and osteoblasts (Rattis et al., 2004; Coultas et al., 2005), as well as the 
extracellular matrix components (Whetton et al., 1999; Arai et al., 2004) the niche is a 
specialized local microenvironment. Growth factors, cytokines, survival factors and other 
substances are secreted by cells in the niche that altogether support and control 
differentiation and proliferation (Morrison et al., 2008). 
 
3.2.2. Embryonic hematopoiesis 
The hematopoietic cell pool and the stem cell hierarchy is already formed during 
embryogenesis and was shown to be molecularly, spatially and temporally highly 
conserved between fish (Amatruda et al., 1999), birds (Godin et al., 2005), amphibians 
(Turpen, 1998) and mammals (Baron, 2003). In all vertebrates, embryonic 
hematopoiesis occurs in two waves, the primitive (or ventral) and the definitive (or 
dorsal) wave, which distinguishes transiently present (primitive) and adult type 
(definitive) blood lineages. In mammals, besides the yolk sac, the aorta-gonads-
mesonephros (AGM) region, the placenta and the foetal liver are involved in the 
establishment of the hematopoietic system before the bone marrow takes over some 
time before birth (Figure 1.1) (Baron, 2003; Mikkola et al., 2006).  
In the following, the establishment of the mouse hematopoietic system is explained.  
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3.2.2.1. Primitive hematopoiesis 
Primitive blood containing erythrocytes, macrophages and megakaryocytes, is short lived 
and only produced between embryonic day (E) 6.5 and E10.5 (Palis et al., 1999; 
Lichanska et al., 2000) These cells are named “primitive” as they morphologically 
resemble the blood cells in lower vertebrates. Primitive erythroid cells differ from their 
adult type counterpart by significantly larger size, an additional haemoglobin-type and by 
the presence of a nucleus. They can also enucleate between E12.5 and E16.5 of mouse 
development, though, and circulate as primitive erythroblasts until 5 days after birth 
(Kingsley et al., 2004).  
Primitive megakaryocytes and macrophages are poorly characterized. Primitive 
macrophages share several characteristics with the adult macrophages as e.g. the 
expression of typical surface markers and the ability for phagocytosis. In contrast to 
definitive macrophages, they bypass the monocyte-stage, do not produce peroxidase 
and lysozyme enzymes. Macrophages in the embryo contribute to tissue remodelling by 
their capacity to engulf dead cells and debris (Lichanska et al., 2000; Shepard et al., 
2000). Similarly, primitive megakaryocytes resemble their adult type counterparts 
Figure 1.1: Embryonic hematopoiesis is established in many sites in the developing 
mouse. Hematopoiesis occurs in two waves, the primitive and the definitive. The yolk sac (YS) 
produces blood cells first, followed by the aorta-gonads-mesonephros region (AGM) and the 
placenta. The fetal liver expands the blood cell pool. Before birth, hematopoiesis shifts to the bone 
marrow where the blood stem cell pool is maintained. With the onset of circulation at around 
E8.25, blood cells start to circulate through the embryo. Figure modified from Baron, 2003 and 
Mikkola et al., 2006. 
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although they show reduced polyploidy. Their protein expression and their ability to 
produce platelets are comparable to adult megakaryocytes (Tober et al., 2007).  
All primitive hematopoietic cells originate exclusively in the yolk sac (YS) (Palis et al., 
1999; Lux et al., 2008). In contrast to the adult hematopoietic system, primitive blood 
cells are not thought to arise from a HSC but rather to differentiate directly from 
mesodermal precursors. These originate from the primitive streak, which forms with the 
onset of gastrulation at E6.5 at the region that will ultimately form the posterior portion 
of the embryo (Lawson et al., 1991; Huber et al., 2004; Gadue et al., 2005). With 
ongoing development, the primitive streak extends towards the distal end of the embryo 
and gives rise to the extraembryonic mesoderm that will differentiate into allantois, 
amnion, blood, endothelium and vascular smooth muscle of the YS (Kinder et al., 1999; 
Tam et al., 2004).  
Primitive blood cells accumulate in blood islands which are structures embedded 
between visceral endoderm and mesothelium and consist of hematopoietic cells 
surrounded by endothelial cells. The latter fuse with ongoing development to form the 
first vascular plexus. Microscopic analysis suggested that blood islands form by E7.5 
(Palis et al., 1995), but primitive erythroblast activity is detectable from E6.5 on (Palis et 
al., 1999). Consistent with the recent finding that blood islands are of polyclonal origin, 
this indicates that primitive blood cells arise before the development of blood islands 
which form later from accumulating angioblasts and primitive erythroblasts (Ferkowicz et 
al., 2005; Ueno et al., 2006). 
 
3.2.2.2. Definitive hematopoesis 
During definitive hematopoiesis, blood cells are generated that are morphologically, 
functionally and molecularly identical to hematopoietic cells produced in postnatal life. 
They can be found in the embryo as soon as day E9.0 and initially consist of myeloid 
cells before lymphoid cells are produced from day E10.5 on (Palis et al., 1999; Douagi et 
al., 2002; Yokota et al., 2006). Many anatomical sites participate in the establishment of 
definitive hematopoiesis: the yolk sac (YS), the aorta-gonads-mesonephros (AGM) 
region, the placenta and the foetal liver. However, as soon as the onset of circulation 
has started between E8.25 and E8.5, the question of where hematopoietic cells arise or 
migrate to is difficult to answer (Downs et al., 1998). In the line with this, the origin of 
the LTR-HSCs is still strongly debated (Dzierzak et al., 2008). 
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3.2.2.2.1. The yolk sac produces adult type blood cells 
Apart from primitive blood, the YS can give rise to definitive type blood. Consisting of 
undifferentiated precursors and differentiated myeloid cells, definitive type blood is 
generated in the YS from day E7.0 on (Palis et al., 1999; Lux et al., 2008). However, 
whether these cells are produced from HSCs or whether they have the capacity to 
circumvent the stem cell hierarchy and directly differentiate from a mesodermal 
progenitor cell is unclear at the moment as controversial results exist about the potential 
of YS cells to generate HSCs. Initially, fusing a chicken YS to a quail embryonic body 
before the establishment of the circulatory system provided evidence that HSCs 
contributing to adult hematopoiesis are exclusively produced by the embryo proper. With 
the onset of circulation, chicken YS-derived cells share a common blood system with 
cells derived from the quail embryo. As identified by the distinct chromatin distribution in 
quail and chicken cells, the origin of adult type HSCs was found exclusively in the quail 
embryo whereas the YS did not contribute to the adult stem cell pool (Dieterlen-Lievre, 
1975; Beaupain et al., 1979).  
Opposing evidence was shown by Yoder and co-workers who transplanted murine E9.0 
and E10.0 YS cells into livers of newborn recipients. Transplanted cells contributed to the 
lymphoid and the myeloid system in adult primary and secondary recipients which 
confirmed the presence of adult LTR-HSCs in the YS (Yoder et al., 1997a; Yoder et al., 
1997b). However, the primary transplantation only succeeded when cells were injected 
into neonatal, but not adult mice, suggesting that the HSCs have not acquired the full 
potential for adult engraftment yet. Furthermore, as the circulatory system is established 
prior to the detection of HSCs, emigration of intraembryonically produced HSCs cannot 
be excluded and several independent groups obtained opposing results to Yoder’s 
studies. As lymphoid cells are believed to arise from HSCs, the detection of lymphoid 
cells was taken as indicator for the presence of HSCs (Nishikawa et al., 2000). In vitro 
cultured YS tissue isolated before the onset of the heartbeat was shown not to give rise 
to B-lymphoid cells (Nishikawa et al., 1998b). Similarly, Yokota and co-workers used the 
lymphoid-specific protein RAG1 as a specific read out and were unable to detect RAG1+ 
cells in YS of E8.0 embryos (Yokota et al., 2006). Likewise, transplantation of in vitro 
cultured E8.0 extra-embryonic YS cells into mice resulted in short-term repopulation 
ability limited to myeloid but not lymphoid potential pointing to the absence of multi-
potent HSCs in the E8.0 YS (Cumano et al., 1996; Cumano et al., 2001). In addition, 
embryos lacking a functional vascular system confirmed the emergence of definitive type 
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erythro-myeloid but not lymphoid precursors in the YS: vascular endothelial (VE-) 
Cadherin-deficient embryos showing impaired endothelial adherence junctions are 
unable to establish a functional vascular system connecting the embryo proper to the YS. 
YS cells isolated from these mice at the age of E9.5 and E10.5 can produce definitive 
type multi-potent hematopoietic cells of the myeloid lineage but are devoid of lymphoid 
potential l(Rampon et al., 2003). Whereas these studies show the intrinsic capacity of 
the YS to give rise to adult type myeloid cells, they indicate that adult type multi-potent 
HSCs with lymphoid potential are not produced in the YS. 
In contrast to these findings, recent results showed that YS-derived definitive type blood 
cells can contribute to the adult HSC pool. Lineage tracing of YS-derived blood cells 
labelled by a genetic marker at E7.5 allowed the identification of YS-derived cells in the 
adult bone marrow thereby verifying that cells emerging in the YS do participate in the 
adult hematopoietic system (Samokhvalov et al., 2007).  
Taken together, this indicates that the mouse YS does have the intrinsic capacity to 
produce adult type hematopoietic cells of the myeloid and erythroid lineage but was not 
observed to have lymphoid potential. In addition, the YS probably also produces adult 
HSCs. 
 
The generation of both primitive and definitive blood cells in the YS suggested that they 
directly relate to one another. Although both arise from Flk1+ cells (Kennedy et al., 
1997), a direct relation between both populations is unlikely. Lineage tracing 
experiments in Xenopus have shown that primitive and definitive blood cells already 
originate from different blastomeres in the blastocyst (Ciau-Uitz et al., 2000). However, 
while this proves that primitive and definitive lineages are not directly related in 
amphibians, it is still outstanding whether this is also the case in mammals. 
 
3.2.2.2.2. The aorta-gonads-mesonephros (AGM) region produces hematopoietic 
stem cells (HSCs) and progenitors 
In addition to the YS, blood cells were found to be produced from the para-aortic 
splanchnopleural (P-Sp) / aorta-gonads-mesonephros (AGM) region that exists from day 
E8.0 of mouse development. The splanchnopleural mesoderm initially differentiates into 
the P-Sp that gives rise to the aorta, the gonads and the mesonephros by E10.0 
(Cumano et al., 1996; Medvinsky, A. et al., 1996). Multi-lineage progenitors were 
identified in the P-Sp between E7.5 and E8.0 which – in contrast to YS cells of mice with 
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the same age – even could produce cells of the lymphoid lineage (Cumano et al., 1996). 
Furthermore, explant cultures of AGM regions could show that adult type HSCs with the 
capacity to reconstitute adult lethally or sub-lethally irradiated mice not only reside in 
this area between E8.0 and E11.0, but are also generated there intrinsically, 
independently of YS or foetal liver tissues (Medvinsky, A. L. et al., 1993; Medvinsky, A. 
et al., 1996; Cumano et al., 2001). Whereas the urogenital ridges and the mesonephros 
are only weakly hemogenic, the aorta has high hematopoietic activity. Notably, 
histological analysis could identify hematopoietic cell clusters in the lumen of the aorta 
sticking to the ventral vessel wall (de Bruijn et al., 2000). Recent studies gained more 
knowledge about this specific localization and showed that, in contrast to the dorsal wall, 
only the ventral portion of the dorsal aorta could initiate the production and support the 
expansion of hematopoietic progenitors and stem cells at E10.5 and E11.5 (Taoudi et al., 
2007).  
However, the cellular origin of the hematopoietic clusters is unclear. Interestingly, 
hematopoietic activity of the AGM region was found beginning E8.5 - remarkably prior to 
the appearance of intraaortic hematopoietic clusters arising at E10.5 (Medvinsky, A. et 
al., 1996; Godin et al., 2005). Subaortic localized blood cells were identified in addition 
to the intraaortic hematopoietic clusters initially in birds, later also in mice (Jaffredo et 
al., 2000). Bertrand et al. found a continuous distribution of cells expressing 
hematopoietic markers between the sub-aortic mesentery and the aorta in mice which 
points to hematopoietic cells migrating between the aorta and the subaortic patches 
(Bertrand et al., 2005). In birds, these paraaortic foci were shown to originate from the 
intraaortic hematopoietic clusters (Jaffredo et al., 1998). This suggests that in birds, 
blood or hemogenic cells from the aortic compartment ingress into the underlying tissue. 
As hemogenic activity can be detected prior to the intraaortic clusters in mice, a different 
mechanism has been postulated in that hematopoietic cells or their precursors emerge in 
the subaortic patches and migrate towards the aorta to pass its wall and enter its lumen 
(Godin et al., 2005). The fact that blood cells in the clusters consist of Sca1-negative or -
positive and CD41-negative and -positive cells, two markers eventually expressed on 
progenitor blood cells, may point to distinct origins of hematopoietic cells (de Bruijn et 
al., 2002; Bertrand et al., 2005). Thus, blood cells arising in the P-Sp/AGM region may 
have multiple cellular and spatiotemporal origins.  
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3.2.2.2.3. The placenta generates hematopoietic progenitors 
The comparison of HSC numbers in the P-Sp/AGM region and in the foetal liver provided 
first evidence for an additional hematopoietic organ to produce HSCs (Kumaravelu et al., 
2002). The placenta was first considered as a hematopoietic and possibly hemogenic 
tissue by Alvarez-Silva and co-workers who found multi-potent hematopoietic progenitor 
activity in this organ (Alvarez-Silva et al., 2003). The placenta is formed from the 
allantois and the chorionic plate which are of extraembryonic mesodermal origin deriving 
from the primitive streak and the proximal epiblast, respectively. Both fuse at E8.5 to 
give rise to the labyrinth of the placenta (Rossant et al., 2001). 
In recent studies the placenta was identified to be an additional niche of HSCs in the 
developing foetus (Gekas et al., 2005; Ottersbach et al., 2005). Besides cells expressing 
Sca1, thus hinting for the presence of multi-potent progenitors (Ottersbach et al., 2005), 
transplantations of placental cell solutions into adult irradiated recipients could prove the 
existence of long-term repopulating HSCs in the placenta between E10.5 and E13.5 
(Gekas et al., 2005; Ottersbach et al., 2005).  
The placenta possesses the intrinsic capacity to produce hematopoietic cells as erythroid, 
myeloid as well as c-kit+ and CD41+ multi-lineage hematopoietic progenitors were 
isolated from the allantois dissociated from the embryo before the chorio-allantoic fusion 
had occurred and before the circulation has established (Zeigler et al., 2006; Corbel et 
al., 2007). The endogenous ability to produce multi-potent hematopoietic cells that can 
give rise to myeloid and lymphoid cells if cultured ex vivo was also discovered in mice 
lacking a circulatory system (Rhodes et al., 2008). This indicates that the placenta is 
indeed a major hematopoietic organ producing blood cells de novo although the final 
proof of the intraplacental emergence of LTR-HSCs is still missing.  
 
3.2.2.2.4. Foetal liver and bone marrow are major hematopoietic organs during 
late embryogenesis 
The foetal liver is the main hematopoietic organ in the developing conceptus, but does 
not produce hematopoietic cells de novo in contrast to YS, AGM, placenta. Thus, it is 
seeded by E9.5 by blood cells that have been produced elsewhere and supports the 
expansion of the existing blood cell pool by providing the right environment. It harbours 
high numbers of foetal type HSCs, undifferentiated and committed progenitors which are 
thought to terminally differentiate in the foetal liver (Mikkola et al., 2006). Little is known 
about the foetal liver microenvironment. It is probably diverse and besides supporting 
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rapid expansion of the foetal liver HSCs it also promotes the differentiation of more 
committed blood cells (Moore et al., 1997).  
Beginning around E11.0 adult hematopoietic niches are colonized, first thymus and 
spleen and finally the bone marrow around E15.0 (Godin et al., 2005). At this time the 
skeletal system has fully matured and hematopoiesis shifts to the bone marrow which 
provides a suitable niche for adult HSCs and progenitors. In mice, some hematopoietic 
activity resides in the foetal liver for several days after birth before the bone marrow 
becomes the main site of hematopoiesis. 
 
3.3. What is the cellular precursor of blood cells? 
The YS, the P-Sp / AGM region and the placenta produce hematopoietic cells de novo. In 
addition to the hemogenic sites many intra- and extra-cellular molecules were discovered 
that promote hematopoiesis (Godin et al., 2005), but the precise developmental steps 
leading to the de novo generation of blood cells are still unknown. To produce 
hematopoietic cells or agents acting on blood cells for clinical approaches, it is highly 
important to understand the biology and development of blood cells. The investigation of 
hemogenic sites is necessary to gain knowledge about the environment determining the 
hematopoietic fate. It is thus of special interest to know and investigate the direct 
cellular precursor of blood cells that is embedded in the hemogenic organs and acquires 
hemogenic or hematopoietic fate in response to intrinsic and extrinsic molecules 
provided by neighbouring cells and the local microenvironment. To study the precursor 
cell would significantly contribute to a better understanding of the biology of 
hematopoietic cells and allow the identification of molecules that support de novo 
hematopoiesis and might be of interest for therapy. 
Interestingly, the identity of the direct cellular precursor of hematopoietic cells is 
unknown. The past 20 years have gained a lot of knowledge about hematopoietic cell 
biology, marker expression and functional properties and have opened new technical 
possibilities. However, the question of the direct blood cell precursor is still highly 
controversial and strongly debated. Although all hemogenic sites are of mesodermal 
origin, it is questionable whether blood cells are directly generated from mesoderm. 
Remarkably, in hemogenic locations, nascent blood cells were always observed close to 
endothelial cells: hematopoietic and endothelial cell appearance could spatially and 
temporally be correlated in the YS, in the AGM region and in the placenta (Figure 1.2): 
blood cells in the YS are surrounded by endothelium to form the blood islands (Ferkowicz 
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et al., 2005), in the AGM region, hematopoietic cells form clusters sticking to the 
endothelial cells lining the aorta lumen (Pardanaud et al., 1996; Tavian et al., 1996; de 
Bruijn et al., 2000; Pouget et al., 2006) and blood cells emerge in the vascular lumen of 
the placenta labyrinth (Ottersbach et al., 2005; Rhodes et al., 2008). In addition, 
molecular analysis revealed that both cell types share the expression of many molecules. 
Surface markers such as CD34, Tie2, Flk1, Sca1, PECAM-1, c-kit,  4-integrin and 
Endomucin were found on embryonic hematopoietic and endothelial cells (Dumont et al., 
1995; Sanchez et al., 1996; Takakura et al., 1998; Yoshida et al., 1998; Ogawa et al., 
1999; de Bruijn et al., 2002; Park et al., 2004; Matsubara et al., 2005). The same holds 
true for several transcription factors like Runx1/AML1, GATA-2, SCL/tal1, Notch1 and 
GATA-1 (Kallianpur et al., 1994; Minegishi et al., 1999; Fujimoto et al., 2001; North et 
al., 2002; Kumano et al., 2003; Ling et al., 2004). This provides strong evidence that 
endothelial and blood cells are developmentally closely related to one another. However, 
the precise steps leading to divergence of these pathways are not yet fully understood.  
 
 
Figure 1.2: Endothelial cells localize in close proximity to blood in hemogenic sites. In 
the extraembryonic yolk-sac (YS) arise hematopoietic cells in the lumen of blood islands which are 
lined by endothelial cells at E8.5. Similarly, hematopoietic cells arise in the placenta vascular 
labyrinth and in the aorta-gonads-mesonephros (AGM) region as clusters sticking to the ventral wall 
of the dorsal aorta (E10.5; DA). Blood clusters were also identified in the vitelline (VA) and umbilical 
(UA) arteries. The foetal liver does not generate blood but supports expansion of the blood cell pool 
(Urness et al., 2000; Yoder et al., 2001; Rhodes et al., 2008).  
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3.3.1. Characteristics of endothelial cells 
Endothelial cells are lining the intra-luminal wall of vessels. As a barrier they separate 
the vascular lumen from the perivascular space and control the permeability of plasma 
solutes, the extravasation of leukocytes and the communication between adjacent cells 
(Bazzoni et al., 2004; Liebner et al., 2006). The vasculature is established from 
mesoderm as one of the first functional systems in the developing conceptus. Initially, 
mesodermal cells differentiate into angioblasts (vasculogenesis) in the extra-embryonic 
YS around day 6.5 of development that fuse to form the first vascular plexus.  
Endothelial cells are a very heterogeneous population of cells in the mammalian body 
and different types contribute to the formation of lymphatic vessels as well as to arterial 
and venous blood vessel. Diverging subsets of endothelium are already observable in the 
developing embryo. Studies of chicken-quail chimeras have shown that endothelial cells 
are of different developmental origin leading to a heterogenous population of endothelial 
cells that contribute to vascular systems of different tissues. The somatopleural 
endothelium derives from the somatic mesoderm, colonizes the vasculature of the body 
wall and forms the lymphatic vessels whereas the splanchnopleural endothelial cells 
arises from the splanchnic mesoderm and gives rise to the vasculature of the visceral 
organs. Both of them participate in the formation of the aorta which is formed by the 
fusion of the initially paired aortae (Pardanaud et al., 1996). During the fusion, the 
vascular wall undergoes extensive remodelling which is closely link to the time- and 
location-restricted capacity of the aortic wall to contribute to the formation of 
hematopoietic clusters (Pouget et al., 2006). Interestingly, blood clusters only form at 
the ventral wall of the aorta where splanchnopleural endothelial cells localize that are 
replaced by somatopleural endothelial cells after the AGM region has lost its hemogenic 
potential (Pardanaud et al., 1996). 
 
3.3.2. Evidence for the existence of the hemangioblast 
Since hematopoietic and endothelial cells arise at same time and locations and share the 
expression of molecules, suggested that both derive from a common origin and are 
produced from a common precursor cell, the hemangioblast. 
First evidence for the hemangioblast was suggested from histological analysis of chicken 
YS blood islands (Sabin, 1920). Immunohistochemistry of blood islands has shown that 
same markers are expressed by luminal blood cells and by endothelial cells which hints 
to a common origin. In addition, the loss of some molecules impairs both, the 
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endothelial cell and the blood cell development. Mice lacking the gene encoding the 
foetal liver kinase (Flk1, VEGF-R2) die between E8.5 and E9.5 due to the lack of blood 
islands in the YS (Shalaby et al., 1995). They do not only fail to establish primitive or 
definitive hematopoiesis but also a functional vascular system (Shalaby et al., 1997). In 
addition, the absence of SCL/tal1 (stem cell leukaemia, T cell acute leukaemia 1) leads 
to a defective hematopoiesis as well as to an impaired vascular remodelling of the YS 
(Robb et al., 1995; Shivdasani et al., 1995; Visvader et al., 1998). The common origin of 
blood and endothelium was also proven by using different embryonic stem cell (ESC) 
lines that were differentiated in vitro. Choi and co-workers observed that both lineages 
are generated from single cells thereby suggesting that both share a common origin 
(Choi et al., 1998). Altogether this hints to the existence of a common precursor of blood 
and endothelial cells. 
However, the molecular characterisation and isolation of the putative hemangioblast is 
still poor. Firstly, it is probably only present very transiently, because mesodermal cells 
rapidly differentiate into committed angioblasts and hematopoietic cells (Kinder et al., 
1999). Secondly, the hemangioblast is a cell that exclusively gives rise to endothelial and 
blood cells but not to cells of other lineages. Even though the hemangioblast can be 
enriched by the expression of Flk1, SCL/tal1 and Brachury (Chung et al., 2002; Fehling 
et al., 2003; Huber et al., 2004), cells expressing these markers can give rise to other 
tissues apart from blood and endothelium, as well (Yamashita, J. et al., 2000; Ema et al., 
2003; Schroeder et al., 2003; Kubo et al., 2004; Bussmann et al., 2007). Thus, although 
a bi-potent hemangioblast is probably present in the embryo, it is still poorly 
characterized and thus difficult to distinguish from multi-potent mesodermal cells. 
 
3.3.3. Hypothesis of the cellular origin of blood cells 
The close developmental relationship between endothelial and blood cells is evident by 
their synchronous appearance at same sites in the embryo and by the expression of 
identical molecules. Meanwhile it is generally believed that both share a common 
mesodermal precursor (Choi et al., 1998; Nishikawa et al., 2000; Mikkola et al., 2002). 
According to previous publications, the two possibilities of how blood and endothelial 
cells could be related to one another are displayed in Figure 1.3 (Nishikawa et al., 2000): 
blood and endothelium could directly arise from a bi-potential hemangioblast 
independently from one another. Alternatively, the hemangioblast could first give rise to 
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endothelium that differentiates into blood. In this case, the endothelial cell would be 
hemogenic because it has acquired hemogenic potential. 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.4. Evidence for the existence of hemogenic endothelium 
Endothelial characteristics as vascular endothelial (VE-) Cadherin-expression or uptake of 
acetylated low density lipoprotein (DiI-Ac-LDL) were transiently found on nascent 
embryonic blood cells expressing CD45, a pan-hematopoietic marker. This indicated that 
blood cells might differentiate from mesoderm through an endothelial intermediate, the 
hemogenic endothelium.  
Labelling of chicken embryonic endothelial cells by DiI-Ac-LDL injection, a modified 
lipoprotein that is taken up by endothelial cells, in ovo before hematopoietic clusters 
became visible in the aortic lumen, resulted in a DiI-Ac-LDL+ vascular tree. Shortly 
thereafter, DiI-Ac-LDL+CD45+ blood cells were detectable in the circulation (Jaffredo et 
al., 1998). This suggested that endothelial cells had taken up DiI-Ac-LDL and 
differentiated into blood cells that are released into the circulation. Furthermore, 
endothelial cells were tagged by retroviral infection before AGM hematopoietic clusters 
were observed in the chicken, and slightly later, virally transfected hematopoietic cells 
were found (Jaffredo et al., 2000).  
In ex vivo cultures, mouse VE-Cadherin+ cells purified from E9.5 embryos could give rise 
to VE-Cadherin-CD45+ blood cells (Nishikawa et al., 1998b). Consistent with this, in vitro 
Figure 1.3: Two hypothesis displaying the possible relation 
between endothelial and blood cells in the developing embryo. 
Blood and endothelial cells can either share a common progenitor that 
independently generates both, endothelium and blood (A). In contrast, a 
mesodermal progenitor could first differentiate into endothelium which then 
produces blood and endothelial cells (B). Modified from Nishikawa et al. 
2000.  
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studies using ES cell differentiations could show that ESC-derived VE-Cadherin+ cells can 
give rise to CD45+ hematopoietic cells (Nishikawa et al., 1998a; Hashimoto et al., 2007). 
Evidence for the existence of hemogenic endothelium in mice was strengthened by in 
vivo analysis. Sugiyama et al. could identify DiI-Ac-LDL+ erythrocytes and multi-potent 
hematopoietic precursors in E10.5 mouse embryos that were pulsed with DiI-Ac-LDL 
before the onset of the circulation (Sugiyama et al., 2003). In addition, a very small 
number of VE-Cadherin+CD45+ cells was identified in E9.5 or E11.5 AGM regions (Fraser 
et al., 2003; Taoudi et al., 2005) and VE-Cadherin+ cells co-expressing embryonic 
haemoglobin were found in E6.75 blood islands (Ema et al., 2006). Kim et al postulated 
that virtually all foetal liver HSCs co-express VE-Cadherin at E13.5 which suggests an 
endothelial intermediate step in the development of HSCs (Kim et al., 2005).  
In human embryos, the existence of hemogenic endothelial cells was also suggested. 
Upon their cultivation purified endothelial cells gave rise to blood cells (Oberlin et al., 
2002).  
Collectively, these data indicate the possible existence of hemogenic endothelial cells.  
 
However, doubts exist whether the endothelial markers VE-Cadherin and DiI-Ac-LDL 
uptake are indeed exclusively expressed by endothelial cells. Although VE-Cadherin was 
shown to be expressed by endothelial cells (Breier et al., 1996; Nishikawa et al., 1998b), 
the detection of VE-Cadherin on embryonic blood cells also led to the suggestion that 
VE-Cadherin may not be restricted to endothelium (Dumont et al., 1995; Drake et al., 
2000; Kim et al., 2005). Furthermore, DiI-Ac-LDL might not exclusively label endothelial 
cells but also macrophages which are present from day 7.0 dpc on (Palis et al., 1999; 
Sugiyama et al., 2003). Concentrating on single markers, all previous lineage tracing 
experiments did not show convincingly that hemogenic endothelium exists. In addition, 
the lack of morphological identification of cells leaves considerable room for 
speculations. Most importantly, all previous analysis performed end-point analysis which 
cannot rule out the existence of possible intermediate stages. Thus, strong doubts exist 
about the existence of hemogenic endothelial cells. 
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3.3.5. Requirement for time lapse microscopy 
Although hematopoiesis in the developing embryo has been in the focus of research for 
a very long time, the controversy over the exact relation between blood and endothelium 
could not be solved yet. Most publications dealing with the differentiation of mesoderm 
into blood cells used approaches that couldn’t answer this question precisely because of 
the following difficulties: (i) performing end-point analysis only allows studying of the 
outcome. The differentiation of mesoderm into endothelium and blood is a continuously 
changing process that might involve intermediate stages that are not considered in these 
analyses. (ii) As pointed out before, the presumptive precursor of blood and endothelium 
is poorly characterized. This automatically leads to the use of impure populations which 
can lead to false read-outs if all cells are analysed as a bulk. (iii) The simultaneous use 
of molecular markers, morphological appearance and cellular behaviour can significantly 
contribute to the identification of cells. Lineage tracing experiments in in vivo studies 
failed to analyse the morphology in combination with molecular or functional markers. 
 
Consequently, a different approach is required that allows the continuous observation of 
single cells while they are generated to be able to clarify the differentiation pathway and 
to identify intermediate stages leading to a differentiated blood cell (Schroeder, 2005).  
Thus, a novel imaging and tracking system was developed in our lab in which a culture is 
continuously observed using timelapse microscopy. Images of a high quality allowing the 
identification of subcellular structures are acquired in regular time intervals for up to 14 
days. During acquisition, the specimen is kept in an atmosphere identical to a tissue 
culture incubator which ensures viability of cells. The employment of an automatic 
microscope stage permits recording of images at different positions and the detection of 
large areas of a culture. In addition, fluorescent signals to identify cell of certain lineages 
can be detected in regular time intervals without cytotoxic effects (Rieger et al., 2008; 
Schroeder, 2008).  
After collecting the images, they are analysed frame-by-frame using a single cell tracking 
system that allows to manually follow individual cells and their progeny. Their 
proliferation and differentiation behaviour is displayed in pedigrees that contain 
information like cell division, apoptosis, generation times, morphologies, migration 
speed, behaviours in co-culture and fluorescence that altogether contribute to the 
identification of cells of a certain lineage as well as fate choices and ancestral 
relationship of each individual cell. Thus, the combined use of high throughput bio-
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imaging and single cell tracking allows the efficient detection and precise analysis of 
many single cells providing indispensable information for the understanding of the 
differentiation process (Schroeder, 2008).  
 
3.4. In vitro differentiation of embryonic stem (ES) cells 
3.4.1. In vitro differentiation of embryonic stem (ES) cells: a model system 
to study embryonic hematopoiesis 
Studying mouse embryogenesis at the cellular level in vivo is often limited by the difficult 
accessibility of tissues, low numbers of cells of interest and lack of knowledge about 
interactions or signalling from neighbouring tissue. The same holds true for embryonic 
hematopoiesis. Although the YS is part of the extraembryonic portion its observation is 
challenged by the internal localization of the embryo within mother and uterus. Even 
more complicated is the analysis of intraembryonic locations which can only be analysed 
after destroying the embryo.  
 
To overcome these problems, embryonic stem cell (ESC) differentiation systems are used 
since several decades to investigate cellular processes of mouse development. ES cells 
derive from the inner cell mass of blastocyst-staged embryos (Evans et al., 1981; Martin, 
1981). They are pluri-potent and have the capacity to differentiate into all different cell 
lineages in the body (Niwa, 2001; Chambers et al., 2004). Besides their unlimited 
expansion in culture and their comparably easy genetic manipulation, ES cells can be 
differentiated in defined culture conditions thereby allowing the control of the 
differentiation (Keller, G. M., 1995; Smith, 2001). 
The in vitro differentiation of ESCs was shown to be highly similar to embryonic 
development in vivo. Defects resulting from the loss of transcription factors observed in 
in vivo studies could be replicated by ESC differentiations (Weiss et al., 1994; Porcher et 
al., 1996; Lacaud et al., 2002; Lacaud et al., 2004). In addition, the presence of cells 
with identical surface marker profile and lineage potential found in the embryo could be 
identified in ESC differentiation systems, as well (Nishikawa et al., 1998a; Yamashita, J. 
et al., 2000; Mitjavila-Garcia et al., 2002; Mikkola et al., 2003; Hashimoto et al., 2007). 
This demonstrates that the sequence of the cellular development as well as the kinetics 
of molecular and functional marker expression is highly similar to embryonic 
development. Thus, ESC differentiation is widely accepted as valid model system to 
study embryonic processes (Mikkola et al., 2002; Kitajima et al., 2003; Keller, G., 2005).  
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Besides differentiating ES cells to study embryonic development in vitro, ES cell 
differentiations can be used to easily and quickly generate cells of all different lineages. 
This is of special interest for clinical applications and therapy since putatively 
transplantable cells can be produced in large numbers. As pluri-potent cells can now be 
generated in vitro from somatic cells by nuclear transfer or by lentiviral transfection 
(Yamanaka, 2007; Hanna et al., 2008) the generation of differentiated cells from pluri-
potent cells might become an important tool to cure diseases and cancers, e.g. anaemia 
or leukaemia. Although all hematopoietic lineages can be differentiated from ESCs in 
vitro, their precise differentiation pathway is not yet fully understood as a LTR-HSC could 
not be detected in ESC differentiation systems so far. Although this limits the use of 
ESCs to produce LTR-HSCs, other ESC-derived cells have successfully been transplanted 
into recipients thereby showing that in principle functional adult type hematopoietic cells 
can be differentiated from ESCs (Keller, G., 2005). 
 
In all differentiation systems, the differentiation of ESCs into lineages of interest is based 
on the withdrawal of LIF (leukaemia inhibitory factor), a cytokine that efficiently prevents 
differentiation, and optionally the addition of factors that induce the differentiation into 
cells of interest (Chambers et al., 2004). To induce mesoderm formation, ESCs are either 
differentiated in embryoid bodies, on type IV collagen coated dishes or on OP9 stromal 
cells (Keller, G., 2005). As cells of all three germ layers are produced in the embryoid 
body differentiation, the ratio of mesodermal derivatives is very low (Nishikawa et al., 
1998a; Zhang, W. J. et al., 2005). In contrast, type IV collagen and OP9 cells 
preferentially support mesodermal differentiation (Nakano et al., 1994; Nishikawa et al., 
1998a). 
 
3.4.2. Co-culture system of mouse embryonic stem cells and OP9 stroma 
cells 
ES cells cultured on OP9 stroma spontaneously differentiate first into mesodermal cells 
which upon re-plating give rise to a variety of mesoderm-derived cell types. The culture 
is performed in the presence of FCS (foetal calf serum) which provides a multitude of 
cytokines and growth factors. SCF (stem cell factor, kit ligand, steel factor) is added as it 
was shown to enhance growth and differentiation of stroma-dependent cultures (Lyman 
et al., 1998). Also OP9 are thought to support survival and induce differentiation by the 
Introduction 25 
secretion of a variety of factors (Yoshida et al., 1990; Matsumura et al., 2003; Groger et 
al., 2004). 
Besides cardiomyocytes, mural cells and endothelial cells, a wide range of blood cells 
belonging to the primitive and definitive lineages are produced on OP9 stromal cells 
(Kodama et al., 1994; Nakano et al., 1994; 1996; Hirashima et al., 1999; Yamashita, J. 
et al., 2000; Schroeder et al., 2003). The generated hematopoietic cells can be primitive 
and definitive erythrocytes, granulocytes, macrophages, megakaryocytes and cells of the 
B-lymphoid lineage (Nakano et al., 1994; 1996). OP9 cells were established as a 
polyclonal cell line from the calvaria of neonatal osteopetrotic mice (op/op) lacking the 
gene encoding M-CSF (macrophage colony stimulating factor) (Yoshida et al., 1990). In 
contrast to other stroma cell lines used to support hematopoiesis, OP9 cells are devoid of 
secreting M-CSF which prevents the macrophage-dominated differentiation over other 
blood cell lineages (Nakano et al., 1994).  
 
In contrast to the embryoid body differentiation, the OP9 co-culture is expanded in only 
2 dimensions thereby allowing the visualization of each individual cell contained in the 
culture by microscopic approaches. Thus, the OP9 differentiation system provides an 
ideal tool to analyse the differentiation of ESC-derived cells into hematopoietic cells by 
time lapse microscopy, to study embryonic hematopoiesis and to clarify the 
developmental pathway leading from a mesodermal starting cell to differentiated blood 
cells. 
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4. Goals of the Thesis 
 
 
 
The existence of hemogenic endothelium was postulated many decades ago but is still 
under dispute and strongly debated. 
In my thesis, the longstanding controversy of the existence of hemogenic endothelium 
should be clarified by continuous observation at the single cell level. ESC-differentiation 
on OP9 cells should be employed as a model to study embryonic hematopoiesis, 
recorded by time lapse imaging and analyzed by single cell tracking. The combination of 
multiple lineage markers should unequivocally prove the nature of endothelial and blood 
cells observed and thus eliminate any doubts about cell identities. Furthermore, the 
presumptive hemogenic endothelial cell should be analysed in respect to its surface 
marker profile. In addition, the results obtained from in vitro studies should be replicated 
by imaging of mesodermal cells purified from mouse embryos differentiating into 
hematopoietic cells. 
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5. Results 
 
 
5.1. Generation and purification of embryonic stem cell-derived 
mesodermal cells and time lapse imaging of their progeny 
Investigating the putative existence of hemogenic endothelium requires to continuously 
follow the development and differentiation of individual cells to clarify their cellular 
origin. To solve whether endothelial cells can give rise to blood, the embryonic stem cell 
(ESC) differentiation on OP9 was observed by time-lapse imaging and analyzed by single 
cell tracking. 
 
  
 
 
 
 
 
 
Figure 5.1: Experiment setup. A: ESCs are differentiated on OP9 stroma into mesodermal cells 
within 4 days of culture. Purification of mesodermal cells by FACS and re-culture on OP9 induces their 
differentiation into endothelial, hematopoietic and other mesodermal derivatives within another 5 days 
of culture. While mesodermal cells differentiate into blood and endothelium a time lapse video is 
recorded for up to 7 days. B: Purification of mesodermal cells by FACS. Of ESC-derived cells of the 
right size (FSC) and granularity (SSC, green) only living cells (PI-) are gated (red) and Flk1+E-
Cadherin- cells are sorted (blue). C: Re-analysis of sorted cells is performed to confirm a high purity of 
sorted cells.  
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A detailed overview of the experimental setup is depicted in Figure 5.1. At first, ESCs 
were differentiated on OP9 stroma cells to mesoderm that up-regulates the surface 
marker Flk1 by day 4.0 of differentiation (Figure 5.1 A) (Nakano et al., 1994; Kataoka et 
al., 1997). Purified Flk1+ cells are known to possess the potential to differentiate into a 
multitude of mesodermal derivatives including blood, endothelium, cardiomyocytes and 
smooth muscle cells upon re-culture on OP9 stroma (Nakano et al., 1994; 1996; 
Hirashima et al., 1999; Yamashita, J. et al., 2000; Schroeder et al., 2003; Hashimoto et 
al., 2007). Flk1+ cells are a well known population that represents undifferentiated 
precursors of endothelial and blood cells. Thus, this population is a suitable starting 
population for the time lapse experiments to address the question of whether endothelial 
cells can produce blood cells.  
E-Cadherin (epithelial Cadherin) was included in the sorting scheme because it is 
expressed by undifferentiated ES cells some of which are still present after 4 days of 
culture. As these cells should be excluded from the sorting population, only E-Cadherin- 
cells were selected (Hirashima et al., 1999; Yamashita, J. et al., 2000). In detail, by 
gating propidium iodide- (PI) cells of small size and low granularity the sorted fraction of 
the cell mixture was limited to living ESC-derived cells. Live, Flk1+E-Cadherin- cells were 
selected and sorted into differentiating medium (Figure 5.1 B). A high sort quality was 
confirmed by re-analysing few sorted cells. If more than 97% of events could be 
detected in the sorting gate, cells were used for further analysis (Figure 5.1 C). 
After purification, cells were counted and re-suspended in stem cell factor (SCF) – 
containing differentiating medium that had been previously equilibrated with CO2. 
Enrichment of differentiating medium was sufficient to maintain 5% CO2 for another 
week. Upon seeding living cells on fresh OP9, the culture was incubated for 1 hour to 
obtain gas exchange. After tightly sealing the flask, time-lapse imaging was started and 
performed for up to 7 days.  
 
5.2. Cells with endothelial morphology can generate blood cells 
5.2.1. Endothelial and blood cells exhibit specific morphologies 
The differentiation of ESCs on OP9 performed has been intensely described previously 
(Nakano et al., 1994; 1996; Nishikawa et al., 1998a; Hirashima et al., 1999; Fraser et 
al., 2002a). It has been routinely used for several years and well understood. The 
identification of ESC-derived cells by their unique morphology and their ability to form 
distinct colonies has been analyzed in several studies in the past that confirmed that 
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free-floating cells are hematopoietic and adherent, flat cells with prominent nucleus that 
form sheet-like colonies are endothelial (Figure 5.2) (Nakano et al., 1994; 1996; 
Hirashima et al., 1999; Fraser et al., 2002a). This prompted us initially to perform time-
lapse imaging in phase contrast only using morphological identification to address the 
question of the existence of hemogenic endothelium.  
 
 
 
 
 
 
 
 
 
5.2.2. Imaging of wildtype embryonic stem cell-derived cells points to the 
existence of hemogenic endothelial cells 
In order to analyze whether endothelial cells are capable of producing hematopoietic 
cells ESC-derived mesodermal cells were purified and imaged as described above.  
As depicted in Supplementary Movie 5.1 and Figure 5.3, one single mesodermal cell 
(Figure 5.3 A) proliferates and differentiates into endothelial cells forming a sheet-like 
colony within 2 days after the start of the movie (Figure 5.3 C). Although all endothelial 
cells contained in the colony were morphologically indistinguishable from one another 
(Figure 5.3 C, enlarged section), some endothelial cells embedded into the sheet detach 
from the surrounding cells, become semi-adherent and move to the surface of the 
adherent colony still maintaining contact to the endothelial layer (Figure 5.3 D). 
Connections between semi-adherent and adherent endothelial cells are formed and 
loosened again, resulting in elongated looking cells moving on the endothelium (Figure 
5.3 E). Upon adopting a semi-adherent appearance cells do not insert into the 
endothelial sheet anymore but round up around day 8 of ESC-differentiation, detach 
Figure 5.2: Morphology of ESC-derived endothelial cells and 
blood cells cultured on OP9. A: Two endothelial sheet colonies are 
depicted by arrows. B: Free-floating blood cells (arrowhead). 
Scale bar: 100 µm. 
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from the endothelial sheet and free-float in the culture (Figure 5.3 F). The fact that 
nascent free-floating cells keep dividing eliminates the possibility that these cells were 
apoptotic.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Besides endothelial cells with hemogenic potential, non-hemogenic endothelial cells 
developed from the same mother cell. A morphological difference between both types of 
endothelial cells was not visible. Instead, all endothelial cells contained in the colony at 
day 6.2 of ESC differentiation exhibited the same typical endothelial morphology as 
Figure 5.3: Cells with endothelial morphology can produce blood cells. Images extracted 
from the time lapse experiment shown in Supplementary Movie 5.1. Wildtype ESC-derived 
mesodermal cells were seeded on OP9 and recorded by time lapse imaging. Time after start ESC-
differentiation is indicated. A: One single wild-type ESC-derived mesodermal cell (arrowhead in 
enlarged image) proliferates (B) and differentiates into an endothelial sheet colony (C) of that 
some cells detach from the endothelial sheet and are semi-adherent on the endothelial colony (D, 
E). After some time the semi-adherent cells loose contact to endothelial cells and are present as 
free-floating blood cells (F). Arrowheads in enlarged images of C, D and F depict the morphologies 
of adherent endothelial, semi-adherent and free-floating blood cells. The arrow in C highlights a 
non-hemogenic endothelial cell. 
Scale bars: 100 µm and 50 µm in zoomed images. 
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depicted in the enlarged part of Figure 5.1 C. While all offspring of hemogenic 
endothelial cells transformed into blood, non-hemogenic endothelial cells maintained 
their morphology and sheet formation. 
 
These findings indicate that (i) hemogenic endothelial colonies exist in ESC-derived 
cultures, (ii) a hemogenic endothelial colony of monoclonal origin contains hemogenic 
and non-hemogenic subsets of endothelial cells, both of them sharing the same 
morphology, and that (iii) hemogenic endothelial cells transform into putative 
hematopoietic looking cells by going through a semi-adherent intermediate phase.  
 
5.2.3. Imaging of embryonic stem cell-derived cells with constitutive 
nuclear label allows reliable continuous single cell tracking of all 
cells in a colony 
To clarify the exact relationship of cells within the hemogenic endothelial colony to one 
another it is indispensable to follow each individual cell starting from the mesodermal 
mother until hematopoietic-looking cells have developed.  
Tracking single cells in movies of wild-type ESC-derived cultures proved to be very 
challenging, because endothelial precursors often form 3-dimensional aggregates making 
it difficult to recognize single cells (Figure 5.1 B). To improve their identification wild-
type ES cells carrying a constitutive nuclear label were established that allows their 
identification in the culture. A plasmid encoding a Histone2BVENUS (H2BVENUS) fusion 
and a puromycin selection cassette controlled by the chicken beta actin (CAG) promoter 
(Okita et al., 2004) was electroporated into wildtype ESCs. Selection for Puromycin 
resistant cells resulted in stably transfected ES cells that were pooled to obtain a 
polyclonal cell line constitutively expressing the fusion protein H2BVENUS. To ensure that 
the cell line produced behaves similar to wild-type ES cells its differentiation capacity was 
verified by culturing it on OP9 stroma. The differentiating cells were analyzed by FACS 
analysis and microscopy in regard to the presence and ratio of generated cell types and 
compared to equally treated wild-type cells (data not shown). 
 
Phase contrast time lapse imaging of differentiated H2BVENUS ESC-derived mesodermal 
cells confirmed that endothelial cells can give rise to presumptive blood cell as observed 
in videos obtained from differentiated wild-type ESCs: an endothelial colony of 
monoclonal origin contained hemogenic subsets that produced free-floating cells through 
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a semi-adherent intermediate. By acquiring fluorescence images in regular intervals it 
was not only possible to confirm the monoclonal origin of the colony but also to track 
single cells starting from the mesodermal founder cell until free-floating cells were visible 
at day 8.5 of differentiation (Figure 5.4 and Supplementary movie 5.2).  
 
  
 
 
 
 
 
 
 
The corresponding pedigree is depicted in Figure 5.4 A. The Flk1+E-Cadherin- sorted 
mesodermal starting cell (Figure 5.4 B) proliferates and in the 5th generation around day 
6 of ECS-differentiation cells form a colony containing cells with typical endothelial 
morphology, as highlighted by triangles in the tree. By day 6.3 of differentiation all cells 
Figure 5.4: Single cell tracking of a hemogenic endothelial colony shows that endothelial 
cells can generate blood cells. Flk1+E-Cadherin- cells constitutively expressing H2BVENUS were 
cultured on OP9 stroma for 4 days while recording a time lapse video. Days of ESC differentiation are 
indicated. A: Pedigree corresponding to the colony shown in the images B-G and Supplementary 
Movie 5.2. B-G: Images extracted from the Supplementary Movie 5.2. Phase contrast images are 
shown left, fluorescent images detecting H2BVENUS are shown on the right. One mesodermal cell 
(B) produces an endothelial colony (C), of that some cells become semi-adherent (D, enlarged in 
F) and finally free-floating (E, enlarged in G). 
Scale bar: 100 µm 
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look and behave identically and no difference between individual cells was obvious. 
Hemogenic and non-hemogenic endothelial cells show typical endothelial morphology at 
around the same time (Figure 5.4 C).  
Shortly after acquiring endothelial morphology, four cells irreversibly become semi-
adherent cells, two of them being sisters (Figure D and F). After two to three cell 
divisions all daughters of the hemogenic endothelial cells detach from the surface and 
are free-floating (Figure E and G). 
Besides of their morphological appearance, endothelial and blood cells differ in the 
length of their cell cycle. With the onset of semi-adherence nascent free-floating blood 
cells show shorter and uniform generation times (generation time 11.2 hours ± 3.5 
hours; n=69), whereas the non-hemogenic endothelial cells divide slower and in a very 
irregular fashion (generation time 18.0 hours ± 8.5 hours; n=185). This strengthens the 
point that adherent and suspension cells of monoclonal origin are indeed different cell 
types. 
Blood cells were not tracked until the end of the movie since the rapid movements and 
the three-dimensional expansion of free-floating cells makes it difficult to reliably follow 
individual cells – despite the nuclear label. However, free-floating cells were followed and 
were not observed to incorporate into the endothelial sheet anymore. This is strong 
evidence that suspension cells have lost the potential to integrate into the endothelial 
colony. 
Some endothelial cells were observed to transiently detach from the endothelial sheet as 
well. In most cases this was due to the cell division process that is accompanied by short 
detachment during cytokinesis observable in many adherent cell types (e.g. OP9). 
Detachment of adherent endothelial cells was additionally visible towards the end of the 
movie which can be explained by an increased number of apoptotic events of adherent 
cells leading to free-floating cell clumps.  
Increased cell death of endothelial cells with proceeding differentiation could be 
observed occasionally within this study and is probably due to the age of the culture and 
the limited space in the adherent cell layer which might lead to increased apoptosis. 
Although the three hemogenic sub-trees of the pedigree visible in Figure 5.4 are not 
directly related to one another, all of them show the similar length and length of semi-
adherence and the same onset of free-floating morphology. Furthermore, the temporal 
sequence of the transition was identical to the ones analyzed in wild-type movies. 
Strikingly, endothelial to blood cell transitions were never observed at later time-points 
Results 34 
than described above. This suggests that endothelial cells may possess hemogenic 
potential only within a very limited time window of differentiation.  
 
  
 
 
 
 
 
More than 100 hemogenic endothelial colonies producing blood cells were observed in 16 
independent experiments that were performed with 4 different ESC-lines under different 
culture conditions throughout this study. All of them displayed the same sequence of 
cellular behaviour – timing of endothelial cell maturation, detachment of hemogenic 
endothelial cells and their transition into free-floating blood cells as visible in some 
additional pedigrees displayed in Figure 5.5. Although some variability can be seen in 
colony size and the number of hemogenic endothelial cells within each colony, colonies 
consisting of 4 to up to 20 cells at the time point of hemogenic transition were able to 
Figure 5.5: Additional pedigrees depicting endothelial cell – blood cell transitions 
(compare Figure 5.4). Kinetics and cellular behaviour are reproducible between all pedigrees 
shown in A-C and Figure 5.4. In contrast, the total size of the hemogenic endothelial colony and the 
number of hemogenic endothelial cells are variable.  
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produce hemogenic endothelial cells. Similarly, endothelial colonies could contain 1 to 4 
hemogenic endothelial cells. In contrast, the sequence of cellular behaviour and the 
kinetics of nascent free-floating cells appearing were highly reproducible. This suggests 
the presence of a mechanism that is strongly controlled on the cellular and molecular 
level.  
 
5.2.4. Non-hemogenic endothelial colonies can morphologically not be 
distinguished from non-hemogenic endothelial cells in hemogenic 
endothelial colonies 
To compare whether endothelial cells of non-hemogenic endothelial and hemogenic 
endothelial colonies show a major difference in their behaviour, single cell tracking of 
non-hemogenic endothelial colonies was performed in H2BVENUS expressing ESC-
derived cells. 
 
 
 
Figure 5.6: Single cell tracking of endothelial cells in non-hemogenic colonies. Indicated 
is the time after induction of ESC-differentiation. A-F: Images extracted from a movie. The upper 
panel show phase contrast, the lower panel shows fluorescent images detecting H2BVENUS signals. 
G: Pedigree corresponding to the images in A-F. 
Scale bar: 50 µm. 
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Non-hemogenic endothelial colonies do not show any difference in proliferation, numbers 
of cell divisions, generation times nor in onset of endothelial morphology. This shows 
that non-hemogenic endothelial cells in hemogenic colonies behave as other non-
hemogenic endothelial cells in the culture. 
 
5.2.5. Hemogenic endothelial colonies appear in very low frequencies in 
OP9 differentiation cultures 
In the movies, several different types of monoclonal colonies could be identified: 
colonies with endothelial sheet morphology, with blood morphology (suspension and 
adherent blood cells generated by a non-endothelial sheet colony) and colonies with 
unequivocal morphology (cardiomyocytes, pericytes or other). The frequency of all 
morphologically-identifiable types of colonies counted in 6 independent time-lapse 
experiments of ESC-derived mesodermal cells is shown in Table 5.1. Only 1.2% of all 
observed colonies are endothelial sheet colonies which produce blood. Vice versa, most 
blood cells observed are produced from non-endothelial cells (82.9%) whereas only 
17.1% derive from endothelial sheet colonies. 
 
Table 5.1: Colonies originating from one ESC-derived mesodermal cell were identified by 
morphology in time lapse experiments. Average colony numbers from 6 independent experiments 
are shown. No difference could be observed in the resulting colony frequencies when using 3 different 
ESC lines or different culture conditions (see below). Other: cardiomyocyte colonies and colonies 
without unequivocal morphology. 
Colony type Average colony number / experiment Mean % 
Blood colony 30 (± 12) 5.8 
Non-hemogenic endothelial sheet colony 231 (± 61) 44.4 
Hemogenic endothelial sheet colony 6 (± 4) 1.2 
Other 253 (± 129) 48.6 
 
This very low frequency of endothelial cell to blood cell transitions were reproduced in 16 
independent experiments collected from differentiations of 4 different ES cell lines. 
It is known from other studies that in addition to endothelial colonies with sheet-like 
morphology endothelial clusters with a less apparent morphology are present in these 
cultures (Hirashima et al., 1999; Matsumura et al., 2003; Hashimoto et al., 2007). This 
means that probably more endothelial colonies producing hematopoietic cells are present 
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that were scored as pure blood colonies here. Therefore, our analysis represents a 
conservative evaluation of the frequency of blood generation from endothelium. 
 
5.3. Endothelial and hematopoietic cells can be distinguished by 
specific fluorescent markers in time lapse experiments 
The reliable identification of endothelial and blood cells is crucial to prove the existence 
of hemogenic endothelium. Although both differ considerably in their morphological 
appearance, it had to be excluded that the observed hemogenic endothelial cell is of a 
different celltype that localizes within the endothelial sheet colony. Vice versa, since 
angioblasts have been shown to float in peripheral blood (Asahara et al., 1997) the 
possibility of free-floating cells that are not hematopoietic had to be excluded. Thus, the 
hemogenic transition of endothelial cells has to be verified by showing the presence of 
specific endothelial and hematopoietic markers on these cells. As hemogenic endothelial 
cells can only be identified by continuous time-lapse imaging and single cell tracking so 
far, the used markers not only have to be exclusive but also applicable in long term 
imaging of in vitro cultures. 
 
5.3.1. Cells with endothelial morphology exhibit typical functional and 
molecular endothelial characteristics 
To confirm that blood precursors are endothelial, the identity of these cells can in 
addition to the morphology be evidenced by the incorporation of acetylated low density 
lipoprotein (Ac-LDL), by the expression of VE-Cadherin and by the presence of functional 
tight junctions. 
 
5.3.1.1. Endothelial cells specifically take up DiI-Ac-LDL 
Endothelial cells exhibit an increased uptake of acetylated low density lipoprotein (Ac-
LDL) compared to other cell types. Its addition to living cultures or its injection into living 
animals results in specific binding and engulfment of the modified lipoprotein by 
endothelial cells (Voyta et al., 1984; Yablonka-Reuveni, 1989; Bollerot et al., 2006). DiI- 
labelled Ac-LDL (DiI-Ac-LDL), when used in living cultures, is internalised, enzymatically 
degraded and the lipophilic DiI accumulates in the endosomal membranes thereby 
labelling the vesicles of the endothelial cells (Voyta et al., 1984; Lodish et al., 1999). 
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It was tested if DiI-Ac-LDL added to the normal differentiating medium is specifically 
enriched in endothelial cells even in the presence of serum-derived LDL contained in the 
culture medium is present. As shown in Figure 5.7 A, it exclusively stained endothelial 
sheet colonies. Upon their differentiation, cells of sheet-like endothelial colonies 
accumulate DiI-Ac-LDL in their vesicles as was evaluated in a time lapse experiment 
detecting DiI-Ac-LDL present in the culture. In contrast, DiI-Ac-LDL staining was not 
visible in blood cells (Figure 5.7 A, image extracted from a movie at day 6.5 of ESC-
differentiation) or cells with cardiomyocytic morphology (not shown). Microscopically 
comparing colony frequencies with cultures lacking DiI-Ac-LDL verified that cell fates are 
not changed by the permanent presence of DiI-Ac-LDL. However, as the signal intensity 
Figure 5.7: DiI-Ac-LDL specifically labels endothelial but not 
hematopoietic cells. ESC-derived mesodermal cells were cultured on OP9 in the 
presence of DiI-Ac-LDL and analyzed at day 8 (A) and day 6.5 (B) of 
differentiation. A: Endothelial cells forming a sheet colony are DiI-Ac-LDL+ 
(asterisk), free-floating blood cells are DiI-Ac-LDL-(arrowhead). B: FACS analysis 
showing that all in culture stained DiI-Ac-LDL+ cells can be detected by an anti-
VE-Cadherin antibody. Left hand side: negative control; right hand side: DiI-Ac-
LDL containing culture stained with an anti-VE-Cadherin antibody. 
Scale bar: 100 µm. 
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was very bright the concentration of the modified lipoprotein in the culture was 
decreased to 50 ng/ml to minimize any potential toxic effects.  
 
5.3.1.2. Endothelial cells specifically express vascular endothelial (VE-) Cadherin 
and form tight junctions 
As endothelial cells are an integral part of vessels, they separate the vascular lumen 
from perivascular tissue. Their function relies on the formation of cell-cell junctions to 
maintain cellular polarity, permeability to plasma solutes, leukocyte extravasation and 
communication between adjacent cells (Bazzoni et al., 2004; Liebner et al., 2006). 
Adherence and tight junctions consist of a multitude of integral membrane proteins, 
most of them being expressed by both epithelial and endothelial cells. Two proteins, 
vascular endothelial Cadherin (VE-Cadherin) and Claudin5 are restricted to endothelial 
adherence and tight junctions, respectively (Lampugnani et al., 1995; Dejana, 1996; 
Morita et al., 1999).  
Therefore, to identify endothelial cells, the expression of VE-Cadherin and the presence 
of tight junctions were analyzed. Recently, Hisatsune et al. (Hisatsune et al., 2005) have 
cloned the regulatory elements directing the endothelial-specific expression of VE-
Cadherin. Here, this promotor was initially cloned in front of a mitoVENUS fusion gene 
(Okita et al., 2004) and stable transfected into ES cells. Although stable transfected 
monoclonal ESC lines were established within my thesis (data not shown), these cells 
were not employed in time lapse videos. Guo and co-workers subsequently created 
another ESC line that uses the endothelial-specific VE-Cadherin promotor to drive a 
VENUSClaudin5 fusion protein exclusively in endothelium (VE-Cadherin::VENUSClaudin5 
ES cells) (Guo, R. et al., 2007). Upon differentiation, the ESC-derived cells produce 
VENUSClaudin5 protein only in endothelial cells expressing VE-Cadherin. As endothelial 
cells form intercellular tight junctions they integrate the VENUSClaudin5 fusion protein 
into the junctions thereby labelling cell membranes.  
 
In order to elucidate which cells in our system express VE-Cadherin and tight junctions 
the VE-Cadherin::VENUSClaudin5 ESC line was differentiated on OP9 and analyzed by 
morphology and FACS. In Figure 5.8 A an image taken at day 6.5 of differentiation 
depicting the specificity of these markers is shown: an endothelial sheet colony is not 
only expressing VE-Cadherin visible by the detectable fluorescence signals but is in 
addition forming tight junctions with surrounding endothelial cells as the VENUSClaudin5 
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fusion protein integrates into the cell membranes. In contrast, hematopoietic suspension 
cells do not express VE-Cadherin and cannot integrate VENUSClaudin5 into tight 
junctions. 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: Endothelial cells specifically express VE-Cadherin and form tight 
junctions. A: VE-Cadherin::VENUSClaudin5 ESC-derived mesodermal cells were 
cultured on OP9 for 4 days. VENUSClaudin5 fusion protein is produced and 
incorporated into tight junctions by cells with endothelial morphology (asterisk) but 
not by blood cells (arrowhead). B: FACS analysis confirming that cells expressing the 
VENSClaudin5 fusion also express endogenous VE-Cadherin antigen. As negative 
controls differentiated unstained wildtype (left panel) and VENUSClaudin5 (middle 
panel) cells are shown. After culture of VE-Cadherin::VENUSClaudin5 ESC-derived 
mesodermal cells for 2.5 days, cells were stained with an antibody detecting VE-
Cadherin (right panel). 
Scale bar: 100 µm. 
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5.3.2. Proof of blood cell character by immunostaining in the living culture 
5.3.2.1. In culture immunostaining against blood surface markers specifically labels 
free-floating blood cells 
Blood cells can be identified by the specific expression of surface markers. The 
distinction of different blood cell types by the expression of certain surface molecules is 
routinely used in basic research as well as in clinical diagnostics to characterize and 
purify different populations from a mixture of cells (Nakano et al., 1994; 1996; Choi et 
al., 1998; Fraser et al., 2002a; Fehling et al., 2003). 
To ensure that free-floating cells arising from endothelium are in fact blood cells we took 
advantage of the well characterized profile of surface marker expression on ESC-derived 
blood cells (Fraser et al., 2002a). As it is necessary to identify free-floating cells after 
they have been stained, staining in the movie is crucial to maintain the architecture of 
the culture and the position of individual blood cells. To prevent the loss of identity or 
the difficulties of identifying single cells but to make antigens visible while performing 
time-lapse imaging we tested whether the addition of fluorescently-labelled antibody to 
the culture medium of the living culture can specifically stain cells without affecting the 
differentiation procedure. 
Initial experiments in differentiation cultures were performed with a labelled anti-CD45 
antibody, because it recognizes the pan-hematopoietic surface molecule CD45. This 
resulted in brightly stained cells within 30 minutes after the addition of diluted PE-anti-
CD45 antibody. Cells that were previously named blood cells according to their free-
floating morphology, brightly stained for CD45 (Figure 5.9 A). The addition of PE-labelled 
isotype-matched control antibodies to the living culture did not bind to any cell within the 
culture (data not shown) thereby showing antibody specificity.  
To confirm that the staining in the culture medium at 37°C over days is still highly 
specific, cells were flushed off the stromal layer and only stained with an anti-Mac1 
antibody recognizing cells of the monocytic-granulocytic lineage (Springer, 1971). As 
shown in Figure 5.9 B most cells detectable with CD45 stained in culture co-express 
Mac1 antigen thereby showing that in culture immunostaining against CD45 stains blood 
cells of the myeloid lineage.  
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Preliminary experiments to test efficiency, specificity and concentrations were 
successfully performed with PE- or APC- conjugated anti-CD45, PE- or FITC-anti-CD41, 
PE- and FITC-anti-Mac1, FITC-anti-PECAM-1, PE-anti-Tie2 and APC-anti-c-kit antibodies. 
Their titration revealed that the best signal to noise ratio could be obtained if all 
antibodies were used in a final concentration of 20 ng/ml or 100 ng/ml for anti-c-kit.  
Not all antibodies tested were found to be suitable for in culture immunostainings. 
Ter119 antibody used to distinguish erythroid cells from other blood cells did not 
successfully stain cells in culture even if high concentrations or different fluorescent dyes 
(PE or APC) were used.  
Figure 5.9: In culture immunostaining against CD45 specifically 
labels hematopoietic cells. ESC-derived Flk1+E-Cadherin- cells were 
cultivated in the presence of a PE (A) or APC (B) labelled anti-CD45 
antibody. A: Anti-CD45 antibody added to the living culture can 
specifically bind and label cells with free-floating (open arrowhead) or 
adherent (closed arrowhead) hematopoietic morphology although not all 
cells to be expected to be blood cells are stained (arrow). Cells contained 
in a colony with endothelial sheet morphology cannot be detected by the 
antibody (asterisk) B: The majority of CD45+ living blood cells co-express 
the myeloid hematopoietic marker Mac1 at day 8.5 of ESC differentiation. 
At day 8.5, two days after endothelial cell to blood cell transitions 
occurred, suspension cells were flushed off. They were stained only with a 
PE-Cy7-anti-Mac1 antibody and analyzed by FACS. Propidium iodide 
negative, living cells are shown.  
Scale bar: 100 µm.  
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Antibody-containing cultures were kept for several days (up to 7 tested) the staining was 
still present and specific. Furthermore, it could be excluded that the addition of antibody 
is increasing cell death, influencing the proliferation behaviour or affecting the 
differentiation process.  
 
5.3.2.2. In culture immunostaining does not label dead cells 
Besides living blood cells dead cells of different origins can be found in the supernatant 
of differentiation cultures. The possibility of antibody binding by dead free-floating cells 
could be eliminated by analysing movies of differentiation cultures containing anti-CD45 
antibody in the culture. Live cells which are dividing and actively moving were compared 
to passively floating cells in their ability to bind anti-CD45 antibody (Table 5.2). Of more 
than 1100 dead cells counted only 1 was positively stained. This shows that the antibody 
does not bind to dead cells. 
On the other hand 1601 of 2154 living suspension cells analyzed expressed the surface 
marker CD45. CD45- living suspension cells are probably blood cells as well. The lack of a 
CD45 signal hints to unequal antibody binding capacity of different blood cell types or 
the presence of CD45- cells belonging the erythroid lineage (Kina et al., 2000). However, 
to stringently read-out the hematopoietic identity of endothelium-derived suspension 
cells, the analysis was restricted to CD45 expressing cells in following experiments.  
According to the results obtained from experiments addressing the specificity of DiI-Ac-
LDL uptake, VE-Cadherin expression and tight junctions formation, living suspension cells 
never expressed the endothelial markers VE-Cadherin::VENUSClaudin5 and/or DiI-Ac-
LDL.  
 
 
Table 5.2: In culture immunostaining against CD45 only labels living free-floating cells. VE-
Cadherin::VENUSClaudin5 ESC-derived mesodermal cells were cultivated on OP9 in medium containing DiI-
Ac-LDL and APC-anti-CD45 antibody while recording the movie. Staining of cells was evaluated on day 9 of 
ESC differentiation. Living cells were identified by the following criteria: morphology, proliferation and active 
movement in the movie.   
Phenotype of cells analyzed Cells / total number analyzed 
VE-Cadherin::VENUSClaudin5+ and/or DiI-Ac-LDL+ live suspension cells 0 / 2154 
CD45+ endothelial cells in sheets (adherent) 0 / ~ 7000 
CD45+ live suspension cells 1601 / 2154 
CD45+ dead suspension cells 1 / 1139 
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5.3.2.3. In culture immunostaining against  blood-surface markers does not label 
endothelial cells 
To extend the analysis of specific antibody binding in culture time-lapse experiments of 
cultures containing all endothelial markers (VE-Cadherin::VENUSClaudin5, DiI-Ac-LDL) 
and anti-CD45 antibody were performed.  
 
  
 
 
 
 
 
 
 
 
In these movies, there were no CD45+ endothelial cells embedded into endothelial sheet 
colonies. Vice versa, no suspension cell expressing endothelial markers could be 
identified (Figure 5.10). This shows that all described markers for the distinction of 
endothelial and blood cells can be employed in one imaging approach. 
 
 
 
Figure 5.10: Identification of endothelial and hematopoietic cells by molecular markers in 
living ESC-derived cultures. VE-Cadherin::VENUSClaudin5 ESC-derived mesodermal cells were 
cultivated on OP9 in the presence of DiI-Ac-LDL and APC-anti-CD45 labelled antibody while recording 
a movie. Part (10%) of one frame of a movie at day 8.5 (end of endothelial to blood cell transition) of 
ESC-differentiation is shown. Left panel: phase contrast; right panel: overlay of all images recorded in 
fluorescent wavelengths. The arrow points to CD45+ suspension blood cells, the arrowhead to one 
CD45+ adherent blood cell. The asterisk depicts an endothelial sheet colony expressing endothelial 
markers, the diamond a colony showing molecular endothelial characteristics but no typical sheet 
morphology. Only living adherent cells expressed endothelial markers. All CD45+ cells were alive, as 
evidenced by their proliferation in the movie. No living and free floating cells expressing endothelial 
specific markers were observed.  
Scale bar: 100 µm.  
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5.4. Hemogenic endothelium generates blood: proof of cell identities 
by the simultaneous use of multiple markers in time lapse 
experiments 
Since VE-Cadherin::VENUSClaudin5 ESCs, the addition of DiI-Ac-LDL and fluorescent 
labelled anti-CD45 antibody to living cultures were successfully employed in time-lapse 
movies, we combined all three molecular and functional markers into one imaging 
approach. We imaged the appearance of blood from endothelium derived from VE-
Cadherin::VENUSClaudin5 transgenic ES cells in the presence of DiI-Ac-LDL and APC-
anti-CD45 antibody.  
In Figure 5.11 (and Supplementary Movie 5.3) a blood producing endothelial colony of 
monoclonal origin and the corresponding lineage tree are depicted. The endothelial cell 
adopted an endothelial morphology, expresses VE-Cadherin dependent VENUSClaudin5 
fusion protein, forms tight junctions with adjacent cells and enriches DiI-Ac-LDL to 
detectable levels as soon as the cell is semi-adherent (Figure 5.11 first row). At this 
stage, it is not yet expressing the blood specific antigen CD45, thereby excluding the 
possibility of the existence of a bi-potent blood and endothelial precursor expressing 
molecules of both lineages (Figure 5.11 second row). As soon as the endothelial cell 
detaches from the sheet and transforms into free-floating cells, the endothelial markers 
VE-Cadherin::VENUSClaudin5 and DiI-Ac-LDL labelling are already undetectable (Figure 
5.11 third row). Shortly after, anti-CD45 signals slowly increase on nascent blood cells 
and become detectable approximately three hours after cells are free-floating. These 
CD45+ cells (Figure 5.11 fourth row) keep proliferating as soon as they detach from the 
endothelial sheet which ensures that the endothelium-derived free-floating cells are 
definitely living blood cells. 
These data prove not only by morphology but also by the expression of several specific 
molecular markers that endothelial cells can produce blood cells. 
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5.5. Non-sheet endothelial colonies producing blood cells can be 
observed in time lapse movies 
Previous studies performed by others (Hirashima et al., 1999; Matsumura et al., 2003; 
Hashimoto et al., 2007) have described two types of Flk1+ or VE-Cadherin+ colonies 
having distinct phase contrast morphologies: sheet-like colonies consisting of flat cells 
with prominent nucleus forming circular clusters and cord-like colonies, showing an 
elongated colony morphology consisting of densely packed cells with less unique 
appearance. In line with these studies the use of VE-Cadherin expression, tight junction 
Figure 5.11: Identification of endothelial and blood cells by continuous analysis of 
functional and molecular markers. Part of a pedigree depicting marker expression during 
hemogenic transition of an EC is shown on the left side. Hours after the start of the movie at day 4 of 
ESC differentiation are indicated. Coloured lines to left of the tree depict marker expression. In the 
shown hemogenic EC, VE-Cadherin::VenusClaudin5 expression and tight junction formation was 
detectable 18 h, and DiI-Ac-LDL uptake 40 h after the start of the movie (not shown). A hemogenic 
endothelial cell expresses VE-Cadherin, incorporates VENUSClaudin5 into tight junctions and takes up 
DiI-Ac-LDL (62h).The endothelial cell is negative for CD45 expression (63h). As a positive control for 
functional anti CD45 staining, other CD45+ stained cells are visible at the same time point in 
Supplementary Movie 5.3. Emerging blood cells lose VE-Cadherin::VENUSClaudin5 expression and DiI-
Ac-LDL uptake (67h). The generated blood cells express CD45 (81h). Arrowheads indicate the cells 
shown in the images. 
Scale bar: 50 µm. 
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formation and DiI-Ac-LDL uptake in time-lapse experiments identified non-sheet 
endothelial colonies in this study. Most colonies express VE-Cadherin, form tight 
junctions and take up DiI-Ac-LDL (Table 5.3). Of these, only 29.5% are sheet-like 
endothelial colonies and 67.3% are of cord-like morphology. Figure 5.12 shows an image 
taken from a movie highlighting two VE-Cadherin::VENUSClaudin5+DiI-Ac-LDL+ colonies 
from both different morphological appearances.  
 
 
Table 5.3: Cells expressing VENUSClaudin5 and take up DiI-Ac-LDL can produce blood cells. 
Flk1+E-Cadherin- ESC-derived cells were differentiated on OP9 and imaged by time lapse microscopy. 
Monoclonal colonies were evaluated for the presence of endothelial characteristics. More than 770 colonies 
from 5 independent experiments were counted. The combination of all markers including clear sheet colony 
morphology allows the highest stringency for EC colony detection. Only colony types highlighted in grey were 
observed to produce blood.  
Endothelial marker Presence (+) or Absence (-) of marker 
VE-Cadherin::VENUSClaudin5 - - - + + + + 
DiI-Ac-LDL + - + - - + + 
Sheet morphology - + + + - + - 
% Colonies of all colonies with endothelial characteristics 0 0 0 0.5 2.7 29.5 67.3 
 
 
In our movies we only observed endothelial colonies that are VE-
Cadherin::VENUSClaudin5+ and in addition take up DiI-Ac-LDL to produce blood cells 
(Table 5.3). Quantifications of 5 independently generated movies lead to the conclusion 
that both VE-Cadherin::VENUSClaudin5+DiI-Ac-LDL+ colonies with sheet-like and with 
cord-like morphology have approximately the same ability to give rise to blood cells: 
6.5% and 4.8% of sheet-like and cord-like endothelial colonies produce blood cells, 
respectively. We further compared both colony types to understand whether the blood 
cell generation is regulated by an identical mechanism. 
 
In Figure 5.13 A and Supplementary movie 5.4 one cord-like endothelial colony is shown 
expressing VE-Cadherin::VENUSClaudin5 and DiI-Ac-LDL (first panel). At this time-point, 
no cell expresses the hematopoietic cell antigen CD45 (second panel). Upon detaching 
from the endothelial colony the blood cell cluster present in the surrounding area does 
not express endothelial markers anymore (third panel), but up-regulates CD45 shortly 
after (fourth panel).  
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The comparison of 9 endothelial to blood transitions from cord-like endothelial cells 
revealed that the nascent blood cells leave the endothelial colonies either as adherent or 
as suspension cells but neither of them is going through a semi-adherent phase. 
However, onset of VE-Cadherin expression, tight junctions formation, DiI-Ac-LDL 
incorporation as well as endothelial transition into blood (first detection of free-floating 
blood cells evaluated in cord-like endothelial colonies was compared to onset of semi-
adherence in hemogenic sheet-like endothelial colonies; Figure 5.13 B) took place within 
the identical time window and same kinetics as in the sheet-like endothelial colonies. 
This suggests that the basic mechanism of blood cell production from endothelial cells is 
identical in both colony types. The lack of a semi-adherent state rather seems to be 
unnecessary for endothelium-derived blood cells to adopt their hematopoietic fate. 
Instead, semi-adherence is probably closely linked to the expression of certain surface 
molecules expressed on sheet-like rather than on cord-like endothelial cells. 
 
 
Figure 5.12 Colonies displaying molecular and functional endothelial characteristics can 
appear in different morphologies. VE-Cadherin::VENUSClaudin5 transgenic ESC-derived 
mesodermal cells were cultured on OP9 for 3 days in the presence of DiI-Ac-LDL. Two colonies of 
monoclonal origin are shown that take up DiI-Ac-LDL (B), express VE-Cadherin and form tight 
junctions (C). An overlay of B and C is depicted in D. As shown in A, these colonies have different 
morphologies: sheet-like (asterisk) and cord-like (diamond). 
Scale bar: 100 µm. 
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Figure 5.13: Cord-like endothelial colonies can produce hemogenic endothelial 
cells with identical onset of VE-Cadherin::VENUSClaudin5 expression, tight 
junction formation, DiI-Ac-LDL uptake and transition into the hematopoietic 
state. A movie of VE-Cadherin::VENUSClaudin5 transgenic ESC-derived mesodermal cells 
cultivated with DiI-Ac-LDL and APC-anti-CD45 antibody was recorded. A: Images 
extracted from a movie showing the production of blood cells from a cord-like endothelial 
colony.  A cord-like endothelial colony expressing VE-Cadherin, forming tight junctions and 
taking up DiI-Ac-LDL (72h) does not express CD45 (73h) and produces free-floating cells 
that have lost the molecular and functional endothelial characteristics (79h) but have 
acquired CD45 expression after 84h. B: Range of onset of marker expression in sheet- 
and cord-like endothelial cells producing blood. Time after induction of ESC-differentiation 
is indicated. 9 cord-like and 9 sheet-like endothelial colonies from 2 independent 
experiments were analyzed. As “blood morphology” the detection of free-floating blood 
cells generated from cord-like endothelium was compared to the onset of semi-adherence 
in hemogenic endothelial sheet colonies. As visible, sheet-like and cord-like endothelial 
colonies do not distinguish significantly in respect to onset of blood morphology (p=0.99), 
DiI-Ac-LDL uptake (p=0.20) and VE-Cadherin::VENUSClaudin5 expression (p=0.41). 
Scale bar: 50 µm. 
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5.6. Characterization of hemogenic endothelial cells: hemogenic 
endothelial cells express CD41, c-kit and Tie2 
5.6.1. Hemogenic endothelial cells and nascent blood cells express CD41 
Despite its specific expression on megakaryocytes and platelets in adult mice, CD41 is 
also expressed on emerging blood cells in yolk sac (YS) and the aorta-gonads-
mesonephros (AGM) region (Emambokus et al., 2003). Others have postulated that 
CD41 expression in E8.25 YS cells determines the commitment to the hematopoietic 
lineage and that CD41 is the first marker to define the divergence of hematopoiesis from 
putative hemogenic endothelium during development (Mikkola et al., 2003; Li et al., 
2005). Bertrand et al. found that hematopoietic progenitors identified in the sub-aortic 
patches at day 10.5 of mouse embryogenesis rather express CD41 than CD45 pointing to 
the possibility that CD41 is present on early hematopoietic cells before CD45 becomes 
up-regulated (Bertrand et al., 2005). 
 
To prove that the in vitro observed endothelial to blood cell transitions correspond to the 
in vivo situation, we wanted to test whether CD41 can be detected with the same 
expression pattern in the movies of ESC-derived differentiation cultures as for in vivo 
studies. 
By imaging the differentiation of VE-Cadherin::VENUSClaudin5 ESC-derived mesodermal 
cells in the presence of differently labelled anti-CD41 and anti-CD45 antibodies the 
kinetic appearance and subsidence of marker expression was investigated in endothelial 
to blood cell transitions.  
A blood cell producing monoclonal endothelial colony is depicted in Figure 5.14 and 
Supplemental Movie 5.5. Starting at a time-point in which individual cells could be 
identified within the endothelial sheet colony single cell tracking of one hemogenic 
endothelial cell was performed which is depicted in the corresponding lineage tree. We 
discovered that a colony of monoclonal origin acquires the typical endothelial sheet 
morphology after expressing of VE-Cadherin and forming tight junctions (Figure 5.14, 
first row). Simultaneously these cells adopt an endothelial morphology with some VE-
Cadherin+ tight junctions forming cells specifically binding anti-CD41 antibody (Figure 
5.14, second row). Consequently, all CD41+ cells become semi-adherent and down-
regulate VE-Cadherin::VENUSClaudin5 (Figure 5.14, third row). CD41 expression is 
maintained and shortly after the cells become free-floating CD45+ (Figure 5.14, fourth 
row). 
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Our results show at the single cell level that the expression of CD41 is identical to the 
results obtained in in vivo studies. Clearly, the CD41 antibody only labelled endothelial 
cells that were already committed to the hematopoietic lineage whereas endothelial cells 
devoid of hemogenic potential never expressed CD41 antigen. It could therefore be 
confirmed that CD41 is a very early hematopoietic marker being detectable on nascent 
blood cells and on endothelial cells having committed to the hematopoietic fate already. 
In addition, we could show that CD41 bridges the gap between the hemogenic 
endothelial state and the CD45+ blood cell state at the single cell level as it was 
suggested in previous studies (Bertrand et al., 2005).  
 
 
 
Figure 5.14: Nascent blood cells generated by endothelial cells express CD41 before 
CD45. Part of a pedigree depicting marker expression during hemogenic transition of an EC is shown 
(compare Supplementary Video 5.5). A monoclonal endothelial colony expressing VE-
Cadherin::VENUSClaudin5, but not the hematopoietic cell markers CD41 or CD45 was observed in the 
movie (36 h, arrow). Single cell tracking was started at the time-point when individual cells with 
sheet EC morphology could be identified. Some VE-Cadherin::VENUSClaudin5+ cells with sheet EC 
morphology start expressing CD41 (56 h). All CD41+ cells develop into blood cells (76 h) as identified 
by CD45 staining after they have become free-floating (93 h). 
Scale bar: 50 µm. 
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5.6.2. Hemogenic endothelial cells express c-kit and Tie2 
In order to more clearly define the hemogenic endothelial cells, their expression of c-kit 
and Tie2 was analyzed in time lapse experiments. In addition to adult hematopoietic 
stem cells and progenitors, c-kit is expressed on embryonic blood cells (Okada et al., 
1993; Bernex et al., 1996) and functions as the receptor for SCF (Lyman et al., 1998). In 
addition to its blood-specific expression, c-kit was identified on some endothelial cells 
lining hematopoietic cell clusters in the omphalomesenteric and umbilical arteries of E9.5 
embryos – locations where endothelial cell to blood cell transitions might occur (Yoshida 
et al., 1998). Similarly, a crucial role for Tie2 was postulated for the quiescence of adult 
HSCs (Arai et al., 2004). Identical to c-kit, Tie2 was discovered on hematopoietic and 
endothelial cells in the omphalomesenteric artery of E9.5 embryos as well as in the 
vascular network of E8.25 yolk sacs (Takakura et al., 1998; Li et al., 2005; Ema et al., 
2006). Therefore, c-kit and Tie2 might have a role in the hematopoietic transition of 
endothelial cells. Consequently, their expression was analyzed during the transition 
process. 
Although initial experiments showed that, in contrast to Tie2, the c-kit antibody is only 
detectable very weakly in the living culture, requiring a higher antibody concentration as 
usual, the anti-c-kit antibody could be successfully employed in the living culture without 
manipulating it. Tie2 was detected very brightly and seemed to be strongest in 
intracellular vesicles containing the engulfed receptor and antibody. 
As shown in Figure 5.15 (first row of images) and in Supplementary Movie 5.6, Tie2+ 
cells are observed from day 4.5 of ESC-differentiation. The anti-Tie2 antibody brightly 
labels all cells contained in the hemogenic endothelial sheet colony. Hemogenic 
endothelial cells become semi-adherent, maintain the Tie2 expression and weakly started 
to express c-kit (Figure 5.15 middle row). In contrast, non-hemogenic endothelial cells 
are c-kit negative. While c-kit expression increased on hemogenic endothelial and 
nascent blood cells during the transition, Tie2 was either down-regulated on several 
free-floating blood cells (Figure 5.15 last row) or expressed further on.  
The level of Tie2 expression was the same in ten hemogenic endothelial colonies 
observed in three independent experiments. Since Tie2 is detectable in constant 
amounts on hemogenic, non-hemogenic and eventually on nascent blood cells, this 
suggests that Tie2 is not a critical regulator of endothelial to blood cell transitions. In 
contrast, c-kit was only detected on hemogenic endothelial and nascent blood cells. 
Thus, c-kit marks hemogenic commitment but also does not regulate endothelial cell to 
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blood cell transitions, since its expression begins as soon as the endothelial cell has 
already committed to the hemogenic fate. However, it is possible that c-kit is expressed 
at lower levels in a larger population or at different time points since the anti-c-kit 
antibody is only detected very weakly and potentially under the detection level. 
 
 
 
 
 
 
 
 
 
 
 
 
5.7. Endothelium-derived blood cells can express the myeloid blood 
cell marker Mac1 
The use of an additional blood cell specific marker not only confirms the hematopoietic 
identity of the CD45+ suspension cells but also proves that endothelial cells have the 
capacity to produce lineage restricted blood cells. Although lymphoid cells develop from 
ES cells in the OP9 co-culture they are not detectable until day 14 of ESC-differentiation 
(Nakano et al., 1994). In contrast, myeloid cells expressing Mac1 can be detected from 
day 7 on (Fraser et al., 2002a). Thus, Mac1 is one of the first lineage markers to be 
Figure 5.15: Characterization of hemogenic endothelial cells by the expression of the 
surface markers c-kit and Tie2. A part of a pedigree is shown on the left side depicting marker 
expression during hemogenic transition of an EC. Hours after start of the movie at day 4 of ESC-
differentiation are indicated. Coloured lines to the left of the tree highlight marker expression. In the 
shown colony of monoclonal origin an endothelial cell expressing Tie2 surface marker is depicted 
(32h, arrowhead). Its daughter gives rise to a semi-adherent hemogenic endothelial cell that 
expresses Tie2 and c-kit (52h, arrowhead). Emerging blood cells are strongly positive for c-kit and 
partly down-regulate Tie2 (60h, arrowhead). 
Scale bar: 50 µm. 
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detectable on blood cells in ESC-derived cultures. Therefore, we tested whether blood 
cells produced by endothelium can express Mac1. 
A time-lapse experiment of a differentiation culture containing a mixture of differently 
labelled anti-Mac1, anti-CD41 and anti-CD45 antibodies was performed and analyzed at 
the single cell level. An endothelial colony producing blood is depicted in Figure 5.16 and 
Supplementary Movie 5.7. 
 
 
 
 
 
 
 
 
 
 
Initially, one CD41 expressing nascent blood cell develops from endothelium (Fig 5.16 
first row). As its daughter becomes semi-adherent, CD41 is down-regulated as it is no 
longer detectable by antibody staining anymore. Shortly after, Mac1 expression starts 
with CD45 soon after (Fig 5.16 second and Fig 5.16 third row, respectively). 
This leads to the conclusion that some blood cells co-express CD45 and the myeloid 
marker Mac1. Comparison of five endothelial to blood cell transitions obtained in two 
independent experiments revealed that the temporal onset of Mac1 and CD45 expression 
on individual cells is the same when both are co-expressed. Furthermore, only a portion 
of all blood cells derived from one endothelial colony expresses Mac1 and therefore 
belong to the granulocytic-monocytic lineage (Springer, 1971). Thus, one endothelial 
Figure 5.16: Hemogenic endothelial cells can give rise to Mac1+ cells. ESC-derived 
mesodermal cells were cultivated in the presence of FITC-anti-CD41, APC-anti-CD45 and PE-anti-
Mac1 antibodies. Time after start of the movie is indicated. Arrowheads point to the cell depicted in 
the pedigree on the left. One endothelium-derived CD41+ blood cell does not yet express CD45 and 
Mac1 (56h). One of its daughters up-regulates Mac1 (78h) shortly before CD45 is detectable. 92h 
after start of the movie CD45 and Mac1 but not CD41 are expressed on its descendant. 
Scale bar: 50 µm. 
Results 55 
colony can give rise to blood cells of the granulocytic-monocytic lineage in addition to 
hematopoietic cells of different lineages. 
 
5.8. Hemogenic endothelial cells cannot give rise to smooth muscle 
cells 
Although hemogenic endothelial cells expressed several endothelial markers including 
the morphology, the tight integration into an endothelial sheet, VE-Cadherin expression 
and DiI-Ac-LDL uptake, it remained possible that they are not endothelium but a multi-
potent mesodermal precursor. We therefore tested whether hemogenic endothelial cells 
are capable of generating cells of mesodermal lineages other than blood and 
endothelium. As Flk1+ cells can give rise to mural cells (vascular smooth muscle and 
pericytes) in the OP9 co-culture (Yamashita, J. et al., 2000; Schroeder et al., 2003) we 
tested whether smooth muscle cells can be produced by hemogenic endothelial cells.  
After imaging ESC-derived mesodermal cells with constitutive nuclear label for four days, 
the culture was fixed and stained with an anti-  -smooth muscle actin (α-SMA) antibody 
(Figure 5.17). In the videos cell fates of all cells within hemogenic endothelial colonies 
were analyzed at the single cell level (last image of the movie is shown in Figure 5.17 A, 
left panel) and compared to the end-point staining against α-SMA. Although α-SMA+ 
cells were observed in the culture (Figure 5.17 B), their relationship to hemogenic 
endothelial cells was excluded (Figure 5.17 A, right panel). α-SMA+ cells were never 
generated from any non-hemogenic cell within a hemogenic endothelial colony. These 
findings could be verified in 12 endothelial to blood cell transitions obtained from three 
independent experiments. In summary this means that hemogenic endothelial colonies 
do not have the potential to produce smooth muscle cells. 
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Figure 5.17: ESC-derived hemogenic endothelial cells do not produce 
smooth muscle cells. A time lapse experiment with ESC-derived H2BVENUS+ mesodermal 
cells seeded on OP9 was performed. After 4 days the culture was fixed and the existence of 
smooth muscle cells (α-smooth muscle actin, α-SMA) was verified by immunostaining. While 
suspension cells can change position, morphology and position of adherent cells is preserved 
during fixation. Single cell tracking of the hemogenic colony identified all adherent cells derived 
from the shown colony (A, left panel). Neither of them expresses α-SMA (a, right panel). The 
presence of α-SMA – positive cells in an adjacent position in the same culture is shown as  
positive control for smooth muscle cell generation and α-SMA detection under the used 
experimental conditions (B, arrow). 
Scale bar: 100 µm 
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5.9. Purified mesodermal cells from E7.5 dpc embryos can give rise to 
hemogenic endothelium 
In movies of ESC-derived cultures it was visible that a limited number of endothelial cells 
can produce blood cells within a clearly defined time window. This transition process 
includes a phase in which the hemogenic endothelial cells are semi-adherent and stick to 
the endothelial cells underneath. These results recapitulate in vitro, what has been 
observed in vivo: only during a short time frame during embryogenesis hematopoietic 
clusters stick to the endothelial layer at hematopoietic sites. As was shown here in vitro, 
also in vivo CD41 is observed as the first hematopoietic marker expressed before CD45 
can be detected (Bertrand et al., 2005). Same holds true for c-kit (Okada et al., 1993; 
Bernex et al., 1996; Yoshida et al., 1998) and Tie2 (Takakura et al., 1998; Li et al., 
2005; Ema et al., 2006). It is therefore very likely that the in vitro observed endothelial 
to blood cell transitions also occur in vivo. However, as a final proof for the existence of 
hemogenic endothelial cells, ex vivo time-lapse imaging and single cell tracking of 
purified embryonic cells was necessary.  
Initially, we tested which sorted embryo-derived population could give rise to endothelial 
and blood cells when cultured on OP9. As described for the ESC-derived cultures, cell 
identities were evaluated by the formation of sheet colonies and DiI-Ac-LDL uptake 
(endothelium) as well as suspension cells expressing CD41 (blood). Different embryo-
derived populations were tested with respect to this potential. According to previous 
publications Flk1+VE-Cadherin- mesodermal or Flk1+VE-Cadherin+ endothelial cells may 
fulfil these criteria (Fraser et al., 2002b). In order to prevent contamination of these 
cultures with previously generated blood cells which can also express Flk1 (Choi et al., 
1998; Yoshida et al., 1998; Drake et al., 2000; Li et al., 2005), Flk1+CD41- cells were 
sorted and analyzed.  
De novo hematopoietic activity is detectable in mouse embryos between E6.5 and E11.5. 
It is known that hemogenic cells in E6.5 embryos are extremely few (Kinder et al., 1999) 
which prompted us to use embryos of an older age. Whole embryos of E7.5, E8.5 and 
E9.5 wild-type mice were sorted by FACS and cultured on OP9 in the presence of SCF. 
In four independent experiments it was confirmed that only CD41-Flk1+VE-Cadherin- cells 
from E7.5 embryos were able to produce endothelial sheet colonies and hematopoietic 
cells within 10 days of culture (data not shown). Even if these are cultivated for longer 
time, cells from E8.5 and E9.5 embryos were not able to generate endothelial sheet 
colonies, although free-floating and adherent blood cells as well as DiI-Ac-LDL+ cell 
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clusters were observed in each case. Therefore, only cells from E7.5 embryos have the 
potential to from endothelial sheets. Since sorted CD41-Flk1+VE-Cadherin+ cells were 
only occasionally able to produce endothelial sheet colonies (approx. 3 cells per 25000 
cells seeded had the potential to form sheet colonies) this population was not used for 
time-lapse experiments either. 
In addition, culturing of sorted cells revealed that the colony forming potential of 
embryo-derived cells was much lower than compared to ESC-derived cells, probably due 
to increased apoptotic events of the sensitive embryonic-derived cells. Thus, more cells 
were seeded onto confluent OP9 cells in the following experiments. 
Identical to ESC-derived cultures CD41-Flk1+VE-Cadherin- cells were sorted into CO2-
enriched ESC-differentiating medium, seeded onto OP9 in the presence of DiI-Ac-LDL as 
well as FITC-anti-CD41 antibody, and incubated to enrich medium and gas phase ad 5% 
CO2 for 1h. After sealing the tissue culture flask tightly the time-lapse video was started. 
 
As depicted in Figure 5.18 and Supplementary Movie 5.8, a cell cluster of monoclonal 
origin still negative for the markers DiI-Ac-LDL and CD41 (22h) gives rise to an 
endothelial sheet of which all cells have taken up DiI-Ac-LDL (38h). Some of the cells 
adopt a semi-adherent morphology and express the hematopoietic marker CD41. The 
semi-adherent cells detach after some time, down-regulate the DiI-Ac-LDL uptake and 
are free-floating in the supernatant. Only free-floating cells then brightly express CD41 
with the adherent endothelial cell sheet remaining DiI-Ac-LDL+ and CD41- (55h). 
Altogether this shows that ex vivo cultured mesodermal cells purified from E7.5 dpc 
embryos can differentiate into hemogenic endothelium. It is thus very likely that within 
the developing embryo reside hemogenic endothelial cells. 
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Figure 5.18: Mesodermal cells purified from E7.5 dpc mouse embryos differentiate into 
blood via an endothelial intermediate. Images extracted from Supplementary Movie 5.8. A: 
E7.5 embryos are dissociated and CD41-Flk1+VE-Cadherin- mesodermal cells are purified by FACS 
before they are re-plated on OP9 and recorded by time lapse imaging. Ep: embryo proper, YS yolk 
sac. B: Single cell tracking was started at the time point when individual cells with sheet EC 
morphology could be identified. Part of a pedigree depicting marker expression during hemogenic 
transition of an EC is shown. Time after start of the movie is given. A mesodermal colony that not 
yet expresses endothelial or hematopoietic marker (22h) differentiates into an endothelial colony 
that takes up DiI-Ac-LDL. Some cells with sheet EC morphology take up DiI-Ac-LDL and start 
expressing CD41 (38 h). Upon their differentiation into suspension cells they strongly express the 
hematopoietic cell marker CD41+. 
Scale bar: 50  m if not indicated differently. 
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5.10. Establishment of an embryonic stem cell-line expressing 
tamoxifen inducible Cre 
After proving the existence of hemogenic endothelial cells, the molecular mechanisms 
regulating their determination was investigated. Several transcription factors as Runx1, 
Notch1, GATA-2, SCL/tal1, c-myb and others are hypothesised to play a role in 
embryonic hematopoiesis and might be important for the specification of hemogenic 
endothelium (Swiers et al., 2006; Loose et al., 2007). Previous studies have addressed 
this issue using ESC differentiation systems with overexpression or knocked-outs of 
transcription factors to elucidate their role in embryonic hematopoiesis (Tsai et al., 1997; 
Persons et al., 1999; Yokomizo et al., 2001; Endoh et al., 2002; Kitajima et al., 2002; 
Lacaud et al., 2002; Kitajima et al., 2003; Schroeder et al., 2003; Lacaud et al., 2004; 
D'Souza et al., 2005; Dai et al., 2006). However, the continuous overexpression or 
complete loss of transcription factors can cause a multitude of effects during all 
differentiation steps that lead to unspecific read-outs. To analyze hemogenic 
endothelium which is a rare, transient population of cells, an inducible system is needed 
to manipulate transcription factor expression only at the time point of its specification 
and existence. 
Although regulatory elements could not be identified within my thesis, an ESC cell line 
was prepared that expresses the Cre recombinase when exposed to hydroxytamoxifen 
(OHT). 
 
Cre is a protein isolated from the bacteriophage P1 that catalyzes the site-specific 
recombination of two loxP carrying DNA strands. The loxP sites are two 34 bp 
attachment sites that are recognized, cleaved and recombined by the Cre protein which 
leads to the excision of the loxP-flanked DNA. Similarly, the FLP recombinase from 
Saccharomyces cerevisiae recognizes and recombines two frt-sites in DNA (Lewandoski, 
2001). 
As published by Zhang and Verrou, inducible control of Cre protein was achieved by 
fusing the Cre reading frame to two domains encoding a mutated form of the human 
estrogen receptor ligand-binding domain (ERT2-Cre, TBDCreTBD) that responds to 
tamoxifen (Zhang, Y. et al., 1996; Verrou et al., 1999). In the absence of tamoxifen the 
fusion protein of ERT2-Cre resides in the cytoplasm of the cell bound to the heat-shock 
protein 90 (hsp90). Upon its addition, tamoxifen uncouples the hsp90 from the ERT2-Cre 
protein thereby allowing the transport of the fusion into the nucleus where it implements 
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recombination of the loxP flanked DNA segments (Figure 5.19)(Vallier et al., 2001; Guo, 
C. et al., 2002).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
To activate gene expression the reading frame is located 3’ of the loxP sites which flank 
a STOP cassette that induces a transcriptional arrest at this specific location. Upon 
recombination the STOP cassette is deleted and the open reading frame is transcribed. 
 
To produce an ES cell line expressing tamoxifen-inducible Cre, wild-type EB3 ESCs were 
first transfected with a linearized plasmid carrying the fusion protein of ERT2-Cre driven 
by the chicken beta actin (CAG) promotor and a cytomegalovirus (CMV) enhancer 
(Figure 5.20 A). As this plasmid encodes a puromycin resistance cassette, all stable 
transfected cells could be selected by puromycin. Resistant ESC colonies were picked 
and several monoclonal ES cell lines were established. These were transiently 
transfected with the plasmid pCAGGS-FLPe encoding the enhanced FLP recombinase 
(Schaft et al., 2001) thereby removing the puromycin resistance cassette that is flanked 
by two frt-sites. Successful recombination was tested in a parallel approach with or 
without puromycin to select the clones that are sensitive to puromycin. Although the 
efficiency of FLP catalyzed recombination is supposed to be 70% in undifferentiated 
ESCs (Schaft et al., 2001), only 2.2% (11 of 492 expanded monoclonal ESC lines) of all 
analyzed clones were successfully deleted of the resistance gene in this study.  
 
Figure 5.19: Recombination by 
tamoxifen inducible Cre. In the absence 
of tamoxifen (OHT) the TBDCreTBD is 
inactive because it is bound by hsp90. By 
OHT addition the TBDCreTBD is released 
from the hsp90 and translocates into the 
nucleus. Here, it catalyzes the 
recombination of two loxP sites (triangles) 
flanked DNA. Contains the cleaved DNA a 
transcriptional STOP-cassette, gene 
expression of the 3’ regions is initiated by 
recombination. Figure modified from Guo 
et al., 2002. 
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Inducible gene expression of transcription factors is performed by transfecting a plasmid 
encoding the gene of interest followed by an internal ribosomal entry site (IRES) and a 
fluorescent reporter gene such as VENUSnucmem (Okita et al., 2004). 5’ of the gene of 
interest, the loxP cassette including a puromycin resistance gene as well as the STOP 
cassette and the CAG promoter are localized. To verify the kinetics of gene expression 
the empty vector (without a gene encoding the transcription factor) was stably 
transfected into the OHT-inducible-Cre ESC line. Selection of puromycin resistant 
monoclonal colonies resulted in stable transfected ESC-lines.  
Clones were selected after each step for (i) good mesodermal, endothelial and 
hematopoietic differentiation of ESCs on OP9, (ii) OHT-dependent expression of 
VENUSnucmem after transient transfection with the pCAG-loxP-Puro-STOP-loxP-
VENUSnucmem reporter plasmid (iii) strong expression of the reporter reflecting a high 
Figure 5.20: Generation of ESCs stably expressing OHT-inducible Cre and the empty 
reporter vector pCAG-loxP-Puro-STOP-loxP-MCS-IRES-VENUSnucmem. A: Monoclonal 
ESCs stably expressing OHT-inducible Cre were produced by transfecting pCAG-TBDCreTBD-frt-PGK-
Puro-frt and selecting puromycin (puro) resistant clones. The puro resistance gene was removed 
afterwards by transient transfection with a plasmid encoding the FLP-recombinase which recognizes 
frt sites (black ellipses). B: Resulting monoclonal ESC lines were stable transfected with the reporter 
plasmid pCAG-loxP-Puro-STOP-loxP-MCS-IRES-VENUSnucmem. Transfectants were selected by 
puromycin. Upon OHT-addition the loxP (black triangles) flanked DNA is recombined, the STOP 
cassette is removed and VENUSnucmem is produced. Figure modified from Vailler et al., 2001 and 
Zhang et al., 1996. 
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Cre activity in more than 80% of all cells of each clone and (iv) no expression of the 
VENUSnucmem reporter plasmid when cultured without OHT (leakiness). 
To test the efficiency and the kinetics of the stably transfected tamoxifen-inducible Cre 
an empty vector reporter construct containing Cre inducible VENUSnucmem expression 
vector was electroporated into the OHT-inducible-Cre ESC lines (Figure 5.20 B). Plasmid-
carrying ESC clones were selected by puromycin. In addition to their capacity to 
differentiate into mesoderm, blood and endothelium (data not shown) the established 
ESC lines were tested in respect to VENUSnucmem expression after exposure to OHT. 
 
  
 
 
 
 
 
 
 
 
Figure 5.21: Cre activity in the established undifferentiated ESC line indicated by 
VENUSnucmem expression. Analysis of one (Clone EB3x230-22x407ax309-2 (Clone 1); A,C) and 
two (Clones EB3x230-22x407ax309-2 (Clone 1) and EB3x230-22x407ax309-8; (Clone 2) B ) ESC lines 
that stable expresses OHT-inducible Cre and pCAG-loxP-Puro-STOP-loxP-MCS-IRES-VENUSnucmem is 
shown. A: FACS analysis of undifferentiated monoclonal ESCs gated for living (PI-) cells of the right 
size and granularity (not shown). All cells are VENUSnucmem- when cultured without OHT (left panel). 
91.1% of cells express VENUSnucmem after 3 days of OHT exposure (right panel). B: Two different 
clones were culture with OHT up to 3 days and analyzed by FACS at different time points. 
Approximately 90% of VENUSnucmem up-regulation can be achieved in both tested clones after 72h 
of OHT exposure. C: Images extracted from a time-lapse experiment depicting the onset of 
VENUSnucmem expression within 55h in one ESC clone. Although being of monoclonal origin cells in 
the colony vary in their expression of VENUSnucmem. 
Scale bar: 50 µm. 
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Undifferentiated ESC lines were cultivated with or without OHT and analyzed by FACS for 
the expression of VENUSnucmem. One example is shown in Figure 5.21 A. In the 
absence of tamoxifen no VENUSnucmem expression is detectable demonstrating that the 
Cre activity is tightly controlled. Upon addition of tamoxifen for 3 days 91.1% of 
analyzed cells up-regulated VENUSnucmem, whereas 8.9% are VENUSnucmem- cells 
that failed to recombine and initiate gene and/or protein expression. Similar results were 
obtained from other clones tested. As previously reported, the efficiency of Cre mediated 
recombination and target gene activation is dependent on the ESC clones selected and 
can be a mosaic of recombined (VENUSnucmem+) and not recombined (VENUSnucmem-) 
cells (Zhang, Y. et al., 1996; Lewandoski, 2001; Vallier et al., 2001).  
To study detailed kinetics of the onset of gene expression after addition of OHT, FACS 
analysis was performed at different time points after the addition of OHT (Figure 5.21 
B). Two different ESC-clones are depicted that up-regulate VENUSnucmem expression to 
about 90% within 3 days of OHT induction. This shows firstly that the kinetics of Cre 
activity are very similar in the two tested clones and second that it takes 3 days for 
complete recombination. These results are similar to published data by Zhang, Vallier 
and others who showed that a maximal Cre recombination in undifferentiated ES cells 
can be achieved 75 hours after OHT induction (Zhang, Y. et al., 1996; Vallier et al., 
2001). 
In an additional approach, the applicability of tamoxifen-mediated Cre recombination in 
time-lapse movies was tested. In Figure 5.21 A images from a time lapse experiment 
show the sequential activation of the VENUSnucmem gene in undifferentiated ES cells. 
Again not all cells contained in the colony exhibit the same start and intensity of 
VENUSnucmem expression. All cells shown in Figure 5.21 A derive from a monoclonal 
origin. However, variances in protein expression can be explained by the slow activity of 
tamoxifen-inducible Cre recombinase which results in recombination after the starting 
cell has divided and thus induces gene expression in the progeny at different time-points 
and with different efficiency.  
 
In summary we shown that (i) the Cre recombinase is slowly acting and (ii) that not all 
transgenic cells exposed to OHT express Cre and/or recombine the loxP-flanked DNA 
sequence which is consistent with previous publications. Although these results were 
generated in undifferentiated ESCs and these experiments would have to be repeated 
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with differentiated cells, we don’t think that the Cre expression and recombination is 
faster in cells that have a slower generation time, e.g. mesoderm-derived cells observed 
in time lapse analysis. 
Even though the Cre-loxP system is routinely used in basic research, our analysis 
highlights certain disadvantages that might impair the use of this cell line for the analysis 
of hemogenic endothelium considering that hemogenic endothelial cells are a very small 
population that is only very transiently present in the culture. As the Cre is active during 
three days after induction, the Cre recombinase could be active before or after the time 
of interest. Since in addition only a portion of cells express Cre or recombine at all the 
potentially analysable cell population is even smaller than it already is. Thus, if the OHT-
inducible Cre is employed to gain knowledge about hemogenic endothelium it should be 
considered that the OHT-inducible Cre can hardly be controlled in time. 
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6. Discussion 
 
 
6.1. Endothelial cells can act as direct precursors of blood cells 
We report here that endothelial cells can give rise to blood cells. Time lapse imaging of 
ESC-derived cells allowed the observation of single endothelial cells arising from 
mesoderm during their differentiation into blood. Beside their morphological 
identification, cell identities of endothelial and blood cells were proven by simultaneous 
detection of specific molecular and functional markers. Hemogenic endothelial cells 
express the surface antigens that can also be detected in intraembryonic hemogenic 
sites in the embryo. In addition, hemogenic endothelial cells can give rise to blood cells 
of different types, among them being cells of monocytic-granulocytic lineage. We 
showed that hemogenic endothelial cells and its relatives only produce hematopoietic or 
endothelial cells, thus, the precursor of the hemogenic endothelial colony is bi-potent but 
not multi-potent. Finally, the existence of hemogenic endothelial cells in the developing 
embryo was verified by imaging mesodermal cells purified from E7.5 embryos to 
differentiate into blood via an endothelial intermediate ex vivo. In summary this proves, 
that hemogenic endothelial cells do exist during embryonic development. 
 
Tracing more than 200 single hemogenic endothelial cells within more than 100 
hemogenic endothelial colonies of monoclonal origin showed that only during a short 
time window of differentiation a very limited number of endothelial cells acquires a 
hemogenic fate and differentiates into blood. The hemogenic endothelial cells were 
observed to loosen the connection to the adherent endothelial cell layer and kept contact 
to the endothelium for approximately one day before being released to the supernatant. 
Irrespective of the ESC lines used, all observed endothelial to blood cell transitions were 
highly similar in respect to (i) the frequency of events within the culture, (ii) the number 
of hemogenic endothelial cells within the endothelial sheet colony and (iii) the time 
window in that blood cells are produced from endothelial cells. The identical kinetics 
point to the existence of a complex developmental process that is strongly controlled on 
the cellular and molecular level. 
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Although strong similarities between in vitro ESC-differentiation systems and embryonic 
development in vivo have been demonstrated in many previous studies (Weiss et al., 
1994; Porcher et al., 1996; Nishikawa et al., 1998a; Yamashita, J. et al., 2000; Lacaud et 
al., 2002; Mitjavila-Garcia et al., 2002; Mikkola et al., 2003; Lacaud et al., 2004; 
Hashimoto et al., 2007), the presence of hemogenic endothelial cells in vivo remained 
questionable. Thus, we also visualized ex vivo cultured mesodermal cells purified from 
E7.5 embryos and monitored their differentiation into blood thereby recapitulating the in 
vivo situation. Like ESC-derived cells, embryonic mesodermal cells differentiated into 
endothelial sheet colonies containing cells that adopt a hematopoietic morphology. 
Interestingly, marker expression, morphological changes and kinetics were identical to 
endothelial cell to blood cell transitions observed in ESC-differentiations. This proves that 
ESC-derived mesodermal cells differentiating into endothelium and blood directly copies 
embryogenesis. Both systems in addition resemble in vivo hematopoiesis in several 
features:  
Firstly, de novo hematopoiesis in the mammalian embryo is restricted to a very short 
time frame within development: the YS produces blood between E6.5 and E10.5, the 
AGM region between E9.5 and E12.5 and the placenta between E10.5 to E14.5 (Palis et 
al., 1999; Baron, 2003; Godin et al., 2005; Ottersbach et al., 2005; Rhodes et al., 2008). 
The same holds true for the in vitro and ex vivo observed endothelial to blood cell 
transitions which were only observed to occur between day 6 and day 7.5 in ESC-
differentiations or between day 1 and 2 in primary cell culture but never later.  
Secondly, few hemogenic cells exist in the developing embryo: few cells having 
hemogenic potential exist in the YS (Kinder et al., 1999), in placenta (Ottersbach et al., 
2005) and AGM region (Taoudi et al., 2007) could be hemogenic. Similarly, only about 2 
% percent of endothelial cells present in the in vitro or ex vivo cultures acquire 
hemogenic potential.  
Thirdly, hematopoietic clusters visible in the lumen of the dorsal aorta, the umbilical, 
vitelline and omphalomesenteric arteries at day 11.5 dpc appear to stick to the vessel 
wall (Taoudi et al., 2007). Consistent with this, in in vitro and ex vivo time lapse 
experiments blood emerging from endothelium forms clumps, as well, and maintains the 
contact to the endothelial cells approximately 1 day. 
Fourthly, endothelial and blood cell markers analysed in this study, e.g. CD41, are 
expressed with identical kinetics compared to in vivo analysis in previous publications 
(Mikkola et al., 2003; Bertrand et al., 2005; Li et al., 2005). It was suggested in these 
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studies, since CD41 is detectable as first hematopoietic molecule before CD45, it shows 
the hematopoietic identity already at the endothelial level (Mikkola et al., 2003). We 
observed the onset of CD41 antigen at a time-point when endothelial cells still express 
VE-Cadherin::VENUSClaudin5 and form tight junctions with neighbouring cells. 
Throughout the transition process CD41 is strongly detectable on developing blood cells 
but CD45 can be detected first when blood cells are free-floating. This shows again a 
strong similarity to the in vivo situation.  
Based on the similarities between in vitro, ex vivo and in vivo hematopoiesis an identical 
transition process is very likely to exist in vivo as well. 
 
6.2. Identification of endothelial cells 
The continuous observation of differentiating ESC- or embryo-derived mesodermal cells 
provided evidence for the existence of hemogenic endothelial cells that are 
morphologically, molecularly and functionally undistinguishable from non-hemogenic 
endothelial cells: all cells share identical morphology, organization in sheets, formation of 
tight junctions that incorporate Claudin5, expression of VE-Cadherin and uptake of Ac-
LDL – features that do not hold true for other cell types in our cultures. Although blood 
cells never exhibited these endothelial characteristics here, previous studies could show 
the presence of endothelial markers on nascent embryonic blood cells. Tagging chicken 
embryonic endothelial cells in ovo by DiI-Ac-LDL injection resulted in DiI-Ac-LDL+ 
hematopoietic cells (Jaffredo et al., 1998; Jaffredo et al., 2000). Similarly, Sugiyama 
could identify DiI-Ac-LDL+ erythrocytes and multi-potent precursors in E10.5 mouse 
embryos that were pulsed with DiI-Ac-LDL beforehand (Sugiyama et al., 2003). In 
addition, a low number of VE-Cadherin+CD45+ double positive cells were identified in 
E9.5 or E11.5 AGM regions by others (Fraser et al., 2003; Taoudi et al., 2005) and Kim 
found foetal liver HSCs expressing VE-Cadherin between E13.5 and E16.5 (Kim et al., 
2005). Since the specificity of VE-Cadherin and DiI-Ac-LDL uptake was proven in my 
thesis and by others (Voyta et al., 1984; Breier et al., 1996), it is likely that the blood 
cells still expressed a detectable amount of endothelial markers as a consequence of 
their endothelial origin. Here, it is possible that free-floating blood cells are shortly 
positive for the endothelial markers but that the intensity is beneath our detection level. 
Both markers localize in the cytoplasm as soon as suspension cells have developed: DiI-
Ac-LDL and VE-Cadherin::VENUSClaudin5 which we expect to be internalized and 
degraded in the cytoplasm after separating from the adherent endothelial sheet. As free-
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floating blood cells usually contain a large nucleus, the cytoplasmatic compartment is 
very small. This could explain why we did not detect any staining quickly after cells 
detached from the adherent layer. In contrast, all studies mentioned above proved the 
endothelial markers on hematopoietic cells by FACS analysis, a method that is more 
sensitive compared to the microscope used for the detection of the in culture 
immunostainings.  
However, the used combination of VE-Cadherin expression, DiI-Ac-LDL uptake, tight 
junction formation and morphology allows the clear identification of endothelial cells.  
 
6.3. The bi-potent mother of hemogenic and non-hemogenic 
endothelial cells 
Hemogenic and non-hemogenic endothelial cells derive from one precursor cell. By single 
cell tracking of all its descendants the precursor cell was shown to exclusively produce 
hemogenic and non-hemogenic endothelial cells but not cells of a different lineage, e.g. 
cardiomyocytes. As an additional control its bi-potent character was confirmed by looking 
at smooth muscle cells that are known to develop from the same starting population as 
endothelial cells. Without any exception smooth muscle cells differentiated from a origin 
distinct of hemogenic endothelial cells. Thus, the mother cell of hemogenic and non-
hemogenic endothelial cells is only bi-potential. 
To clarify the identity of the bi-potential founder cells, their expression of all hemogenic 
and endothelial markers employed in the analysis was evaluated. Interestingly the 
common progenitor of hemogenic and non-hemogenic endothelial cells and its mother 
cell was shown to form tight junctions and express VE-Cadherin and Tie2 beginning day 
4.5 of ESC-differentiation. Considering that Tie2, VE-Cadherin and Claudin5 incorporating 
tight junctions are endothelial cell markers, this suggests that the bi-potent mother cell 
displays endothelial characteristics. This interpretation is also supported by the analysis 
of PECAM-1 (data no shown) in embryo-derived cultures. PECAM-1 was also shown to be 
up-regulated at day 0.5 after plating embryonic mesodermal cells. Tie2 and PECAM-1 are 
surface molecules that are in addition to their endothelial expression present on 
embryonic blood cells. But blood cell identity could be excluded by the absence of other 
hematopoietic markers. This clearly shows the endothelial character of the bi-potential 
mother cell. 
The typical endothelial sheet morphology and the incorporation of DiI-Ac-LDL were 
observed to start shortly before hemogenic endothelial cells became semi-adherent. The 
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development of the sheet morphology as well as the uptake of Ac-LDL probably requires 
the activity of a multitude of molecules the expression of which might be delayed in 
contrast to the up-regulation of single molecules as VE-Cadherin, Tie2 and PECAM-1 
expression. The incorporation of Ac-LDL into the membrane of endosomes additionally 
suggests that the dye has to accumulate to reach detectable levels which might also 
delay the detection. 
However, the existence of a bi-potent cell producing one cell with exclusive hemogenic 
and one with solely angiogenic potential, raises the question if an asymmetric cell 
division occurs to generate daughters with different developmental fates. A cell divides 
asymmetrically when cues present during the cell division lead to asymmetric fates of the 
daughters, e.g. asymmetric influence of the niche or protein segregation (Yamashita, Y. 
M. et al., 2003; Faubert et al., 2004). This requires that the asymmetric fate is 
determined during the division process itself and should be detectable at defined time-
points during generation time. Here, we observed that hemogenic characteristics as e.g. 
the onset of semi-adherence, start at distinct time-points in different hemogenic cells 
(data not shown), which suggests that the decision leading to an hemogenic and non-
hemogenic daughter is not correlated to the cell division.  
 
6.4. Specification of hemogenic endothelial cells 
Cell fate decisions can occur as a result of intrinsic or extrinsic cues. Intrinsic signals, for 
example the activity of transcription factors, can modulate gene expression to either 
induce or inhibit a cell fate. Signals influencing the cell fate from outside can be soluble 
factors such as cytokines, growth factors, hormones, secreted proteins or ligands being 
present on neighbouring cells or on surrounding matrix. 
While the analysis of VE-Cadherin, Tie2 and PECAM-1 clearly shows that the mother cell 
already displays endothelial characteristics before giving rise to two daughters with 
different fate, it also points to the dispensability of these molecules for the endothelial to 
blood cell transition itself. If Tie2, PECAM-1 or VE-Cadherin would be important for the 
specification of hemogenic endothelium or the endothelial cell to differentiate into blood 
we would expect the expression to be limited to a subset of cells. As this was not 
observed in the time lapse movies of ESC or embryo-derived mesodermal cells 
differentiating into blood, a significant role for these molecules to influence the transition 
process is very unlikely. This is in accordance with previous publications that show a 
broad expression pattern of Tie2 and PECAM-1 on most endothelial and blood cells 
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(Dumont et al., 1995; Drake et al., 2000; Ema et al., 2006; Takahashi et al., 2007). 
Altogether, the ubiquitous expression of Tie2 and PECAM-1 leads to the conclusion that 
these markers doe not have a specific function in the specification of hemogenic 
endothelium. 
Apart from surface markers expressed on embryonic endothelial and hematopoietic cells, 
many transcription factors have been shown to be indispensable for the initiation and 
regulation of early hematopoesis in vivo and in vitro, e.g. Runx1, SCL/tal1, GATA-2, c-
myb, Notch1 and others (Kallianpur et al., 1994; Minegishi et al., 1999; North et al., 
2002; Kumano et al., 2003; Ling et al., 2004). Hence, it is not yet exactly clear at which 
cellular differentiation level transcription or growth factors act. In particular, it is basically 
unknown whether the listed transcription factors or any cytokines influence the 
appearance of hemogenic endothelium or its transition into blood cells at all or whether 
they function in the proliferation of lateral plate mesoderm, endothelial cells or nascent 
blood cells. To analyse these questions the importance of the transcription factors could 
be analysed by over-expressing or down-regulating them using RNAi and observe the 
effects on the hemogenic transition of endothelial cells at the single cell level.  
 
It was not possible to elucidate the role of transcription factors within the bounds of my 
thesis, but we took a look at external other cues that might lead to the determination of 
a hemogenic fate of endothelial cells. 
 
6.5. Direct interactions with neighbouring OP9 
The frequency of hemogenic endothelial cells in ESC- or embryo-derived differentiation 
cultures is very low although about 50% of seeded mesodermal cells gave rise to 
endothelial colonies. Previously it was seen that ESCs differentiated on OP9 stroma can 
generate venous, arterial and lymphatic endothelium (Kono et al., 2006; Yurugi-
Kobayashi et al., 2006). Since the hematopoietic clusters are only found in the arteries of 
the embryo, we only expected arterial endothelium to produce blood cells in our cultures. 
This could explain why not all endothelial colonies gave rise to a hemogenic subset. 
However, we looked for cues that induce the hemogenic fate of some endothelial cells 
but not of others. 
Initially, we compared hemogenic and non-hemogenic endothelial cells according to their 
behaviour, motility and localization and looked for extrinsic stimuli that might initiate 
hemogenic specification. Accordingly, the importance of direct interactions between 
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immature embryonic and OP9 cells to induce differentiation into blood was shown 
previously: culture of whole E6.5 to E7.5 epiblast mouse tissue on OP9 cells failed to 
give rise to blood cells whereas dissociation of the tissue led to blood formation 
suggesting the necessity of direct interaction of putative hemogenic cells with OP9 
(Kanatsu et al., 1996).  
Addressing the localization of individual cells within the mesoderm-derived colony before 
day 6.0 of ESC-differentiation is difficult as cells form 3 dimensional aggregates. 
However, this same clump formation was observed for hemogenic and non-hemogenic 
endothelial colonies. Taking a closer look at the behaviour of individual cells, hemogenic 
endothelial cells in sheet colonies neither preferred to localize at edge (facing OP9) or in 
the centre (facing other endothelial cells) of the colony. In conclusion there was no 
obvious difference in behaviour between hemogenic and non-hemogenic endothelial cells 
or colonies. 
 
It is known from other studies that the surface marker expression of cells can be 
influenced by shear forces. Endothelial cells exposed to shear stress by constant blood 
flow or vascular remodelling can differ in the expression of surface markers as PECAM-1, 
Flk1 and others (Abumiya et al., 2002; Albuquerque et al., 2002; Fujiwara, 2006). 
Furthermore, vascular remodelling of mouse yolk sacs was shown to be affected by 
shear forces (Lucitti et al., 2007). Since it is known that the appearance of hematopoietic 
clusters in the developing aorta is strongly coordinated with the fusion of the initially 
paired aortae (Pardanaud et al., 1996; Pouget et al., 2006), suggests that the vascular 
remodelling induces the formation of intraaortic clusters. Thus, we wanted to know 
whether the hemogenic capacity of endothelium is induced by neighbouring dividing OP9 
cells. Cell divisions of adherent cells are accompanied by stretching of the cell body and 
strong rearrangements of the cytoskleton thereby producing shear forces that directly 
act on surrounding cells. Although it is possible that surface marker expression might be 
altered by shear forces, this could not be proven for endothelial cells to adopt a 
hemogenic fate. 
 
6.5.1. Cytokines, growth factors and secreted proteins 
Although the differentiation cultures performed within this study strongly rely on suitable 
serum as no cytokines apart from SCF were added to the culture, the importance of OP9 
cells is crucial, too. Notably, the quality of OP9 cells was discovered to be one of the 
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most critical factors for the observation of endothelial to blood cell transitions in this 
study. OP9 cells more than 25 passages old or an OP9 layer with a very high amount of 
adipocytes were not sufficient to support the generation of blood cells from endothelium. 
Even though, whether this leads to the loss of cytokine secretion, to the increased 
production of inhibiting signals or to defective cell-cell interactions is unclear. 
In the literature, the OP9 differentiation system was mostly employed as a preparation 
for in vivo studies or to identify intrinsic differentiation mechanisms. As OP9 cells 
themselves were never analysed in greater detail, little is known about their ability to 
produce cytokines, secrete proteins or express surface molecules themselves. The 
analysis of the biology of OP9 cells is difficult because they are polyclonal, consist of a 
variety of cell types (stroma cells, mesenchymal cells, adipocytes) and easily loose their 
supportive capacity. Although the importance of the stroma for hematopoietic 
differentiation is known, its precise role in the establishment of the hematopoietic system 
is currently unclear. 
Recent publications analysed the conditions in the dorsal aorta and tried to identify 
factors that promote the formation of hematopoietic clusters (signalling from ventral, the 
gut and sub-aortic patches). Consequently, IL-3 was discovered to enhance the 
production or expansion of HSCs in the AGM region (Robin et al., 2006) as well as BMP4, 
Activin A, bFGF and VEGF (Durand et al., 2007). While this in summary explains that 
VEGF, IL-3, BMP4, Activin A and bFGF contribute to the establishment of mouse 
hematopoiesis it remains unclear at which cellular differentiation state these factors act: 
whether they induce the hemogenic fate of endothelial cells, induce proliferation of the 
existing hemogenic endothelial or hematopoietic cell pool cannot be answered yet.  
 
We observed endothelial cells to produce blood cells in a culture that is supplemented 
with 10% FCS containing a multitude of soluble factors which influence the 
differentiation process: growth factors, cytokines and secreted proteins that were 
postulated to induce hematopoietic fates in mouse, chicken or ESC differentiation studies 
previously (Johansson et al., 1995; Kanatsu et al., 1996; Pardanaud et al., 1996; North 
et al., 2007). The importance of serum was recently analysed by Era et al. who showed 
that sorted VE-Cadherin+ ESC-derived cells plated on OP9 stroma could give rise to 
hematopoietic cells only when cultivated in serum-containing media but not under 
serum-free conditions (Era et al., 2008). Along the same line, ESC-derived VE-
Cadherin+Ter119-CD45- cells sorted at day 5 of differentiation can give rise to blood cells 
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on type IV collagen coated dishes, a culture in which the mesodermal differentiation 
occurs in the absence of OP9, but only if cultivated in the presence of serum and growth 
factors including SCF, VEGF, IL-3, erythropoietin and G-CSF (Nishikawa et al., 1998a). In 
contrast, Hashimoto failed to induce hematopoiesis from VE-Cadherin+CD41- ESC-derived 
cells isolated at day 5 of differentiation cultured with serum and IL-3, SCF, G-CSF and 
erythropoietin on collagen IV coated dishes whereas the same population was able to 
generate blood cells if cultured on OP9 stroma (Hashimoto et al., 2007). Some evidence 
of OP9 cells to promote endothelial differentiation by secretion of Angiopoietin 1 (Ang1) 
and VEGF was proven by Matsumara and co-workers (Matsumura et al., 2003). In 
addition, OP9 cells were shown to secrete interferon-γ (IFN-γ), interleukin-3 (IL-3) and -6 
(IL-6) (Groger et al., 2004). 
VEGF, which might be the inducer of the hemogenic potential of endothelial cells, is the 
ligand of the surface receptors tyrosine kinases VEGFR-1 (=Flt1), VEGFR-2 (=Flk1) and 
VEGFR-3 (=Flt4), all of them acting in concert to modulate vasculogenesis, angiogenesis 
and hematopoiesis (Hamada et al., 2000). Accordingly, an important role of VEGF 
signalling for the determination of hemogenic fate was suggested previously in quails 
(Eichmann et al., 1997), chicken (Pardanaud et al., 1999) but also in ESC-differentiation 
systems where hemangioblasts differentiated into committed hematopoietic precursors in 
a serum-free culture containing VEGF (Park et al., 2004; Pearson et al., 2008). However, 
whether this shows that VEGF instructs a hemogenic endothelial fate instead of 
increasing proliferation and expansion of present angioblasts or putative hematopoietic 
endothelial cells in favour of hematopoietic cells is unclear and would have to be 
analysed at the single cell level.  
In summary the differentiation of mesoderm into hemogenic endothelium probably relies 
on a multitude of factors that are either provided by the serum or by the OP9 cells. In 
future studies, OP9 cells sould be manipulated by viral transduction to over-express or 
down-regulate putatively involved proteins in combination with a reporter protein, e.g. 
VENUS. These cells could be mixed with un-manipulated cells to induce local patches of 
OP9 cells with normal or enhanced/decreased protein expression. By time lapse 
microscopy it could be evaluated whether hemogenic endothelial cells preferentially arise 
in close proximity to transduced OP9 cells. 
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6.5.2. Down-regulation of tight junctions 
While adherent endothelial cells transform into free-floating blood cells, tight junctions 
were observed to be loosened. This raises the question whether the down-regulation of 
tight junctions actively induces the differentiation of endothelium into hematopoietic 
cells. Whether blocking tight junctions, e.g. by using blocking antibodies, enhances the 
production of blood cells was not tested within this study, but is unlikely as tight 
junctions are still present when the hemogenic fate of single endothelial cells becomes 
obvious: Claudin5 incorporating tight junctions can be observed when semi-adherent 
cells up-regulate CD41+ and c-kit+, the first hematopoietic markers to be expressed. This 
proves that the hemogenic fate of endothelial cells is decided prior to the down-
regulation of tight junctions and consistent with previous results showing that tight 
junctions between endothelial and blood cells exist in the intra-aortic hematopoietic 
clusters (Bollerot et al., 2005). Similarly, Matsumura showed that the addition of a 
blocking antibody against VE-Cadherin antibody, a molecule that is stabilizing tight 
junctions in endothelial cells, to the living culture leads to dispersion of endothelial 
sheets but not to detaching of cells (Matsumura et al., 2003). In addition VE-Cadherin 
knockout-mice still establish multi-lineage yolk-sac hematopoiesis with normal but not 
increased numbers of blood cells (Rampon et al., 2003).  
Thus, although present, tight junctions are dispensable for the establishment of the 
hematopoietic system and play no role in cell specification.  
 
6.6. Endothelial cell identity and different types of endothelial 
colonies 
To judge whether developing blood cells derive from cells with a unequivocal endothelial 
identity, the endothelial character was verified by the combination of morphological, 
molecular and functional criteria. The sheet-like morphology was considered to be one of 
the most reliable characteristics because this morphology was shown in several previous 
studies to be typical for clonally grown ESC-derived endothelial cells on OP9 stroma 
(Hirashima et al., 1999; Yamashita et al., 2000; Matsumura et al., 2003; Schroeder et 
al., 2003). Consistent with this, our read-out has proven to be very stringent as all sheet 
colonies expressed VE-Cadherin, formed tight junctions and incorporated DiI-Ac-LDL 
when analysed in the movies.  
Additionally, colonies expressing functional and molecular markers specific for 
endothelium (DiI-Ac-LDL+, VE-Cadherin+ and presence of tight junctions) but lacking the 
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typical sheet morphology were observed. A few recent studies described cord-like 
endothelial colonies derived from Flk1+ ESC-derived cells cultured on OP9 or on collagen 
IV (Hirashima et al., 1999; Matsumura et al., 2003; Kono et al., 2006; Hashimoto et al., 
2007). Matsumura and collaborators deduced that cord-like endothelial colonies result 
from VEGF induced signalling through VEGFR-3 leading to dispersed colony morphology. 
Although no exogenous VEGF was added in the cultures in this study, VEGF is produced 
in small amounts by OP9 cells which might induce the formation of cord-like endothelial 
colonies (Matsumura et al., 2003). As OP9 cells are a polyclonal cell line it is possible 
that VEGF is produced unevenly, leading to local patches and accumulation of VEGF 
where cord-like endothelial colonies are induced.  
The biological nature of the cord-like endothelial colonies in comparison to the sheet-like 
endothelial colonies is at the moment unclear because they were never compared in 
detail. OP9 cells support differentiation of ESCs into various types of endothelial cells as 
venous, arterial and lymphatic endothelial cells (Kono et al., 2006; Yurugi-Kobayashi et 
al., 2006). Although unlikely, a different subtype of endothelial cells could explain the 
different morphologies. We showed that cord-like and sheet-like endothelial colonies give 
rise to blood with about the same frequency pointing to strong similarities between both 
types. Interestingly, blood production from cord-like endothelial cells followed the same 
sequential pattern but lacked a semi-adherent intermediate phase. This suggests that 
semi-adherence is not a part of the mechanism or needed for the blood cells to develop 
but instead is mediated by surface molecules expressed on endothelial sheet but not on 
endothelial cord-like colonies.  
In addition to emerging blood cells sticking to the sheet-like endothelial colony, blood 
cells were observed to stick to one another forming hematopoietic clusters in the movies. 
Although an endothelial-hematopoietic interaction is missing in cord-like endothelial 
colonies producing blood, nascent hematopoietic cells formed clusters just like blood 
cells derived from endothelial sheets. This suggests that the molecules involved in both 
kinds of interaction (endothelial-to-blood and blood-to-blood) are different. 
 
6.7. Identification of hematopoietic cells 
Apart from their free-floating morphology emerging blood cells were identified by in 
culture immunostaining. The presence of fluorescently labelled antibodies in the culture 
while a movie is recorded allows not only the detection of living blood cells without 
manipulating the culture but also shows the expression of transiently present antigens. 
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Consequently, typical hematopoietic markers such as CD45, CD41 and Mac1 were 
employed in time lapse experiments. Consistent with previous publications, CD41 was 
transiently expressed on nascent endothelium-derived blood cells, and, shortly 
overlapping with CD41, most free-floating blood cells up-regulated the pan-
hematopoietic antigen CD45, some of which also stained for the monocytic-granulocytic 
marker Mac1. Whereas the use of CD45, CD41 and Mac1 clearly distinguished blood cells 
from cells of other lineages, it leaves room for speculations about the identity of the 
hematopoietic cells. 
 
6.7.1. Are hematopoietic stem cells generated from hemogenic 
endothelium? 
Mac1+ cells were shown to arise from hemogenic endothelium. As Mac1 is expressed on 
monocytic and granulocytic cells (Springer, 1971) we concluded that endothelial cells can 
generate blood cells of the myeloid lineage. In addition, Mac1 is detectable on foetal 
HSCs, which can be purified from E14.5 embryos by the surface marker profile 
Thy1lowSca1+lineage-Mac1+ (Bertrand et al., 2005; Kim et al., 2005). However, the 
possibility that HSCs are produced from ESC-derived endothelium in this study is unlikely 
for two reasons: embryonic HSCs were shown not to express CD45 purified from E10.5 
AGM regions (Bertrand et al., 2005). Here, Mac1 was expressed by the same cells that 
also stained brightly for CD45. This proves that Mac1+ exclusively stains 
monocytes/macrophages and granulocytes in this culture. Second, in vitro differentiation 
of ES cells into HSCs that are able to reconstitute adult recipients was never performed 
successfully without genetic manipulation of the ES cells (Wang et al., 2005), thus HSCs 
probably do not arise in this culture or cannot be maintained. Alternatively, putatively 
generated HSCs need to be transferred into the proper environment to maintain or 
develop their stem cell characteristics, e.g. the fetal liver of newborn mice that has the 
capacity to maintain foetal HSCs. 
 
6.7.2. Living blood cells not expressing CD45 
In addition to CD45+ and Mac1+ cells, we also observed suspension cells negative for 
both markers arising from endothelium. CD45 is a pan-hematopoietic marker that is at 
least transiently expressed on all nascent blood cells including erythrocytes, which are 
the only lineage that down-regulate CD45 after maturation (Kina et al., 2000). However, 
very big free-floating CD41hi blood cells that did not show CD45 expression were 
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observed in the movies at day 8 of ESC-differentiation. According to their large 
morphology and their expression of CD41 these cells are probably megakaryocytes which 
normally express CD45. This means that not all cells expected could be stained by in 
culture immunostaining, but whether this results from the inability of cells of certain 
lineages to bind the antibody under these conditions is unclear at the moment. In the 
future, this should be tested by incubating differentiation cultures in the presence of 
labelled antibodies until mature blood cells are present. All cells from the culture should 
be flushed off, immunostained with various antibodies reliably identifying certain 
lineages and FACS analysed.   
 
6.8. Does hemogenic endothelium produce primitive or definitive type 
blood cells? 
Definitive and primitive type blood cells co-exist in the developing embryo. Whether 
hemogenic endothelium produces either or both of them is currently unknown. 
Results found by others rather suggest a distinct origin of both. Analysing the 
haemoglobin-chain of suspension cells, Nakano and co-workers characterized the kinetic 
appearance of erythrocytes and found that, identical to the embryo, erythrocytes arise in 
two waves in ESC-differentiations. Primitive erythrocytes were generated predominantly 
before day 7 of ESC-differentiation and definitive erythrocytes did not arise until day 8 
after induction of ESC-differentiation (Nakano et al., 1996). In addition to the different 
timing, only primitive but not definitive erythrocytes can still be generated after blocking 
signalling through c-kit, thereby pointing to distinct origin (Ogawa et al., 1993; Nakano 
et al., 1996). This view is supported by a different study in which VE-Cadherin+ cells 
purified from mouse embryos only had a minor capacity to produce primitive type 
erythrocytes (Fraser et al., 2002b) whereas these cells were able to give rise to multi-
lineage blood of the definitive type. This hints towards an endothelial origin of definitive 
type blood and to a non-endothelial origin of primitive hematopoietic cells. 
Here, in addition to blood cells arising from endothelium, hematopoietic cells produced 
from a non-endothelial source were observed in time lapse movies. Quickly dividing free-
floating blood cells of non-endothelial origin were generated from very few (2 or 3 
mesoderm-derived cells) adherent cells that were not forming a colony. The free-floating 
cells were observed to all die by day 8 pointing to their primitive character. Since 
primitive erythrocytes decrease until day 8 of ESC-differentiation in the study explained 
before (Nakano et al., 1996), it is very likely that this early wave of hematopoietic cells 
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represents primitive type blood whereas definitive type blood arises from endothelial 
colonies around day 8 of differentiation.  
Besides primitive erythrocytes also primitive megacaryocytes and monocytes exist in the 
embryo (Palis et al., 1999; Tober et al., 2007). Whether the latter two are generated 
from ESCs is questionable and rather difficult to analyse as these cells are poorly 
characterized and few markers are known to unequivocally distinguish definitive and 
primitive blood lineages. A potential endothelial origin of primitive megacaryocytes, 
macrophages and monocytes can therefore not be excluded. 
Thus, the only molecular marker clearly distinguishing primitive from definitive type 
blood so far is embryonic haemoglobin that is expressed by primitive erythocytes but not 
by definitive erythrocytes. As haemoglobin is an intracellular molecule, the addition of 
labelled antibody detecting foetal haemoglobin can not be detected in living cultures. To 
address this question, an transgenic ESC or mouse line expressing a fluorescent reporter 
protein controlled by the regulatory sequences for foetal haemoglobin should be imaged 
and analyzed at the single cell level. 
 
6.9. Correlations to extra- and intraembryonic hematopoeisis 
Hemogenic endothelial cells potentially exist in all hemogenic places, the yolk sac, the 
AGM region or the placenta. ESCs differentiated on OP9 produce primitive hematopoietic 
cells on one hand and lymphoid cells on the other (Nakano et al., 1994; 1996). This 
suggests that ESC-differentiation systems share features of YS hematopoiesis, which is 
the only location that produces primitive blood (Palis et al., 1999), and hematopoiesis of 
AGM region or the placenta, since only these locations have the intrinsic potential to 
produce lymphoid cells (Cumano et al., 1996; Rhodes et al., 2008). 
 
Convincing proof for the production of blood cells from endothelium either in the YS or in 
intraembryonic sites requires time lapse microscopy of living embryos. Due to the 
inaccessibility of living embryonic hematopoietic tissues these experiments cannot be 
performed yet. The primary cultures established from dissected E7.5 embryos in this 
study included a mixture of cells from YS and embryo proper. At this stage the P-
Sp/AGM region has not yet developed which points to the YS as the origin of 
mesodermal cells giving rise to hemogenic endothelium, consequently. However, in E7.5 
to E8.0 embryos, the para-aortic splanchnopleura has intrinsic potential to generate 
hematopoietic cells after ex vivo culture (Cumano et al., 2001). This leaves the possibility 
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open that E7.5 embryos contain intra-embryonic mesodermal cells that produce 
hemogenic endothelial cells. We thus cannot conclude whether the hemogenic 
endothelium maturing from E7.5 purified mesodermal cells observed in this study 
derived from intra-or extra-embryonic origin. To answer this question, the YS should be 
manually separated from the embryo proper during the dissection procedure and imaged 
in a different culture from cells deriving from the embryo proper. 
 
6.10. Interests for post-natal hematopoiesis 
Here, we have shown that nascent endothelial cells can have a hemogenic potential 
within a short time window of the differentiation. As pointed out previously this is in 
accordance with the findings obtained from in vivo studies that suggested a very 
transient existence of hemogenic cells. Consistent with this, markers that are initially 
expressed on endothelial and on blood cells are down-regulated on one or the other cell 
type, e.g. Runx1 or SCL/tal1 which are restricted to blood cells in postnatal life. Even 
though a bi-potential precursor cell of hematopoietic and endothelial cells in postnatal 
life was suggested in recent publications. 
Wu et al showed that a CD34+CD133+ population from human umbilical cord blood can 
gave rise to endothelial and to hematopoietic cells (Wu et al., 2007). Bailey et al could 
transplant adult hematopoietic stem cells that contributed to the vasculature in the 
recipient animal (Bailey et al., 2004). Moreover, upon isolation of CD34+Flk1+ cells from 
human bone marrow and cord-blood could give rise to endothelial and hematopoietic 
cells (Pelosi et al., 2002). It was thus claimed that a bi-potential cell giving rise to 
endothelium and blood exists in post-natal life.  
Within the time window we observed hemogenic endothelial cells only exist during a 
short time and endothelial cells loose the potential to achieve a hemogenic fate after 
passing this critical time window. It is very likely that unknown intrinsic factors modulate 
the capacity of endothelium to differentiate into blood and that the required molecules 
are expressed only during a certain maturation state. We in addition think that extrinsic 
cues are important to acquire a hemogenic fate. Probably these factors might be present 
at later stages of development or adult life and could thus maybe convert non-
hemogenic into hemogenic cells. Thus, the complete absence of adult hemogenic 
endothelial cells cannot be ruled out. 
The difficulty of the identification and analysis of bi-potential endothelial cells lies in the 
lack of knowledge about them and in the small number of hemogenic endothelial cells 
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that can only be analysed at the single cell level. Thus, whether CD34+Flk1+ or 
CD34+CD133+ cells are a homogeneous or a heterogeneous population of cells is unclear 
and requires single cell analysis to convincingly prove the existence of hemogenic 
endothelial cells in postnatal or adult life. 
 
We propose a model (Figure 6.1) summarizing the results obtained in our study showing 
that mesodermal cells can differentiate into hemogenic endothelial cells before giving 
rise to blood cells. Using time lapse imaging and single cell analysis this study solves for 
the first time the controversy of the existence of hemogenic endothelium. This 
contributes significantly to the basic understanding of the origin and development of the 
mammalian hematopoietic system. 
 
  
 
 
 
 
 
 
 
Figure 6.1: Model summarizing the results generated within this study. Mesodermal cells 
were shown to give rise to endothelial cells that display typical molecular and functional endothelial 
characteristics. They can produce daughters of different fate: non-hemogenic and hemogenic 
endothelial cells, both of which express identical endothelial markers. With ongoing differentiation, 
hemogenic endothelial cells up-regulate early hematopoietic molecules and down-regulate 
endothelial markers. Finally, hemogenic endothelial cells differentiate into blood cells that express 
several hematopoietic but no endothelial markers anymore. 
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7. Experimental Procedures 
 
 
7.1. Molecular biology 
7.1.1. Purification of plasmid DNA 
High copy plasmids were purified from competent bacteria using the Qiaprep Spin 
Miniprep Kit or the Qiagen Plasmid Maxi Kit (cat no 27104 and 12165, respectively, 
Qiagen, Hilden, Germany). All DNA was solved in sterile bi-distilled water. 
 
7.1.2. Construction of plasmid DNA 
DNA was constructed using the Clone Manager software 7, 8 and 9 Professional Edition. 
 
7.1.3. Transformation of bacteria 
To transform bacteria with plasmids, heat-shock competent Escherichia coli (DH5 ) 
were defrosted on ice for about 15 to 30 min. 25 ng plasmid DNA or the entire heat 
inactivated ligation cocktail were added to 50  µl bacteria. After incubating for 0.5 h on 
ice, cells were heated to 42°C for 45 sec before cooling them in ice for 2 min. Cells were 
mixed with 0.5 ml LB (LB Broth Base, cat no 12780-029; Invitrogen, Karlsruhe, 
Germany) medium without any antibiotics and kept on 37°C constantly shaking. 40 and 
400 µl bacteria were plated on LB agar plates containing the required antibiotic, 
respectively, and cultured over night at 37°C. 
 
7.1.4. Restriction digestions and ligations 
Restriction digestions and ligations were carried out using enzymes and suitable buffers 
from NEB (New England Biolabs, Ipswich, USA) or Fermentas (St.Leon-Roth, Germany) 
according to the manufacturer’s instructions. 
 
7.1.5. Agarose gels 
After digestion DNA fragments were separated on 0.8 to 2% agarose gels prepared with 
in TAE (Tris: cat no 5429.2, Roth, Karlsruhe, Germany; Acetate: cat no 1.00063.2511, 
Merck, Darmstadt, Germany; EDTA disodium salt dihydrate: cat no 8043.2, Roth, 
Karlsruhe, Germany), agarose (cat no 8700500, Biozym, Oldendorf, Germany) and 
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Ethidium bromide (cat no 2218.2, Roth, Karlsruhe). DNA fragments were separated with 
a voltage between 70 and 200 V in TAE-buffer depending on the size of gels. 
 
7.1.6. Purification of DNA fragments 
DNA fragments were cut out from agarose gels using a scalpel and purified from the 
agarose gel using the QIAEX II Gel Extraction Kit or the QIAQUICK Gel Extraction Kit (cat 
no 20021 and 28704, respectively, both Qiagen, Hilden, Germany). Purification of PCR 
products was performed using the QIAquick PCR Purification Kit (cat no 28104, Qiagen, 
Hilden, Germany). 
 
7.1.7. Sequencing 
For sequencing, DNA and primers were sent to MWG, Ebersberg, Germany. 
 
7.2. Preparation of DNA for stable transfection 
7.2.1. Phenol-Chloroform purification 
Proteins and salts were removed from the DNA by Phenol-Chloroform purification. In 
detail, Phenol-Chloroform-Isoamylalkohl (25/14/1, cat no P2069, Sigma, Taufkirchen, 
Germany) was added to the reaction at the same volume and vortexed and centrifuged 
for 5 min at a speed of 19940 RCF. The aqueous layer was transferred into a new 
reaction tube and mixed with the equal volume Chloroform (cat no 1.02432.2500, Merck, 
Darmstadt, Germany), centrifuged and the aqueous layer was again purified with 
Chloroform twice. Afterwards the DNA was precipitated by Ethanol. 
 
7.2.2. Ethanol precipitation 
DNA sedimentations were carried out with Ethanol. To the solved DNA 10% of volume 3 
M Sodiumacetate buffer solution (cat no S7899, Sigma, Taufkirchen, Germany) and 2 
volumes of 100% Ethanol (EtOH, cat no 1.00983.2511, Merck, Darmstadt, Germany) 
were added and incubated 1 h at -80ºC. The sample was centrifuged for 15 min at 4ºC 
with 19940 RCF. The pellet was washed once with pre-cooled 70% EtOH carefully and 
centrifuged again before removing the supernatant. The pellet was dried on air for 
several minutes and solved in water. 
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7.3. LIF production 
To produce leukemia inhibitory factor (LIF), calcium chloride (CaCl2) competent bacteria 
(cat no 200235, Stratagene, La Jolla, USA) were transfected with the plasmid pGEX-2T-
MLIF-amp encoding the LIF protein according to the manufacturer’s instruction. Bacteria 
were plated onto 50 µg/ml ampicillin sodiumsalt (amp, cat no K039.1, Roth, Karlsruhe, 
Germany) containing LB agar plates, cultivated over night before a monoclonal colony 
was picked, transferred to 50 ml liquid LB-medium containing amp and again incubated 
over night.  
The following day, the bacteria culture was mixed with 500 ml fresh LB medium with 
amp and cultivated in the presence of 0.5 ml 100 mM isopropyl-ß-D-
thiogalactopyranoside (IPTG, cat no 2316.3, Roth, Karlsruhe, Germany) until the optic 
density of the culture was between 0.6 and 1. During the incubation, glutathione-
sepharose beads (Glutathione Sepharose high Performance, cat no 17527901, 
Amersham Bioscience, Piscataway, USA) were prepared. 5 ml bead solution was 
centrifuged 2 min at 1250 RCF and washed three times with 20 ml MTPBS. The MTPBS 
was prepared from 150 mM NaCl (cat no S/3160/65, Fisher Scientific, Schwerte, 
Germany), 16 mM Na2HPO4 x 2 H2O (cat no T876.2, Roth, Karlsruhe, Germany) and 4 
mM NaH2PO4 x 2 H2O (cat no 1.06346.1000, Merck, Darmstadt, Germany) in bi-distilled 
water and the pH was adjusted to 7.3 with HCl (cat no K028.1, Roth, Karlsruhe, 
Germany). The pellet was solved in 50% of the resulting volume MTPBS (1.5 ml MTPBS 
per 3 ml beads) and stored at 4 °C.  
The bacteria were sedimented for 5 min at 4230 RCF at 4 °C and solved in 5 ml MTPBS. 
In the following, bacteria were only kept on ice. The bacterial suspension was sonificated 
four times for 15 sec at 90% with 20 sec pauses in between. 0.5 ml 10% Trition-X-100 
(cat no 3051.2, Roth, Karlsruhe, Germany) was added before vortexing the suspension 
and incubating it on ice for 5 min. The LIF-containing supernatant was obtained by 
harvesting the solution for 5 min using 12000 RCF at 4 °C. Afterwards the supernatant 
was collected in a 50 ml polypropylene tube and stored on ice. 5 ml of supernatant was 
added to 2-2.5 ml solution of glutathione-sepharose beads and gently shaken at 4 °C for 
2h. 10 ml pre-cooled 20% D(+)sucrosis (cat no 9286.1, Roth, Karlsruhe, Germany) 
solved in MTPBS was carefully added to the beads and sedimented for 5 min at 1250 
RCF. After removing the supernatant, the beads are washed twice with 10 ml buffer 1 
(1% Triton-X-100 in MTPBS) and once with 10 ml elution buffer prepared from 50 mM 
Tris pH8.5 (cat no 5429.2, Roth, Karlsruhe, Germany), 150 mM NaCl (cat no S/3160/65, 
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Fisher Scientific, Schwerte, Germany) and 2.5 mM CaCl2 x 2 H2O (cat no 5239.1, Roth, 
Karlsruhe, Germany). Finally the beads were re-suspended in 750 µl elution buffer. The 
thrombin (cat no 27-0846-01, Amersham, Bioscience, Piscataway, USA) was solved in 
450 µl elution buffer and 150 µl were added to the bead solution. The mixture was 
incubated over night at 4 °C and shaken gently.  
The next day, the beads were sedimented at 4 °C with 4300 RCF and washed with 2 ml 
elution buffer five times. All washing solutions were collected separately at 4 °C. 10 µl of 
each eluted fraction and few µl of commercially available LIF (cat no ESG1107, Millipore, 
Schwalbach, Germany) were mixed with 2.5 µl 1M DTT (cat no D0632, Sigma, 
Taufkirchen, Germany) and 12.5 µl 2 x SDS Bluebuffer separately. The Bluebuffer was 
was prepared from 12.5 ml 1.25 M Tris/HCl pH 6.8, 5 g SDS (cat no 2326.2, Roth, 
Karlsruhe, Germany), 12.5 ml 2-mercaptoethanol (cat no M6250, Sigma, Taufkirchen, 
Germany), 25 ml glycerine (cat no 3783.2, Roth, Karlsruhe, Germany) and some 
bromphenolblue (cat no 8122.0005, Merck, Darmstadt, Germany). All samples were 
separated by SDS-PAGE according to standard methods for 1h at 125 V. The gel was 
stained with Coomassie Blue using a staining solution prepared from 0.1% Coomassie 
Brilliantblue R250 (cat no A1092.0010, AppliChem, Darmstadt, Germany), 20% methanol 
(cat no 1.06007.2500, Merck, Darmstadt, Germany), 10% acetic acid (cat no K33632663 
432, Merck, Darmstadt, Germany) over night at RT. To remove access staining solution, 
the gel was de-stained with 20% Methanol and 10% Acetic acid in water for 4h at 60 °C 
in the water bath. During this time, the de-staining solution was exchanged three times 
and the gel was shaken gently. Finally, the gel is washed with bi-distilled water for 15 
min at RT while carefully shaking. Finally, the size of the LIF protein was compared to 
commercially available LIF. Both had to have a size of 23.4 kDa. 
Whether the produced LIF can keep ESCs undifferentiated, EB3 ESCs were cultured in 
maintenance medium containing different concentrations of the produced LIF for more 
than 14 days and microscopically compared to a culture containing commercially 
available LIF (107 U/ml, cat no ESG1107, Millipore, Schwalbach, Germany) which was 
used at a concentration of 1500 U/ml. In following experiments, the produced LIF was 
used in the concentration that was suitable to keep ESCs undifferentiated. 
 
7.4. Cell culture 
All cells were cultured at 37°C, 5% CO2 and 95% relative air humidity in a standard 
tissue culture incubator (Microbiological Incubator CD210; Binder; Tuttlingen, Germany). 
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All centrifugation steps were carried out with 200 RCF for 5 min if not indicated 
differently. Washing of cells was performed using sterile PBS prepared from 8 g NaCl 
(cat no S/3160/65, Fisher Scientific, Schwerte, Germany), 0.2 g KCl (cat no 4936.1000, 
Merck, Darmstadt, Germany), 0.2 g KH2PO4 (cat no 1.04873.1000, Merck, Darmstadt, 
Germany) and 1.18 g Na2HPO4 (cat no T876.2, Roth, Karlsruhe, Germany) in 1 l bi-
distilled water and sterilized. To ensure good quality of the media, cell culture media 
were not stored for longer than 4 weeks after preparation. 
 
7.4.1. OP9 cell culture 
OP9 cells were cultured as described previously (Kodama et al., 1994). OP9 cells were 
kept in medium containing 20% of pre-tested FCS (cat no P30-3302, PAN Biotech GmbH, 
Aidenbach, Germany) in  α-minimal essential medium (α-MEM). α-MEM was prepared 
from powder (cat no 25080, Gibco/Invitrogen, Karlsruhe, Germany) which was solved in 
a Sodium bicarbonate solution (cat no 11900-016, Gibco/Invitrogen, Karlsruhe, 
Germany) and sterile injection water (cat no 7202A161, Braun, Melsungen, Germany) 
according to  manufacturer’s instructions.  
As OP9 cells easily loose their supportive capacity, their quality was verified continuously 
by their morphology: OP9 cells had to be large flat cells, not fibroblastic or transformed. 
The culture medium was exchanged every two days to remove dead cells and debris. 
OP9 cells were only kept for a maximum of 25 passages and only dissociated and diluted 
when 100% confluent as otherwise cells lost their supportive properties. In general, OP9 
stroma was diluted every 3 to 4 days 1:4 by washing with PBS, trypsinizing with 0.05% 
Trypsin/EDTA (cat no 25300-054, Gibco/Invitrogen, Karlsruhe, Germany) for 2 min at 
37°C. Dissociated OP9 cells were re-suspended in culture medium and mixed gently to 
obtain a homogenous cell solution which was diluted with medium, seeded onto fresh 
tissue culture dishes and moved carefully to ensure equal distribution of cells on the 
culture plate.  
 
7.4.2. Embryonic stem cell maintenance culture 
ESCs were maintained as described by Schroeder and co-workers (Schroeder et al., 
2006). All ESCs were kept on gelatine coated dishes. 0.01% powdered gelatine (cat no 
G1890, Sigma, Taufkirchen, Germany) in bi-distilled was prepared and autoclaved to 
ensure sterility and homogeneity of the solution. Coating was performed by incubating 
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sterile gelatine solution in tissue culture plates for 15 min at RT. Afterwards, the 
supernatant was discarded. 
In this study EB3 and EB5 (both different monoclonal ESC-lines derived from E14tg2a 
with one allele of Oct3/4 inactivated by targeted integration of the gene encoding the 
blasticidin resistance) ES cells, both kind gifts from Dr. Niwa (Niwa et al., 2000), were 
used because both showed good hematopoietic differentiation in comparison to other 
ESC lines (data not shown). EB3 and its transgenic offspring were cultured in 10% pre-
tested FCS (cat no 2602P250915, PAN Biotech GmbH, Aidenbach, Germany), 1 mM Na-
Pyruvate (cat no S8636, Sigma, Taufkirchen, Germany), 0.1 nM MEM nonessential 
aminoacids (cat no 11140035, Gibco/Invitrogen, Karsruhe, Germany), 10-4 M 2-
mercaptoethanol (cat no 31350010, Gibco/Invitrogen, Karsruhe, Germany), 3 µl LIF 
solution per 1 ml medium (self-prepared and tested, see below) and Glasgow minimal 
essential medium (GMEM; cat no 21710-082, Gibco/Invirogen, Karlsruhe, Germany). EB5 
and EB5-derived transgenic ESCs (VE-Cadherin::VENUSClaudin5; Guo et al., 2006) were 
cultured in 10% knockout serum replacement (KSR; cat no 10828-028, Gibco/Invitrogen; 
Karlsruhe, Germany), 1% FCS; Na-Pyruvate, nonessential aminoacids, 2-
mercaptoethanol and LIF in GMEM.  
If cells are kept too dense, ESCs spontaneously differentiated, even in the presence of 
LIF. Undifferentiated ESCs grow clonally and form densely packed cell clusters whereas 
differentiated ESCs loose the contact to each other and rather grow disperse. Thus, the 
cultures were checked every 1 to 2 days microscopically and controlled in regard to their 
density. Usually, cultures were separated every Monday, Wednesday and Friday 1:10 by 
washing with PBS and trypsinizing with 0.05% Trypsin/EDTA (cat no 25300-054, 
Gibco/Invitrogen, Karlsruhe, Germany). To maintain undifferentiated ESCs, cells were 
trypsinized very gently for 2 min at RT and re-suspended in culture medium as soon as 
the cells were observed to come off the culture plate. Afterwards cells were plated on 
cell culture dishes coated with gelatine beforehand. 
 
7.4.3. Mesodermal differentiation of embryonic stem cells on OP9 
The mesodermal differentiation of ESCs on OP9 was carried out as described by Fraser 
et al. (Fraser et al., 2002a). 
To induce their differentiation, undifferentiated ESCs of passage number lower than 20 
were trypinized as usual  and re-suspended in ESC-differentiating medium containing 
10% pre-tested FCS (cat no P30-3302, PAN Biotech GmbH, Aidenbach, Germany), 5x10-5 
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M 2-mercaptoethanol (cat no 31350010, Gibco/Invitrogen, Karlsruhe, Germany) and α-
MEM (cat no 11900-016, Gibco/Invitrogen, Karlsruhe, Germany). For a good mesodermal 
differentiation process the medium was always prepared immediately before starting the 
differentiation. Care was taken especially of the 2-mercaptoethanol, as this agent can 
µonly support the differentiation if not too old. Thus, the 2-mercapoethanol solution 
should not be used for longer than 6 weeks after opening. After re-suspension, ESCs 
were counted in a Neubauer counting chamber and 80.000 cells were re-suspended in 
differentiation medium and carefully seeded per 60 cm2 dish containing confluent OP9 
stroma cells of a passage number lower than 25. ESCs differentiated to mesoderm within 
4 days of culture without washing or changing the media (Nakano et al., 1994). To 
induce endothelial or hematopoietic differentiation cells were re-plated on a new layer of 
OP9 cells grown confluent at day 4 of differentiation. Either, ESC-derived cells and OP9 
cells contained in the culture were directly transferred in a ratio of about 1:100 to a 
fresh confluent OP9 layer by trypsinizing the culture with 0.05% Trypsin/EDTA. After 
incubating for 2 min at 37°C, the reaction was stopped with differentiating medium, cells 
were re-suspended carefully and diluted to the amount needed with differentiating 
medium. Alternatively, the culture was FACS sorted (see below) at day 4 of 
differentiation to enrich for mesodermal cells. After dilution or purification of the culture, 
ESC-derived cells were plated onto fresh OP9 and cultured in ESC-differentiation medium 
supplemented with 100 ng/ml stem cell factor (SCF, PeproTech, Rocky Hill, USA, cat no 
250-03) for the desired length. 
 
7.4.4. Freezing and thawing of cells 
To store ESCs and OP9 cells, cells were first frozen in dimethylsulfoxide (DMSO) -
containing culture medium. After trypsinization, cells were re-suspended in normal 
culture medium and sedimented by centrifugation. The pellet was solved in culture 
medium containing 10% DMSO (cat no D2438, Sigma, Taufkirchen, Germany) and 
transferred to cryotubes and frozen in Cryo Freezing containers (cat no 5100-0001, 
Nalgene, Rochester, USA) at -80 °C. After one day, cells were transferred into the 
nitrogen tank. In the nitrogen tank, all cells were stored in the gas phase. 
For thawing ESCs or OP9 cells were removed from the nitrogen tank and the lid of the 
cryotube was slightly opened to permit gas pressure release upon warming up. Cells 
were kept in a 37 °C water bath for the time the cells needed to defrost completely. 
After transferring them carefully into a Falcon tube, 9 ml preheated culture medium was 
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slowly (the suspension was dropped onto the cells within 10 min). To allow the solving 
of DMSO from the cells, the suspension was incubated for 10 min at RT before 
centrifuging it. The pellet was re-suspended carefully in preheated medium and cells 
were transferred into cell culture dishes and incubated. Approximately 5 x 105 frozen ES 
cells were transferred into a 10 cm2 dish and approximately 4 x 105 frozen OP9 cells 
were plated in a 25 cm2 dish after thawing.  
 
7.4.5. Transfections 
7.4.5.1. Transient transfections 
All transient transfections were carried out using Lipofectamin2000 (cat no 11668-019, 
Gibco/Invitrogen, Karlsruhe, Germany) and Opti-MEM (cat no 51985, Gibco/Invitrogen, 
Karsruhe, Germany). 
 
7.4.5.1.1. Embryonic stem cells 
For transient transfection, ESCs were cultured to approx. 30% confluence in a 96-well-
tissue culture plate. 0.16 to 0.2 µg DNA were prepared for each well of a 96 well plate 
and mixed with Opti-MEM to a volume of 50 µl. Separately, 5 µl Lipofectamin2000 (1 
mg/ml) per each µg DNA was mixed with Opti-MEM to 50 µl volume. DNA and 
Lipofectamin2000 were pooled, vortexed and incubated for 20 min at RT. The 
supernatant of the ESCs was removed and cells were washed twice with Opti-MEM 
before incubating them with 100 µl Lipofectamin-DNA-mix per well for 4 h at 37ºC. 
Afterwards the medium was replaced by ESC maintenance medium. The analysis was 
carried out 24 to 48 h after transfection. 
 
7.4.5.1.2. HEK 293T cells 
To check the fluorescence signal produced from ubiquitously expressed plasmid DNA, 
HEK cells were transfected. Cells were prepared in a 10 cm2 dish to be approx. 30% 
confluent at the day of transfection. For transfection 10 µl Lipofectamin2000 were mixed 
with 90 µl Opti-MEM and incubated 15 min at RT. 2 µg of DNA was added and vortexed 
well. After incubating another 15 min at RT the culture medium was removed and 
replace with new the Lipofectamin2000-DNA medium. Cells were growing in the 
Lipofectamin-DNA-containing medium for at least 24 h before analysis. 
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7.4.5.1.3. OP9 cells 
To check specific localization of ubiquitously expressed tagged fluorescent proteins, OP9 
cells were transiently transfected. 30% confluent OP9 grown in a 6-well dish were 
transfected as follows: 15 µl Lipofectamin2000 were mixed with 85 µl opti-MEM. 
Separately, 2 µg DNA were mixed with Opti-MEM to a final volume of 100 µl. Both were 
incubated for 20 min at RT, mixed and incubated for another 20 min at RT. Afterwards, 
the medium of OP9 cells was removed, replaced with the lipofectamin-DNA mixture and 
incubated for 2 days before analysis. 
 
7.4.5.2. Stable transfections 
7.4.5.2.1. Stable transfection of embryonic stem cells 
For stable transfection a 60cm2 dish containing confluent grown ESCs with a low passage 
number (maximum 3 passages after thawing) was prepared. Cells were trypsinized for 2 
min at RT using 0.05 % Trypsin/EDTA (cat no 25300-054, Gibco/Invitrogen, Karlsruhe, 
Germany). The reaction was stopped by adding ESC maintenance medium and cells were 
centrifuged, washed with PBS, counted and sedimented again. The pellet was solved in 
pre-cooled PBS to a concentration of 107 cells per ml. 400 µl cell suspension was pored 
into a cuvette (4mm diameter; cat no 1652088, BioRad, Munich, Germany) and mixed 
gently with 40 µg DNA solved in sterile water (see above). After incubating 10 min on 
ice, the electroporation was performed with 240 V, capacitance of 700 µF, resistance of 
300 Ω using a GenePulser II (BioRad, Munich, Germany). As a selection control, mock 
transfected cells were treated equally. Electroporated cells were transferred into 8 ml 
preheated differentiation medium immediately, transferred into gelatine-coated 60 cm2 
dishes and incubated over night. The following day, the medium, dead cells and debris 
was removed by washing once with PBS. Afterwards cells were cultured for another 
week in maintenance medium containing a selecting agent, e.g. puromycin 
dihydrochloride (cat no 0240.3, Roth, Karlsruhe, Germany) at a concentration of 1 
µg/ml, or geniticin (G418, cat no 10131-019, Gibco/Invitrogen, Karlsruhe, Germany) at a 
concentration of 200 µg/ml. Selection was carried out up to 10 days before monoclonal 
ESCs were picked or all cells were pooled to obtain a polyclonal ESC line. 
 
7.4.5.2.2. Stable transfection by co-transfection of plasmids 
Large plasmids containing no selection cassette (pVE-mitoVENUS-IE) (Hisatsune et al., 
2005) were stably brought into ESCs by co-transfection similarly as described previously 
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(Kitajima et al., 2002). 2x106 undifferentiated ESCs of low passage number were 
transfected with either 4 µg of a VENUS-expressing plasmid (pUC19xIRES-VENUS) or 50 
µg linearized plasmid pVE-mitoVENUS-IE, respectively, each with 3.15 µg plasmid 
encoding geneticin resistance (pCAG-IRES-neo) (= 1/5 molar of the target plasmid). As a 
selection control mock transfected cells were treated equally. The electroporation was 
carried out as described earlier using a GenePulserII (BioRad, Munich, Germany) 
programmed to 240V, 300 µF and ∞ Ω (see stable transfection of ESCs). The following 
day selection with 200 µg/ml geneticin (G418, cat no 10131-019, Gibco/Invitrogen, 
Karlsruhe, Germany) was started and performed for up to 10 days before monoclonal 
ESC colonies were picked and expanded. 
 
7.5. Primary cell culture 
7.5.1. Mouse lines 
For the isolation of mesodermal cells from mouse embryos CD-1 wild-type mice were 
mated over night and checked for vaginal plugs before noon on the following day. 
Females which showed vaginal plugs were taken as 0.5 dpc. 
 
7.5.2. Preparation of single cell suspensions from E7.5 to E9.5 dpc embryos 
Staging and dissection of embryos was performed as described previously (Fraser et al., 
2002b). Pregnant mice carrying E7.5 dpc, E8.5 dpc or E9.5 dpc embryos were sacrificed 
immediately before dissection. Uteri were uncovered and the uterus tissue was cut 
between each embryo without complete separation thereby facilitating the following 
dissection. Uteri were removed from the pregnant mice and washed in PBS. Importantly, 
all uteri, embryos and primary cells were kept in PBS on ice during the isolation if not 
indicated differently. Embryo-containing deciduae were released from the uterus tissue. 
The deciduae were opened one after another with forceps and whole embryos were 
removed carefully from residual decidua tissue (it is possible to first isolate all embryo 
containing deciduae before isolating the embryo proper; alternatively, deciduae can be 
dissected immediately). All extraembryonic tissue and embryo proper was used for cell 
preparation from E7.5 and E8.5 embryos. E9.5 embryos were dissected into yolk sac and 
AGM regions further on. The AGM region was extracted by cutting posterior of the heart 
and anterior of the vitelline and umbilical arteries. All embryos were collected in 10 ml 
4°C cold PBS and stored on ice. Storing dissected embryos for longer then 2 h in PBS on 
ice is not recommended as cell death increases quickly. Thus, all dissections were carried 
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out as fast as possible. Nor more than embryos of 8 pregnant mice should be dissected 
by one person, otherwise the dissection will take too long.  
After preparing all embryos, they were centrifuged at 300 G for 5 min and gently re-
suspended in 1ml 0.05% preheated Trypsin/EDTA (cat no 25300-054, Gibco/ Invitrogen, 
Karlsruhe, Germany). It is of major importance that 0.05% Trypsin/EDTA instead 0.25% 
Trypsin/EDTA is used as the reaction is too strong with Trypsin/EDTA of a high 
concentration. According to the size of the embryos, the mixture was incubated for 7 min 
(E7.5) to 10 min (E9.5 AGMs) at 37 °C and shaken carefully to obtain a single cell 
solution. Embryos should not be incubated for longer even if not all tissue is solved yet 
as this kills the cells. Instead, the mixture eventually containing tissue residues will solve 
completely within the next step. The trypsinization was stopped by adding 9 ml sterile 
stop-solution containing 0.05 mg/ml DNAseI (cat no 11284932001, Roche, Penzberg, 
Germany), 0.1% 1M CaCl2 x 2H2O (cat no C7902, Sigma, Taufkirchen, Germany), 20% 
FCS in Hank’s buffered salt solution (HBSS, 10x HBSS diluted with injection water; cat no 
14185, Gibco/Invitrogen, Karlsruhe, Germany) at RT using a 2 ml pipette. The cells 
should be treated very gently avoiding heavy shaking to ensure viability of cells. Then, 
cells were sedimented as before, re-suspended in ESC differentiating medium and 
incubated in a 15 ml Falcon tube with slightly open lid for 1h in the tissue culture 
incubator (37 °C; 5% CO2) to allow the cells to recover. Cells were centrifuged, washed 
with PBS, re-suspended in 4 to 8 ml (according to the size of the pellet) PBS and 
counted. From 1 pregnant mouse carrying E7.5 and E8.5 embryos on average 1.9 x 105 
and 1.2 x 106 living cells were extracted, respectively. The AGM regions of all E9.5 
embryos of one pregnant mouse contained on average 1.3 x 106, the yolk sacs 8 x 105 
cells. All sedimented cells were re-suspended in 100 µl pure FCS and immunostaining for 
FACS was performed. 
 
7.6. Protein detection 
7.6.1. Flow cytometry (FACS) 
7.6.1.1. Detection of fluorescent markers by flow cytometry 
All cells were prepared in FACS buffer containing 20% FCS, propidium iodide (PI, P4170, 
Sigma, Taufkirchen, Germany) and PBS and filtered through a cell strainer (cat no 
352235, BD Falcon, Franklin Lakes, USA) before analysis. 
For analyzing samples by flow cytometry, a FACSCalibur System (Becton Dickinson, San 
Jose, USA) equipped with 488 nm and 635 nm lasers was used. FITC, Dylight488 and 
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VENUS signals were detected using the filter 530/30, PE and tdTOMATO signals were 
analysed with the 585/42 filter, PI was detected with the filter 630 LP and APC and 
Alexa647 signals were detected with the filter 661/16. 
For cell sorting a FACSAria cell sorter (Becton Dickinson, San Jose, USA) was used. 
VENUS, FITC and Dylight488 signals were analyzed using the 488 nm laser and the 
emission filter 530/30. PE or DiI-Ac-LDL were excited with the 488 nm laser and 
detected using the emission filter 575/26. PE-Cy7 signals were evaluated using the 488 
nm laser and the 780/60 emission filter. APC and Alexa647 were illuminated with the 633 
nm laser and detected in the 660/20 emission filter. PI was excited using the 407 nm 
laser and detected using the 585/42 emission filter. Sorting was performed with a 
maximal flow rate of 4 at a high precision mode (0/16/0). All sorted cells were re-
analysed to ensure a pure population of sorted cells. 
Data were analysed with FACSDiVa (Becton Dickinson, San Jose, USA), CELLQuest Pro 
(Becton Dickinson, San Jose, USA) and WinMDI 2.8 (www.facs.scribbs.edu) softwares. 
 
7.6.1.2. Purification of mesodermal cells by flow cytometry 
7.6.1.2.1. Purification of  embryonic stem cell-derived mesodermal cells 
After 4 days of differentiation culture, ESC-derived cells were washed once with PBS and 
solved with 1 ml Hank’s enzyme free dissociation buffer (cat no 13150-016, 
Gibco/Invitrogen, Karlsruhe, Germany) per 60 cm2 of culture for 20-40 min at 37 °C 
(Trypsin/EDTA cannot be used here to dissociate the cells as the destruction of epitopes 
by Trypsin/EDTA prevents antibody binding). The reaction should not be carried out for 
longer as cells will die due to the dissociation. As the OP9 differentiation culture was very 
dense, cells attached strongly to one another. Even 40 min of incubation with Hank’s 
enzyme free dissociation buffer did not completely dissociate the culture, but a single cell 
suspension can be obtained by washing with PBS: 9 ml of PBS was added and mixed to 
obtain a single cell solution. Cells were sedimented, washed once and counted before re-
suspending the pellet in 100 µl pure FCS. Antibody staining was performed in FCS using 
Alexa647 labelled anti-E-Cadherin (clone ECCD2, a kind gift from Shin-Ichi Nishikawa, 
self-labelled with Alexa647 as described below) and biotinylated-anti-Flk1 (clone 
AVAS12a, cat no 13-5821-82, eBioscience, San Diego, USA) antibodies for 20 min at 4 
°C. After washing with PBS staining with Streptavidin labelled with PE or PE-Cy7 (cat no 
12-4317-87 and cat no 25-4317-82, respectively, eBioscience, San Diego, USA) in FCS 
was performed for another 15 min at 4 °C. After washing with PBS, the pellet was solved 
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in FACS buffer containing 20% FCS and PI (cat no P4170, Sigma, Germany) in PBS at a 
final concentration of 107 cells per ml. Living (PI-) Flk1+E-Cadherin- cells of the right size 
and granularity were sorted into ESC-differentiation medium. 
 
7.6.1.2.2. Purification of primary mesodermal cells 
Immunostaining of primary embryonic cells was carried out using an Alexa647 or 
Dylight488 labelled anti-VE-Cadherin (clone VECD1, a kind gift from Shin-Ichi Nishikawa) 
(Shirayoshi et al., 1986), a biotinylated-anti-Flk1 (clone AVAS12a, cat no 13-5821-82, 
eBioscience, San Diego, USA) and a PE- or FITC-labelled anti-CD41 (clone MWReg30, cat 
no 558040 and cat no 553848, respectively, Pharmingen, Heidelberg, Germany) 
antibody. After staining for 20 minutes at 4 °C, cells were washed and stained with PE or 
PE-Cy7-labelled Streptavidin (cat no 12-4317-87 and cat no 25-4317-82, respectively, 
eBioscience, San Diego, USA) in FCS and incubated for another 15 min at 4 °C. After 
washing cells were re-suspended in FACS buffer containing 20% FCS, PI and PBS and 
FACS sorting was performed. Living (PI-) cells of the right size and granularity were 
gated. CD41-Flk1+VE-Cadherin, CD41-Flk1+VE-Cadherin+ and CD41+ cells were sorted 
into ESC-differentiation medium enriched with 5% CO2 beforehand. Sorted cells were 
counted: From one pregnant mouse carrying E7.5 embryos on average 2500 CD41-
Flk1+VE-Cadherin-, 350 CD41-Flk1+VE-Cadherin+ and 50 CD41+ living cells were purified. 
25.000 cells were seeded on 12.5 cm2 confluent OP9 in ESC differentiation medium 
containing 100 ng/ml stem cell factor (SCF, PeproTech, Rocky Hill, USA, cat no 250-03) 
and incubated for 1h at 37 °C and 5% CO2 before starting the time lapse experiment. 
 
7.6.2. Immunhistochemistry of fixed cultures 
The detection of smooth muscle cells in ESC-differentiation cultures was performed as 
described previously (Schroeder et al., 2003). In detail, the supernatant of the culture 
was removed and cells were washed once with PBS shortly. Cells were fixed for 3 min in 
Methanol (cat no 1.06007.2500, Merck, Darmstadt, Germany) containing 5% DMSO (cat 
no D2438, Sigma, Taufkirchen, Germany) on ice. The specimen was washed three times 
3 min with Methanol on ice and air dried. Blocking was performed in a 5% BSA (cat no 
A9418, Sigma, Taufkirchen, Germany) solution prepared in water for 2 h at RT by 
shaking gently. Smooth muscle cells were stained at 4 °C over night with an anti-α-
smooth muscle actin antibody (cat no C6198, Sigma, Taufkirchen, Germany) diluted 
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1:400 in blocking solution. Unbound antibody was removed by washing twice 5 min with 
PBS. The specimen was kept in PBS at 4 °C until analyzed by microscopy. 
 
7.6.3. In culture immunostaining 
For the detection of surface markers in the living culture antibodies directly labelled with 
a fluorescent dye were added to the culture. Table 7.1 lists the antibodies successfully 
used and their final concentration in the culture medium. PE-anti-Ter119 (cat no 553673, 
Pharmingen) antibody was also tested, but no specific staining was observed in ESC-
differentiation cultures although erythrocytes are known to be present (Nakano et al., 
1996). This means that the anti-Ter119 antibody cannot be used in in culture 
immunostainings.  
 
Table 7.1: Antibodies and their fluorescent conjugates that were used for immunostaining 
in the living culture.  
Antibody Fluorescent 
dyes 
Clone Company Cat no Concentration 
in culture 
anti-CD45 PE 30-F11 eBioscience 553081 20 ng/ml 
anti-CD45 APC 30-F11 eBioscience 17-0451-82 20 ng/ml 
anti-CD41 PE MWReg30 Pharmingen 558040 20 ng/ml 
anti-CD41 FITC MWReg30 Pharmingen 553848 20 ng/ml 
anti-Mac1 PE M1/70 eBioscience 12-0112-081 20 ng/ml 
anti-Tie2 PE TEK4, CD202 eBioscience 12-5987-81 20 ng/ml 
anti-c-kit APC 2B8 eBioscience 17-1171-81 100 ng/ml 
anti-CD31 FITC MEC13.3 Pharmingen 553372 20 ng/ml 
 
 
 
7.6.4. Staining of living endothelial cells by DiI-Ac-LDL 
In ESC differentiations, 50 ng/ml 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine 
perchlorate acetylated low density lipoprotein (DiI-Ac-LDL, cat no BT-902, Biomedical 
Technologies, Stoughton, USA) were added to the living culture beginning day 4 of ESC 
differentiation. In primary cell cultures, 100 ng/ml DiI-Ac-LDL was added immediately 
before plating FACS purified cells. 
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7.6.5. Labelling of antibodies 
The labelling of E-Cadherin (Clone ECCD2) and VE-Cadherin (Clone VECD1) (Shirayoshi 
et al., 1986) antibodies, both kind gifts from Dr. Shin-Ichi Nishikawa, was performed 
according to the manufacturer’s instructions.  
Both antibodies were labelled with Alexa647 (cat no A20186, Bioprobes/Invitrogen, 
Karlsruhe, Germany).  
In addition, the VECD1 antibody was labelled with Dylight488 (cat no 46402, Thermo 
Scientific, Rockford, USA). 200 µg VECD1 antibody solved in 34 µl was mixed with 6.22 
µl of Dylight488 solution (2 mg/ml) and gently mixed at RT for 1.5 h in the dark. 
Afterwards, the unbound fluorescent dye was dialysed against PBS for 1.5 days at 4 °C 
using a Slide-A Lyzer Mini Dialysis Unit 10000 Micro (cat no 69574, Pierce Perbio, Bonn 
Germany). To ensure sterility and stability, ad 0.09% NaN3 (cat no S2002, Sigma, 
Karlsruhe, Germany) and ad 5 mg/ml BSA (cat no A9418, Sigma, Taufkirchen, Germany) 
were added to all antibodies and titrated as described below. 
 
7.6.6. Titration of antibodies 
The E-Cadherin antibody was titrated using 0.1, 0.5, 1, 5 and 10 µl labelled antibody per 
106 undifferentiated ESCs that were solved with Hank’s enzyme free dissociation buffer 
(cat no 13150-015, Gibco/Invitrogen, Karlsruhe, Germany) for 30 min at 37 °C before, 
and compared to a previous batch labelled antibody. 
 
The VE-Cadherin antibody was titrated by staining a 7 day-ESC-differentiation culture. 
10.000 undifferentiated ESCs were seeded on a 60 cm2 dish confluent OP9 and 
cultivated in ESC-differentiation medium. After 7 days, cells were solved with 1 ml Hank’s 
enzyme free-dissociation buffer (cat no 13150-015, Gibco/Invitrogen, Karlsruhe, 
Germany) for 30 min at 37 °C, washed with PBS and stained as described below.  
Alternatively, VE-Cadherin antibody was titrated using primary endothelial cells extracted 
from the lungs of adult wild-type mice (Dong et al., 1997). After dissection and washing 
with PBS, the lungs were cut into small pieces of 1-2 mm size using a scalpel before 
digesting them in 10 ml collagenase I (cat no X5D8000, Worthington, Lakewood, USA) 
solved ad 1 mg/ml in PBS to a final activity of 199 U/ml. While incubating for 45 min at 
37 °C, the solution was shaken heavily every few minutes to achieve a single cell 
solution. The solution was filtered through a cell strainer (pore size 70 µm; cat no 
352350, BD Falcon, Franklin Lakes, USA) to remove tissue residues. Cells were 
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centrifuged for 10 min at 370 RCF. The pellet was washed with FACS buffer (20% FCS in 
PBS), counted and centrifuged for 5 min at RCF 370 before solving cells in FCS and 
staining for FACS.  
The antibody staining was performed for 20 min at 4 °C at the concentrations 0.1, 0.5, 
1, 5 and 10 µl per 106 cells in FCS. As a positive control pre-tested antibody, as negative 
control unstained sample were used, respectively. After washing, cells were solved in 
20% FCS in PBS and propidium iodide and living (PI-) cells of the right size were 
analyzed by FACS in respect to ratio of labelled cells and signal intensity. The antibody 
concentration was selected to be suitable that brightly and specifically labelled all 
endothelial cells compared to the control antibody. 
 
7.7. Time lapse microscopy 
7.7.1. Preparation of specimen 
Initial experiments confirmed that cultures behave normal without feeding and constant 
gas exchange (up to 7 days tested) if the medium and the air inside the culture dish is 
saturated with 5% CO2 and gas exchange is prevented. Thus, purified cells to be 
recorded by time lapse analysis were plated in medium already saturated with 5% CO2. 
According to the following formula the time needed for enrichment of the medium with 
CO2 was calculated: t=H2/D with t being the time [s], H the fill level of the media [cm] 
and D being the diffusion coefficient of 5% CO2 (2.0 x 10-5 cm2) (Dr. Marcus Hauser, 
Universität Magdeburg, personal communication). After plating cells the tissue culture 
dish was kept in the incubator for another hour to allow gas exchange. Then the flask 
was tightly sealed quickly inside the incubator and time-lapse analysis was started. 
 
7.7.2. Acquisition of time lapse images 
Time lapse movies were recorded using a Zeiss inverted fluorescence microscope 
(Axiovert 200 M, Zeiss, Hallbergmoos, Germany), a motorized stage (cat no 0431478, 
Märzhäuser, Wetzlar-Steindorf, Germany) and a PECON heating system to heat a XL 
incubator (Erbach, Germany) at 37 °C. Images were acquired using Aviovision 4.5 
software up-graded with a software developed in our laboratory (Timm Schroeder, 
unpublished). 
Phase contrast images were taken every 4 to 5 min with 5x (cat no 440321-9902-000) or 
10x EC-Plan-Neofluar Ph1 (cat no 440331-9902-000) objectives, a 0.63x or 1x TV-
adaptor using a AxioCam HRm camera at 1388x1040 or 2776x2080 pixel resolution (all 
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Zeiss, Hallbergmoos, Germany). Fluorescence images were acquired in regular intervals 
using a mercury (HBO 103 W/2) or a xenon (XBO 75 W/2 ORF, both Osram, Augsburg, 
Germany) lamp. Illumination to detect nuclear staining was performed every 12 to 15 
min (150 msec excitation using filterset 46, cat no 000000-1196-681, Zeiss, or 46HE, cat 
no 489046-0000-000, Zeiss, for H2BVENUS signals). VE-Cadherin::VENUSClaudin5 
signals (1000 msec using filterset 46HE) and all antibody stainings were detected every 
45 to 60 min. For detecting specific antibody signals filterset 46HE was used for FITC, 
filterset 43 (cat no 000000-1114-101, Zeiss) and filterset 43HE (cat no 489043-0000-
000, Zeiss) was used for PE and filtersets 26 (cat no 488026-0000-000, Zeiss) or 50 (cat 
no 488050-0000-000, Zeiss) were used for APC. All antibody stainings were illuminated 
800-1000 msec. DiI-Ac-LDL staining was detected every 12 to 15 min (150 msec using 
filterset 43 or 43HE). All filtersets were purchased from Zeiss (Hallbergmoos, Germany). 
Images acquired were saved as jpg images compressed to 99% of the original quality. 
 
7.7.3. Data analysis 
Data were analysed using TTT (Timm’s Tracking Tool, unpublished software developed 
in our laboratory) on Siemens Celsius R630 workstations with 4 GB of RAM and SUSE 
Linux operating systems with KDE desktop. Movies were analysed using all individual 
images acquired and by separation of phase contrast and all fluorescent wavelengths 
without further compression to maintain highest image quality. Image contrast was 
manually enhanced for optimal recognition of relevant cellular features separately for 
each wavelength channel. Individual cells were observed and tracked manually 
evaluating every time point. As a example demonstrating the analysis of the data using 
TTT, Supplementary Movie 7.1 is added. Each individual frame acquired is loaded and 
played with very low speed to follow individual cells. 
All relevant properties and behaviour (division, death, position, adherence, fluorescence, 
morphology) of cells of interest were stored and displayed in pedigrees. All cells with 
questionable identity were excluded from relevant analyses. 
 
7.7.4. Image processing 
Movies were converted to greyscale, annotated and assembled to Audio Video Interleave 
(avi)-files using Metamorph Offline 6.1r4. To obtain QuickTime Movie (mov)-files, 
assembly of frames was performed by QuickTime 7.1.6 software. Still images were 
processed on Axiovision 4.5 software. 
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7.8. Statistical analysis 
The statistical significance of differences was determined using the student’s t-test for 
unpaired data. 
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9. Legends to Time lapse Movies 
 
 
A DVD containing all time lapse movies is inserted at the back cover.  
 
Supplementary Movie 5.1 
Time lapse movie corresponding to Figure 5.3 showing that cells with an endothelial 
morphology can generate blood cells. ESCs differentiated on OP9 stroma into 
mesodermal cells which were purified by FACS and re-plated on OP9 before starting the 
acquisition of time lapse images. The arrowheads and arrow inserted in the movies point 
to the cells displayed in Figure 5.3. The mesodermal starting cell (1st pause) founds a 
colony (2nd pause) that adopts an endothelial morphology (3rd pause). With ongoing 
differentiation, some cells detach from the endothelial sheet (4th pause) and turn semi-
adherent (5th pause) before they are released into the supernatant and become 
hematopoietic-looking cells (6th pause).  
Time scale: days – hours:minutes:seconds 
 
Supplementary Movie 5.2 
Time lapse movie corresponding to Figure 5.4 displaying phase contrast images (left 
panel) and H2BVENUS detecting fluorescence images (right panel) that show that cells 
with an endothelial morphology deriving from a monoclonal origin can generate blood 
cells. ESCs differentiated on OP9 stroma into mesoderm which were purified by FACS 
and re-plated on OP9 before starting the acquisition of the time lapse movie. The arrow 
is following the starting cell and one daughter after each cell division until the end of the 
movie. The arrowheads in the pauses depict the cells displayed in Figure 5.4. 1st pause: 
single mesodermal cell starting the colony. 2nd pause: all cells of the colony exhibit a 
clear endothelial morphology. 3rd pause in movie: blood cells detach from the endothelial 
sheet but keep adhering to the endothelial cells. 4th pause: blood cells detach and are 
free-floating.  
Time scale: days – hours:minutes:seconds 
 
Supplementary Movie 5.3 
Time lapse movie corresponding to Figure 5.11: proof of cell identity by molecular and 
functional markers. ESCs differentiated on OP9 stroma into mesoderm which were 
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purified by FACS and re-plated on OP9 before starting the acquisition of the time lapse 
movie. Upper left panel: phase contrast, upper right panel: detection of DiI-Ac-LDL, 
lower left panel: detection of VE-Cadherin::VENUSClaudin5, lower right panel: detection 
of APC-anti-CD45 antibody. The arrow marks the hemogenic endothelial cell and follows 
one daughter after each cell division. During the pauses in the movie, the arrowheads 
point to the cells depicted in Figure 5.11. Fluorescent images were all acquired at distinct 
time points and not at each time point a phase contrast image was taken. A single 
hemogenic endothelial cell expressing VE-Cadherin, forming tight junctions and taking up 
DiI-Ac-LDL is depicted (1st pause). It does not express the hematopoietic marker CD45 
(2nd pause). Blood cells arising from the hemogenic endothelial cell have down-regulated 
the endothelial cell markers VE-Cadherin::VENUSClaudin5 and DiI-Ac-LDL uptake (3rd 
pause) but instead express the hematopoietic cell marker CD45 (4th pause). 
Time scale: days – hours:minutes:seconds 
 
Supplementary Movie 5.4 
Time lapse movie corresponding to Figure 5.13: endothelial colonies of cord-like 
morphology can give rise to blood cells. ESCs differentiated on OP9 stroma into 
mesoderm which were purified by FACS and re-plated on OP9 before starting the 
acquisition of the time lapse movie. Upper left panel: phase contrast, upper right panel: 
detection of APC-anti-CD45 antibody, lower left panel: detection of VE-
Cadherin::VENUSClaudin5, lower right panel: detection of DiI-Ac-LDL. Fluorescent 
images were all acquired at distinct time points and not at each time point a phase 
contrast image was taken. The time lapse movie starts, when the cord-like endothelial 
colony has developed. A colony is shown that displays all molecular and functional 
endothelial characteristics (VE-Cadherin expression, tight junction formation and DiI-Ac-
LDL uptake) but no endothelial sheet morphology (1st pause) or the blood cell marker 
CD45 (2nd pause). With ongoing differentiation, the endothelial colony gives rise to 
suspension cells that have lost the ability to express VE-Cadherin, form tight junction or 
take up DiI-Ac-LDL (3rd pause) but they instead express the hematopoietic antigen CD45 
(4th pause). 
Time scale: days – hours:minutes:seconds 
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Supplementary Movie 5.5 
Time lapse movie analyzed in Figure 5.14: hemogenic endothelial cells express CD41 
antigen. ESCs differentiated on OP9 stroma into mesoderm which were purified by FACS 
and re-plated on OP9 before starting the acquisition of the time lapse movie. Upper left 
panel: phase contrast, upper right panel: detection of VE-Cadherin::VENUSClaudin5, 
lower left panel: detection of PE-anti-CD41 antibody, lower right panel: detection of APC-
anti-CD45 antibody. Fluorescent images were not acquired at each time point a phase 
contrast image was taken. The arrow marks the hemogenic endothelial cell and follows 
one daughter after each cell division as soon as single cells can be recognized in the 
movie. During the pauses in the movies, the arrowheads point to the cells depicted in 
Figure 5.14. The time lapse movie starts, when the endothelial colony has developed. A 
colony is shown that displays the molecular and functional endothelial characteristics VE-
Cadherin expression and tight junction formation but not the hematopoietic markers 
CD41 and CD45. It adopts a sheet-like colony with single endothelial cells up-regulating 
CD41 (1st pause). Cells expressing CD41 become semi-adherent (2nd pause) and finally 
free-floating. These cells do not express VE-Cadherin::VENUSClaudin5 anymore but the 
blood cell markers CD41 and CD45 (3rd pause). 
Time scale: days – hours:minutes:seconds 
 
Supplementary Movie 5.6 
Time lapse movie corresponding to Figure 5.15 showing that hemogenic endothelial cells 
express Tie2 and c-kit antigens. ESCs differentiated on OP9 stroma into mesoderm which 
were purified by FACS and re-plated on OP9 before starting the acquisition of the time 
lapse movie. Left panel: phase contrast, middle panel: detection of PE-anti-Tie2 
antibody, right panel: detection of APC-anti-c-kit antibody. Fluorescent images were not 
acquired at each time point a phase contrast image was taken. The movie shown is 
moving slightly as the specimen weakly changed position during the acquisition of the 
movie. The arrow marks the founder cell and follows one daughter after each cell 
division as soon as single cells can be recognized in the movie. During the pauses in the 
movies, the arrowheads point to the cells depicted in Figure 5.15. A mesodermal founder 
cell is shown that differentiates into an endothelial colony expressing Tie2 and displaying 
sheet morphology (1st pause). Tie2+c-kit+ turn semi-adherent (2nd pause). After complete 
detachment, some of them have down-regulated Tie2 but still express c-kit (3rd pause). 
Time scale: days – hours:minutes:seconds 
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Supplementary Movie 5.7 
Time lapse movie corresponding to Figure 5.16 showing that hemogenic endothelial cells 
can give rise to Mac1+ blood cells. ESCs differentiated on OP9 stroma into mesoderm 
which were purified by FACS and re-plated on OP9 before starting the acquisition of the 
time lapse movie. Upper left panel: phase contrast, upper right panel: detection of FITC-
anti-CD41, lower left panel: detection of APC-anti-CD45 antibody, lower right panel: 
detection of PE-anti-Mac1 antibody. Fluorescent images were not acquired at each time 
point a phase contrast image was taken. The arrow marks the hemogenic endothelial cell 
and follows one daughter after each cell division. During the pauses in the movies, the 
arrowheads point to the cells depicted in Figure 5.16. An endothelial sheet colony is 
shown. The semi-adherent hemogenic endothelial cell expresses CD41 (1st pause). With 
ongoing differentiation, its daughter up-regulates Mac1 antigen on its surface (2nd 
pause). Slightly later, it has down-regulated CD41, but expresses Mac1 and CD45 (3rd 
pause). 
Time scale: days – hours:minutes:seconds 
 
Supplementary Movie 5.8 
Time lapse movie corresponding to Figure 5.18: generation of hemogenic endothelial 
cells from mesodermal cells purified from E7.5 dpc mouse embryos. Mesodemal cells 
were purified from E7.5 dpc embryos and plated in OP9 stroma before time lapse 
imaging was started. Left panel: phase contrast, middle panel: detection of DiI-Ac-LDL 
uptake, right panel: detection of FITC-anit-CD41 antibody. Fluorescent images were all 
acquired at distinct time points and not at each time point a phase contrast image was 
taken. The arrow marks the hemogenic endothelial cell and follows one daughter after 
each cell division as soon as single cells can be recognized in the movie. The arrowheads 
point to cells depicted in Figure 5.18. At the start of the movie one single mesodermal 
cell is shown that gives rise to an endothelial sheet colony, that expresses DiI-Ac-LDL 
and partly CD41 (pause in movie). CD41+ cells detach from the endothelial sheet, down-
regulate DiI-Ac-LDL uptake and strongly increase the expression of CD41 antigen. 
Time scale: days – hours:minutes:seconds 
 
Supplementary Movie 5.9 
Time lapse movie corresponding to Figure 5.21 showing undifferentiated ESCs that 
express VENUSnucmem after induction by activation of Cre recombinase with tamoxifen. 
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Upon plating ESCs in the presence of tamoxifen, the time lapse movie was started. Left 
panel: phase contrast images; middle panel: VENUSnucmem detecting fluorescence 
images; right panel: overlay of phase contrast and fluorescent images detecting 
VENUSnucmem. Undifferentiated ESCs form a colony and start the up-regulation of 
VENUSnucmem approx. 12 h after start of the movie. Individual cells forming the colony 
do not express VENUSnucmem equally as visible by the fluorescence intensity of single 
nuclei.  
Time scale: days – hours:minutes:seconds 
 
Supplementary Movie 7.1 
This time lapse movie covering a period of about 5 hours demonstrates the temporal and 
optical resolution of the primary image sequence used for cell tracking. All frames 
acquired in 5 hours are used for the compilation of the movie. Upper left panel: phase 
contrast, upper right panel: detection of fluorescent H2BVENUS, lower left panel: phase 
contrast including the tracks for single cell tracking, lower right panel: overlay of phase 
contrast and fluorescent H2BVENUS images. 
Time scale: days – hours:minutes:seconds 
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10. Abbreviations 
 
 
°C degree Celsius 
µ micro 
AGM aorta-gonads-mesonephros 
AML acute myeloid leukaemia 
amp ampicillin 
APC allophycocyanine 
approx approximately 
BC blood cell 
bFGF bovine fibroblast growth factor 
BMP4 bone morphogenic protein 4 
bp base pair 
BSA bovine serum albumin 
CAG chicken beta actin 
cat no catalogue number 
Clnd5 claudin5 
CMV cytomegalovirus 
d day 
D diffusion coefficient 
DiI  1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate 
DiI-Ac-LDL 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate 
acetylated low density lipoprotein 
DNA deoxyribonucleic acid 
DMSO dimethyl-sulfoxide 
dpc days post coitum 
E embryonic day 
EC endothelial cell 
E-Cadherin epithelial Cadherin 
EDTA ethylene-diamin-tetraacetic acid 
e.g. example given 
Ep embryo proper 
ES  embryonic stem   
ESC embryonic stem cell 
EtOH Ethanol 
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F  Farad 
FACS fluorescence activated cell sorting 
FCS foetal calf serum 
Fig figure 
FITC fluoresceinisothiocyanate 
Flk1 foetal liver kinase 1 
Flt fms-related tyrosine kinase 
FLP FLP recombinase 
FLPe enhanced FLP recombinase 
FSC forward scatter 
g gram 
G418 geniticin  
GB giga byte 
G-CSF granulocyte colony stimulating factor 
h  hour 
H hight 
H2B histone 2B 
HBSS Hank's buffered saline solution 
HSC hematopoietic stem cell 
hsp heat shock protein 
kDa kilo Dalton 
IFN interferon 
IL interleukin  
IPTG isopropyl- β-D-thiogalactopyranoside 
IRES internal ribosomal entry site 
L litre 
LB LB broth base 
LIF leukaemia inhibitory factor 
LTR-HSC long-term repopulating hematopoietic stem cells 
M molar 
m milli 
M-CSF macrophage colony stimulating factor 
MEM minimal essential medium 
min minutes 
n nano 
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neo neomycin (geniticin) 
nucmem nuclear membrane 
OHT 4-hydroxy-tamoxifen 
PAGE polyacrylamide gelelectrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PE phycoerythrine 
PI propidium iodide 
P-Sp para-aortic splanchnopleura 
puro puromycin 
RCF radial central force 
rpm rounds per minute 
RT room temperature 
Sca-1 stem cell antigen 1 
SCF stem cell factor 
SCL stem cell leukaemia 
SDS sodium dodecyl sulfate 
sec seconds 
SMA smooth muscle actin 
SSC side scatter 
TAE Tris acetate EDTA 
tal1 T cell acute leukaemia 
TBD tamoxifen binding domain 
TTT Timm's Tracking Tool 
V Volt 
VE-Cad  vascular endothelial cadherin 
VE-Cadherin vascular endothelial cadherin 
VEGF vascular endothelial growth factor 
VEGFR vascular endothelial growth factor receptor  
wt wildtype 
YS yolk sac 
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